data_2f3w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f3w _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 pttt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.83 0.348 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.3 mt -123.43 119.71 30.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -108.93 121.34 44.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.756 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -79.42 110.93 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.241 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.86 130.59 23.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.566 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.91 120.31 7.93 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.227 1.951 . . . . 0.0 112.544 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.66 107.7 4.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -125.27 141.58 52.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.249 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mp -67.04 144.05 56.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pt -87.21 -28.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -167.91 94.22 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.64 115.5 28.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.354 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mt -80.64 -31.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 68.22 -65.68 0.25 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.16 33.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.689 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -121.44 -77.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -146.13 159.07 43.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.89 148.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.199 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 132.51 41.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -99.14 160.55 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.4 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.797 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -122.63 109.12 13.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.07 29.06 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.75 -4.13 83.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -85.94 127.81 60.69 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.799 0.3 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.69 83.27 2.11 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.563 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.62 111.35 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -86.57 155.01 20.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -123.58 97.5 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 67.51 122.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.77 172.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.66 101.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.971 179.924 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.402 ' HG3' ' CD1' ' A' ' 108' ' ' LEU . 1.4 mm-40 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -120.26 -53.93 2.12 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -124.72 -25.35 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.18 -107.24 3.31 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.588 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 90.1 Cg_exo -44.93 -28.26 2.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.595 2.197 . . . . 0.0 112.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.47 -70.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.653 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.41 -27.86 17.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.734 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 63' ' ' LYS . 10.4 t -70.0 -44.9 68.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.71 97.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.97 -44.26 97.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.113 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 m -76.46 -26.72 55.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 59' ' ' SER . 4.2 mmtp -59.06 -27.87 65.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -91.46 -31.95 15.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.714 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.412 ' HA ' ' CB ' ' A' ' 69' ' ' ALA . 4.7 mmt -62.01 -13.68 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.308 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -117.16 -41.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.715 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -70.33 -67.53 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -45.11 12.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -80.71 60.66 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.81 58.42 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.3 31.66 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.748 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mt -89.31 151.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -146.27 161.79 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 76' ' ' PHE . 4.9 m -96.01 109.64 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -101.4 72.52 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 74' ' ' VAL . 20.9 p90 -177.38 118.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -114.03 30.32 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -59.15 -29.96 67.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.39 -33.67 5.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.14 126.04 30.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.2 -23.73 12.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 83' ' ' ASP . 1.3 t -140.18 133.56 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 82' ' ' THR . 6.5 t0 174.8 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.454 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -80.2 -66.97 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 88' ' ' GLY . 23.4 t80 -118.79 -10.69 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.377 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 102.35 40.6 2.55 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.132 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 4.0 ttp180 89.6 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 110.636 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 85' ' ' TYR . . . -103.0 -13.17 29.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.666 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.78 116.83 31.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.19 130.73 22.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' HB2' ' CD1' ' A' ' 76' ' ' PHE . 47.8 m-85 -61.97 122.0 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.1 pt -118.06 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 81.1 m-85 -121.81 79.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.53 124.47 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.83 47.93 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.629 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.49 21.0 40.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.339 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -146.57 153.92 40.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.068 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 mtm -81.3 148.37 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.19 -32.65 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -65.48 -24.89 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.022 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.16 -18.91 23.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.396 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.73 -84.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.743 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.6 -15.96 13.36 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.435 ' N ' HD11 ' A' ' 103' ' ' LEU . 15.1 t -70.36 -28.53 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -15.78 62.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.062 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.49 10.13 16.21 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.539 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 108' ' ' LEU . . . 97.51 34.58 5.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.622 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 6.2 mt 50.91 108.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 111.45 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 108' ' ' LEU . . . 88.57 -70.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.31 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.169 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mttm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.47 103.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.31 140.58 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 106.86 13.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -130.38 144.02 51.6 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.18 121.61 6.22 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.607 2.204 . . . . 0.0 112.552 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.05 107.62 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.82 163.38 14.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.7 pp -106.06 136.64 45.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.0 mt -74.48 -58.83 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 145.27 14.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.08 150.18 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 2.6 pt -63.11 -14.77 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 59' ' ' SER . 5.3 m-20 82.82 -8.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.2 -38.52 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.06 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 166.66 -18.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.643 0.222 . . . . 0.0 111.475 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 m -96.51 144.27 26.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -138.51 158.05 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.418 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -128.67 105.07 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.635 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -86.94 161.52 18.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.371 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.14 98.09 6.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.838 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -107.82 105.27 15.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 55.18 53.88 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.15 24.23 54.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -128.73 119.0 19.99 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.55 102.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.35 2.033 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.5 ttm -84.28 135.72 34.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 p -86.77 142.12 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.245 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 16.8 t80 -135.68 94.73 3.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.725 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 34.78 74.54 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.936 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mp -98.64 127.0 44.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.2 82.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.733 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.459 ' C ' ' HB1' ' A' ' 109' ' ' ALA . 5.9 mt-10 . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 121.233 0.54 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.453 ' CA ' ' HB2' ' A' ' 109' ' ' ALA . 4.5 pttp -143.84 13.53 1.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.833 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 54' ' ' TYR . 12.7 t80 -126.15 -25.28 3.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.416 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -48.34 174.37 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.156 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.47 2.51 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 113.509 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.61 ' CB ' ' HA ' ' A' ' 109' ' ' ALA . 3.4 mt-10 -96.65 -49.02 5.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.871 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -40.74 -52.39 2.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.948 0.34 . . . . 0.0 111.199 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 57.1 p -61.38 -47.76 84.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.392 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.12 -36.22 28.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.468 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 99' ' ' VAL . 89.0 t80 -51.95 -60.7 2.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.29 -30.98 48.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 1.6 tppp? -61.77 -21.87 64.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.011 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 15.6 ttmt -89.97 -33.48 16.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.509 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 2.2 mtm -58.31 -15.67 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.209 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.9 -41.38 2.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -74.48 -64.88 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 111.49 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.11 -43.56 21.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -70.26 -175.06 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.024 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -129.92 -54.92 1.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.045 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 3.7 mp -143.0 145.22 23.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' N ' HG23 ' A' ' 72' ' ' ILE . 1.8 pt-20 -117.1 164.92 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.2 p -110.94 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.216 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' PHE . 22.3 mt-10 -91.16 128.65 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 75' ' ' GLU . 5.1 p90 48.74 168.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.274 0.559 . . . . 0.0 112.013 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -93.54 -14.15 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.341 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.55 -8.6 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.656 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.54 -77.55 0.25 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -106.34 111.32 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -30.61 8.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.477 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 80.9 p -90.51 -175.71 4.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.4 t0 76.59 -61.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.71 -16.75 63.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -179.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.141 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 109.24 -10.54 33.65 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.348 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 1.1 tpp180 171.96 26.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.191 0.196 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.82 -49.95 4.12 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.906 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.91 109.76 7.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 111.129 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.3 122.51 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.977 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.1 111.97 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.779 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.98 124.72 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.26 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -134.91 88.2 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.72 91.03 5.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.95 51.26 7.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.19 24.8 56.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.246 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 130.39 56.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ttt -104.52 83.87 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 61' ' ' PHE . 6.5 m -68.22 -19.35 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.491 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 1.8 t-20 -56.3 -63.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 111.045 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -18.75 48.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.356 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.55 -46.55 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 tt -111.09 -50.79 2.91 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 59.7 t -58.76 -16.88 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -22.08 18.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.454 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.43 23.17 5.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.555 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 108' ' ' LEU . . . 94.55 -3.03 68.11 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.76 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 1.0 OUTLIER 99.24 22.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.698 0.799 . . . . 0.0 110.98 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . . . -177.73 -165.7 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.697 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.909 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 mttt . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.878 0.371 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -127.32 104.02 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.25 121.86 45.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.912 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -78.0 112.11 14.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.29 137.4 22.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 121.96 9.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.519 2.146 . . . . 0.0 112.351 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.24 107.78 4.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.538 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.04 135.41 54.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -68.18 113.42 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.852 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -31.76 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.39 91.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.545 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.64 106.18 18.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.9 mp -80.38 -53.9 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER 82.34 -19.8 0.39 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.543 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.38 -25.72 65.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.315 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -170.5 -40.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 m -128.27 159.07 36.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.903 0.382 . . . . 0.0 111.276 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.71 145.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -126.1 147.13 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -130.61 156.87 44.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ttp -113.18 97.94 6.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.582 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -103.78 106.16 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.382 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 48.57 36.9 8.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.229 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.05 -21.18 43.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -87.94 125.0 65.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 110.542 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.87 97.36 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.416 2.077 . . . . 0.0 112.462 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.94 129.65 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.4 m -81.2 133.24 35.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 111.294 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -139.24 34.95 2.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.009 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -61.19 127.46 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.57 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tp -134.93 81.69 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.3 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.12 100.1 11.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.339 179.362 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.534 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER . . . . . 0 CA--C 1.52 -0.198 0 CA-C-O 121.281 0.562 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.424 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -24.69 -74.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.873 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -156.03 25.0 0.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.363 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.52 -132.56 2.84 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.148 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.59 -5.34 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.098 1.865 . . . . 0.0 111.133 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 3.5 mm-40 -93.12 -42.34 9.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.817 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 54' ' ' TYR . . . -39.42 -32.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -51.08 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 109.962 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -40.91 -44.1 2.23 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.381 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 3.1 t80 -43.79 -47.45 8.03 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.86 -47.02 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.212 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 67.7 mttt -50.71 -27.64 7.47 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 62.4 mttt -79.15 -32.73 44.43 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.424 ' C ' ' HB1' ' A' ' 69' ' ' ALA . 11.3 mtp -93.16 -0.52 56.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.231 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' THR . 93.2 t -117.69 -41.73 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.669 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.69 -79.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.735 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -57.63 -21.92 42.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.48 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -63.88 178.72 0.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 0.0 111.402 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -69.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.3 133.99 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 3.8 mp -96.06 161.66 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -146.1 139.84 26.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.641 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.74 109.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 3.5 pt-20 -112.31 106.62 15.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.7 p90 175.63 117.89 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.585 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.31 74.39 0.87 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.844 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 -54.98 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.15 -100.71 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.88 121.75 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -89.25 -30.89 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.45 151.1 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.2 -18.87 13.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.02 -78.65 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -108.44 -22.51 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.14 -10.05 70.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -129.93 -24.03 2.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.359 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.93 -78.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.748 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.85 115.09 12.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 0.0 111.069 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.08 158.91 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.051 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.68 142.09 28.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mt -117.05 116.46 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.419 ' C ' HG23 ' A' ' 72' ' ' ILE . 17.1 m-85 -114.61 78.22 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.065 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -78.99 93.25 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 63.99 44.61 4.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.203 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 25.69 58.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.863 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 155.36 44.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.91 0.386 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.0 mtt -120.67 99.16 6.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.79 -8.14 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.609 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.537 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 17.9 p30 -47.82 -30.8 4.32 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -91.2 -18.73 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.811 0.339 . . . . 0.0 111.537 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.98 -69.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -111.37 -32.18 6.81 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 100' ' ' ASN . 5.0 t -59.8 -20.67 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -77.56 -24.37 49.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -61.75 -17.41 55.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.033 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.18 34.5 5.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.425 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -156.52 -115.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.566 ' N ' HD22 ' A' ' 108' ' ' LEU . . . -178.03 16.77 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.233 -0.292 . . . . 0.0 111.706 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.983 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.824 0.345 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.92 154.22 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.0 153.43 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.28 106.81 2.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.67 151.12 46.79 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.235 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.53 120.11 7.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.31 2.006 . . . . 0.0 112.215 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.15 107.83 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.089 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 71' ' ' LYS . 12.2 t -122.05 168.0 12.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.181 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 1.3 mt -78.56 143.96 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.2 mt -75.88 -47.81 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.15 86.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.706 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.14 117.92 13.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.182 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 29.2 mm -60.18 -61.26 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 7.2 p-10 172.43 -137.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.372 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.94 -10.2 58.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.439 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.59 -84.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.786 0.293 . . . . 0.0 111.435 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -125.4 159.12 32.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.366 . . . . 0.0 111.117 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.84 112.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -106.24 145.95 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -110.56 161.19 15.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.098 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 ttt -106.81 104.15 13.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -112.95 91.58 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.97 51.23 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.493 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 23.4 62.17 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.579 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -127.99 114.83 20.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.522 0.201 . . . . 0.0 110.816 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 97.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.443 2.095 . . . . 0.0 112.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.39 144.08 28.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.61 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.51 136.98 32.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.046 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -135.55 107.07 6.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 62.47 157.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.99 8.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 86.03 7.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.776 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.613 0.244 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 110' ' ' LYS . 0.1 OUTLIER 173.11 -8.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 21.9 m-85 -135.79 25.23 3.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.673 0.273 . . . . 0.0 111.016 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.31 -133.15 6.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.97 -1.11 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.3 2.59 4.87 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.107 1.871 . . . . 0.0 111.584 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 8.6 mm-40 -94.92 -64.75 1.03 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.106 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' N ' ' HB3' ' A' ' 109' ' ' ALA . . . -40.25 -33.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.227 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.0 p -79.3 -48.14 14.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.108 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.71 96.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.458 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 30.1 t80 -44.95 -39.42 5.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.456 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -94.15 -29.07 15.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.331 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -26.33 68.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -91.99 -38.3 12.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.987 0.423 . . . . 0.0 110.289 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.493 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -57.43 -17.04 11.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -104.89 -40.5 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -76.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -55.1 -36.28 65.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.381 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -76.17 -170.22 1.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.154 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -71.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER 176.47 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.232 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.2 mt 83.92 146.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 110.948 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' N ' HG21 ' A' ' 72' ' ' ILE . 6.7 pm0 -129.71 147.01 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.068 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 p -97.12 109.64 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.744 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.79 -76.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.255 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 55.0 p90 -85.89 117.67 24.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.17 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.22 24.04 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.969 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -140.44 -55.12 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.44 99.66 0.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.51 157.23 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -96.92 -44.8 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.37 164.09 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -116.88 30.7 7.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.034 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -78.55 -66.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.742 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 93.7 t80 -137.93 11.2 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.35 40.11 97.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.093 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -174.43 -24.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.497 0.189 . . . . 0.0 111.356 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.7 -64.35 3.25 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.26 114.16 26.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 111.048 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.85 146.68 52.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.431 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -83.45 122.58 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.413 HG13 ' CG2' ' A' ' 72' ' ' ILE . 11.2 tt -121.07 110.02 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -129.7 107.6 9.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.954 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -84.74 92.48 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.9 40.06 5.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.16 33.32 69.19 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -103.53 129.93 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.91 84.95 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.75 -7.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.537 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.406 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 3.8 t-20 -56.52 -22.99 36.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -91.03 -18.87 23.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.91 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.871 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.43 -21.18 11.94 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.458 ' CG2' ' CD1' ' A' ' 61' ' ' PHE . 20.1 t -61.93 -23.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 0.0 111.499 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -15.58 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.39 23.14 1.66 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.08 47.18 87.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.685 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 57' ' ' GLU . 5.3 mp -122.83 -44.88 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.816 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB3' ' N ' ' A' ' 58' ' ' ALA . . . -134.33 37.31 3.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 15.2 mtmm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 121.026 0.441 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.21 155.14 19.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.778 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 113.3 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -67.67 106.93 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -96.1 152.08 38.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 119.1 6.07 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.668 1.579 . . . . 0.0 112.286 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.55 107.63 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.362 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 m -123.67 145.86 48.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.34 144.13 25.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.706 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 tp -86.1 -46.27 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.362 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.84 135.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.991 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.21 150.14 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.991 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -55.61 -47.64 78.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.678 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 19.9 t70 169.25 -110.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.809 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.73 -10.47 58.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.748 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -80.27 -90.04 0.06 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 m -97.14 159.09 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.064 0.459 . . . . 0.0 111.671 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.13 108.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.438 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 146.98 27.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.091 0.472 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD12 ' CE2' ' A' ' 34' ' ' PHE . 6.1 mt -124.22 130.92 53.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.681 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.6 tpp -85.45 100.71 12.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 29.8 t80 -126.06 112.47 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 27' ' ' TYR . 10.1 ptpt 47.44 29.05 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.31 -19.79 50.26 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.873 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -86.06 114.97 60.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.34 102.59 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.569 2.179 . . . . 0.0 112.408 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.5 mtt -99.28 127.7 45.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 t -105.55 140.42 38.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CE2' HD12 ' A' ' 25' ' ' LEU . 47.0 p90 -127.17 151.44 48.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 60.49 102.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -135.46 99.65 4.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.561 . . . . 0.0 111.327 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.25 126.88 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.842 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.928 0.394 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HB3' ' N ' ' A' ' 110' ' ' LYS . 4.4 tptt -112.25 -28.51 7.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.645 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -169.61 -26.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -101.04 2.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.29 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 64.5 Cg_exo -40.77 -28.65 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.46 2.107 . . . . 0.0 112.724 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -73.11 -45.38 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.202 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB2' ' N ' ' A' ' 109' ' ' ALA . . . -51.49 -49.07 62.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -64.06 -37.63 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.91 -34.1 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.16 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER -53.54 -44.35 69.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.314 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.409 HG21 ' CZ ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -94.03 -28.39 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.417 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -69.42 -22.11 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 69' ' ' ALA . 6.3 mtpt -84.96 -33.15 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.032 0.444 . . . . 0.0 109.941 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.451 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -58.39 -14.37 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.431 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 67' ' ' GLU . 30.2 m -107.76 -41.68 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.8 mt-10 -95.47 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.39 -28.9 69.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.685 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -86.91 171.65 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.433 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.84 -60.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.71 169.72 24.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.408 HG22 ' C ' ' A' ' 93' ' ' TYR . 3.6 mp -141.51 157.11 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -134.65 171.2 14.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.84 115.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.356 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.7 85.69 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -108.89 130.35 55.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.908 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -63.64 -53.61 48.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.0 -35.83 16.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.64 78.47 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -117.7 110.72 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -28.15 7.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 7.6 p -89.95 -175.79 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 82' ' ' THR . 4.0 m-20 81.09 -57.5 0.28 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -69.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.674 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -153.5 11.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.566 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.45 24.03 71.73 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.221 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 167.99 -24.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.633 0.254 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.39 -39.16 5.5 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.11 109.58 21.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.59 28.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.082 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.424 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -105.28 126.22 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.1 pt -125.72 143.49 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 111.453 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.408 ' C ' HG22 ' A' ' 72' ' ' ILE . 73.3 m-85 -140.24 107.98 5.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.23 107.31 11.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.403 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.78 47.13 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.58 77.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -107.34 119.05 38.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -98.53 83.91 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.754 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.44 -27.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -56.46 -41.75 77.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -86.38 -18.71 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.331 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -24.86 20.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -111.22 -66.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.0 t -52.98 -37.31 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.692 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -15.9 63.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.379 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.58 5.87 26.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.53 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.14 29.08 8.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.529 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 5.6 mt 64.27 107.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.651 0.263 . . . . 0.0 111.112 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 82.41 -117.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.439 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.47 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 mttm . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.01 131.42 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -120.0 110.18 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -101.13 107.36 18.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -138.44 152.42 71.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.795 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.68 120.85 8.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.517 2.144 . . . . 0.0 112.148 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.35 107.91 4.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -120.49 159.4 25.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.71 141.39 35.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -77.49 -58.96 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.239 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.72 124.03 36.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.99 111.29 21.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -94.84 -49.08 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 76.05 -54.89 0.61 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.18 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.39 -25.52 4.42 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.035 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -132.79 -79.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 m -140.82 158.82 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.3 t -132.58 155.27 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.208 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.52 134.28 44.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.12 155.99 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.1 ttp -102.77 101.24 11.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CG ' ' HE2' ' A' ' 32' ' ' MET . 43.2 t80 -114.5 94.79 4.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.011 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 tttm 56.18 29.86 15.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.56 56.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.714 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.81 126.69 65.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.54 0.209 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 95.92 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.428 2.086 . . . . 0.0 112.429 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.416 ' HE2' ' CG ' ' A' ' 27' ' ' TYR . 2.5 mtt -77.42 99.97 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -70.93 132.58 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.466 ' CD1' ' CB ' ' A' ' 90' ' ' ALA . 9.5 t80 -116.79 134.85 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 59.58 164.11 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -127.32 155.43 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.33 102.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.996 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.448 0.166 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.477 ' HA ' ' H ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -107.69 -41.22 5.07 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.532 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -108.11 21.38 17.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 111.704 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.91 -107.78 0.48 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.161 -1.019 . . . . 0.0 110.954 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.9 2.54 7.01 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.55 2.167 . . . . 0.0 111.913 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.471 ' CB ' ' CB ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -97.23 -68.06 0.82 Allowed 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . . . -40.8 -56.43 2.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 0.0 111.953 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -57.37 -18.68 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.908 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -91.1 -40.51 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.443 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.436 ' CD1' HD12 ' A' ' 103' ' ' LEU . 11.0 t80 -62.35 -62.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 66' ' ' VAL . 39.1 p -53.29 -35.75 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.961 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 59' ' ' SER . 3.8 tppp? -48.88 -31.9 8.0 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.616 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 1.8 mmmp? -83.31 -36.93 24.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.473 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.08 -0.8 37.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.741 178.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -109.9 -41.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.386 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 13.3 tt0 -95.26 -72.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.922 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.43 -45.05 85.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -98.46 141.44 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.972 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.65 29.06 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.59 61.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.0 mp -110.16 146.59 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' HG22 ' A' ' 72' ' ' ILE . 7.0 pt-20 -130.68 162.28 29.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 m -95.97 117.26 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.86 166.13 15.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 60.68 163.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -66.68 -17.9 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -177.37 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 110.933 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.97 88.7 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.22 111.01 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.17 -36.0 5.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.028 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.403 HG22 ' HG3' ' A' ' 84' ' ' LYS . 1.9 m -105.95 -176.39 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -109.21 -18.3 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.672 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.403 ' HG3' HG22 ' A' ' 82' ' ' THR . 13.0 mttt -58.38 -161.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 87' ' ' ARG . 1.2 p90 -84.34 11.68 8.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.791 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 89' ' ' LEU . . . 108.13 35.93 2.43 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.486 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.472 ' HB2' ' CE1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -101.89 -24.11 14.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.163 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.88 60.38 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.207 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -107.89 113.08 26.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.251 0.526 . . . . 0.0 111.381 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . . . -144.36 109.87 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.39 126.61 35.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.688 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.14 107.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.602 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -130.07 84.47 2.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.52 110.39 14.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.183 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t70 48.69 30.58 2.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.039 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.45 26.27 63.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.323 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 11.0 mmtt -79.75 164.05 23.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.934 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.89 83.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.7 m -91.4 -34.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -66.71 -33.21 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.29 -20.7 21.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.43 -84.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.55 0.215 . . . . 0.0 111.483 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.16 -24.23 9.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 53.4 t -57.99 -19.38 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.272 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -56.99 -34.86 68.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 110.423 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -98.61 21.97 10.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.684 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 108' ' ' LEU . . . 97.15 -4.59 62.69 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.178 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 58' ' ' ALA . 6.0 mt 140.9 -25.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.595 0.758 . . . . 0.0 111.156 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.471 ' CB ' ' CB ' ' A' ' 57' ' ' GLU . . . -168.57 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' H ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.692 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.861 0.362 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 1.2 mm? -119.99 106.55 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.46 152.34 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -105.98 106.95 17.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -114.17 148.26 39.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.92 120.74 8.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.379 2.053 . . . . 0.0 112.463 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.35 107.84 4.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -115.94 158.73 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -106.04 142.06 36.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.612 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.4 tt -95.9 -47.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.822 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.22 132.87 11.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 111.344 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . . . -114.25 149.75 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.905 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 19' ' ' ASP . 2.8 tt -53.65 -44.24 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.126 0.488 . . . . 0.0 110.143 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.6 OUTLIER 169.1 -108.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.6 -10.05 59.49 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.123 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -95.52 -82.19 0.39 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 18' ' ' ILE . 14.6 t -96.45 159.37 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 3.8 p -148.1 133.17 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.721 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -82.79 143.83 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 3.0 mt -133.32 149.06 51.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.36 97.63 7.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -105.44 106.27 16.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.981 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 58.33 30.29 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.95 -12.86 66.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.789 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.94 125.38 68.77 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.613 0.244 . . . . 0.0 110.723 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 93.78 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.404 2.069 . . . . 0.0 112.321 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.6 tpt -80.73 120.64 24.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -91.85 121.51 33.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -105.14 61.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 85' ' ' TYR . 1.7 mtt-85 -66.65 93.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -110.04 81.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.809 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.92 127.77 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.839 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -125.93 -27.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.54 178.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.558 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.3 t80 -176.72 -25.56 0.01 OUTLIER 'General case' 0 C--N 1.345 0.4 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.666 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 79.99 -104.81 2.26 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.601 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 2.2 Cg_endo -41.13 -28.07 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.912 2.408 . . . . 0.0 112.608 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 15.7 tp10 -78.56 -30.7 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.191 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.698 ' CB ' ' HA ' ' A' ' 109' ' ' ALA . . . -39.27 -60.16 0.95 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -84.09 -47.39 10.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.5 -31.35 6.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.381 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.426 ' CD2' ' HG ' ' A' ' 103' ' ' LEU . 54.8 t80 -56.85 -58.49 7.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.225 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.25 -23.39 43.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.557 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -25.26 63.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -87.13 -26.92 23.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.296 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.426 ' HA ' ' CB ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -70.16 -6.44 34.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.572 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -112.3 -41.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -87.92 -68.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.593 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -73.53 -32.54 64.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 0.0 111.251 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -113.97 149.39 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.086 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -165.35 70.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.86 84.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 94' ' ' ALA . 3.2 mp -135.65 150.73 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' N ' HG21 ' A' ' 72' ' ' ILE . 31.9 tt0 -137.22 149.96 47.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.645 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 76' ' ' PHE . 6.2 m -95.91 109.87 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.804 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.1 82.91 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.432 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.417 ' CE1' ' HB ' ' A' ' 74' ' ' VAL . 45.5 p90 -178.85 133.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.18 16.76 19.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -64.92 -34.67 78.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.51 27.53 68.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.95 110.8 20.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -4.66 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.405 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -89.78 -175.69 4.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.994 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 82' ' ' THR . 3.6 t0 84.94 -49.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -67.86 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.413 ' CZ ' ' HD2' ' A' ' 35' ' ' ARG . 70.5 t80 -149.32 11.4 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.72 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 70.44 18.08 75.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.532 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 169.19 -24.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.622 0.249 . . . . 0.0 111.186 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.87 -38.77 86.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.919 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.42 109.88 15.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.19 117.95 9.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.218 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 93.68 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.435 ' HB ' ' CG2' ' A' ' 72' ' ' ILE . 3.0 pt -112.71 158.18 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.43 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.66 89.56 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.759 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.487 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.87 141.25 36.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.571 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 49.18 31.25 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.434 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.1 -37.62 3.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.744 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -139.33 139.59 37.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.004 0.43 . . . . 0.0 111.235 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.31 94.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.112 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.33 -28.66 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -66.01 -37.4 85.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -29.73 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.3 -33.95 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.426 ' HG ' ' CD2' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -59.29 -58.15 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.66 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 t -66.09 -14.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.537 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -24.88 60.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -94.35 23.29 5.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.17 -3.32 61.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.596 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tt 69.55 86.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.504 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.698 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . . . -166.63 -41.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.088 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.447 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.903 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.886 0.374 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.9 112.91 14.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -82.04 109.64 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.644 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.7 111.09 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -129.25 143.05 47.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.07 120.86 7.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.491 2.127 . . . . 0.0 112.52 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 107.94 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.04 149.87 45.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HB3' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -98.56 139.6 34.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.58 -34.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -137.87 93.27 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.58 111.06 23.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.527 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 mt -101.07 -46.9 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.7 -61.62 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.235 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.33 -27.7 2.92 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.834 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -127.42 -76.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.929 0.395 . . . . 0.0 110.781 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.24 146.82 39.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 t -120.77 143.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -128.65 109.47 11.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -101.88 154.26 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.689 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 tpp -85.62 94.92 9.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -120.71 93.66 4.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 tttm 54.54 41.17 32.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.9 16.03 78.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -118.0 142.29 30.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.643 0.259 . . . . 0.0 110.761 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.15 97.98 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 107.75 7.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 p -72.05 125.94 28.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -115.23 95.94 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.76 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 62.07 89.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 171.95 12.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.32 103.12 10.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.3 mt-10 . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.741 0.305 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' GLU . 0.3 OUTLIER 161.34 -2.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.465 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 8.2 m-85 -131.11 -1.53 4.06 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.12 -140.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.443 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 2.41 7.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.551 2.167 . . . . 0.0 112.864 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HB2' ' CA ' ' A' ' 109' ' ' ALA . 9.9 mt-10 -95.98 -63.8 1.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.105 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . . . -40.43 -33.35 0.25 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.789 0.328 . . . . 0.0 111.517 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -81.65 -57.95 3.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.481 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.05 -28.39 7.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.503 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.468 ' CE1' ' CG2' ' A' ' 104' ' ' VAL . 61.4 t80 -57.64 -65.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.64 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 61' ' ' PHE . 67.6 p -79.58 -26.49 41.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 22.7 ttmt -60.16 -24.73 64.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -92.07 -25.09 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.919 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.586 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -63.7 -9.23 13.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.527 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' CG1' ' CD1' ' A' ' 14' ' ' LEU . 28.3 m -114.72 -41.31 3.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.12 -68.87 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.345 . . . . 0.0 111.912 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.58 -29.96 68.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.355 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -72.29 170.47 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.185 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -108.61 -55.92 2.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.51 163.74 17.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 1.6 mp -142.4 162.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.04 137.44 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.43 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.2 p -95.83 109.81 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 4.5 pt-20 -129.62 139.79 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -166.99 132.01 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.0 -30.28 71.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.983 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -107.81 -47.35 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.838 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.86 -40.66 2.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.75 116.52 32.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.18 -55.04 4.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.515 ' HB ' ' CD ' ' A' ' 84' ' ' LYS . 96.4 m -121.96 158.02 30.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.027 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.89 47.06 0.98 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.761 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.515 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -92.21 -38.79 11.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.723 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.487 ' N ' ' HG2' ' A' ' 84' ' ' LYS . 4.9 t80 -158.3 11.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.415 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.94 32.05 78.5 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.365 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.88 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.559 0.219 . . . . 0.0 111.234 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -45.43 -79.66 0.06 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.945 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.86 122.13 26.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.865 0.365 . . . . 0.0 110.78 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.13 148.35 34.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -72.35 142.07 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.784 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.402 ' CG2' HG21 ' A' ' 72' ' ' ILE . 17.6 mm -128.53 120.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.187 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 91' ' ' TYR . 1.1 m-85 -116.64 78.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.6 111.19 15.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 68.4 45.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.326 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.24 24.64 52.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.062 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -134.19 150.44 51.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.283 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.22 107.19 15.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.7 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.5 -7.9 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.774 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.439 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 4.9 m-80 -58.66 -20.32 47.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.19 -18.72 24.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.394 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.71 -84.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.14 -22.23 11.08 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.468 ' CG2' ' CE1' ' A' ' 61' ' ' PHE . 14.6 t -54.83 -23.29 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -57.72 -24.12 55.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.963 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -103.76 19.12 20.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.29 -3.2 82.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.854 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.62 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER 78.38 74.0 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.584 0.231 . . . . 0.0 110.874 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.62 ' CB ' ' O ' ' A' ' 108' ' ' LEU . . . 131.15 -71.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.638 0.775 . . . . 0.0 110.226 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.985 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 mt -127.06 103.96 7.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -94.55 128.8 41.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.732 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -81.21 115.73 20.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.87 129.29 18.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.443 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.67 120.52 8.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.368 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.42 107.39 4.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -116.99 164.08 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.92 144.04 27.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.896 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -40.61 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.57 126.02 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.985 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 23' ' ' VAL . . . -103.84 148.59 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 4.2 pt -51.12 -40.36 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 4.5 p30 165.11 -113.66 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.37 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.31 -10.12 59.77 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.618 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -82.46 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.4 m -130.14 159.43 36.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.418 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 22.9 m -124.8 154.4 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.229 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.99 135.33 54.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 mp -110.95 159.89 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.9 94.91 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.33 95.35 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.11 30.16 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.01 43.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.685 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -85.81 114.99 59.9 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.518 0.199 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.88 102.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.504 2.136 . . . . 0.0 112.337 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ttp -87.6 150.04 23.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -104.84 140.01 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.935 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.41 ' HB2' ' CD1' ' A' ' 25' ' ' LEU . 13.6 t80 -124.56 112.85 17.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.73 87.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.211 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.75 81.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tp -125.53 145.7 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.674 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 8.3 tttt -167.06 -45.8 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.572 ' CG ' ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 169.81 -22.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.14 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.78 -111.75 0.77 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.214 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.42 -19.79 45.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.002 1.801 . . . . 0.0 111.011 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -88.56 -20.82 24.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.572 ' HA ' ' CG ' ' A' ' 54' ' ' TYR . . . -39.98 -35.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.452 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -79.21 -43.32 24.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 0.0 109.719 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' GLU . . . -50.71 -40.37 53.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.527 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.44 ' CD1' HG23 ' A' ' 104' ' ' VAL . 10.6 t80 -40.23 -61.58 0.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.948 0.404 . . . . 0.0 110.427 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 65' ' ' MET . 2.4 m -88.19 -49.74 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.114 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' HA ' ' CG1' ' A' ' 66' ' ' VAL . 34.1 ttmt -40.34 -29.32 0.08 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 2.9 tttm -85.8 -33.25 21.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.0 110.421 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 62' ' ' THR . 6.7 tpp -94.15 -0.67 55.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.011 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.482 ' CG1' ' HA ' ' A' ' 63' ' ' LYS . 7.4 p -123.48 -41.72 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -95.59 -55.2 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 111.828 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -87.06 5.26 38.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.791 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.452 ' HB1' ' CA ' ' A' ' 65' ' ' MET . . . -99.54 173.53 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.403 . . . . 0.0 111.482 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 -66.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.83 -176.72 3.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 73' ' ' GLU . 4.1 mp -143.68 145.58 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' HG21 ' A' ' 72' ' ' ILE . 14.8 pt-20 -113.72 133.14 55.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.403 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 4.2 m -95.67 118.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 111.207 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -94.61 78.58 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.285 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 74' ' ' VAL . 8.0 p90 -171.21 136.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.75 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -63.92 -60.86 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.471 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.31 -30.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.281 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -41.73 134.75 3.4 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.26 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 142.49 55.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -34.08 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 p -122.09 147.16 46.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.42 -9.9 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -27.77 6.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -178.13 -37.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.06 -10.23 34.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.633 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.22 -5.6 6.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.508 0.194 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.54 -76.28 0.64 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.545 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.01 110.08 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.829 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.92 139.82 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.39 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -109.37 156.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -141.99 83.56 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.981 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.9 106.81 12.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 64.77 42.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.801 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 21.75 74.43 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.669 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -158.0 156.66 31.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 166.75 22.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.41 HG13 ' CE1' ' A' ' 61' ' ' PHE . 19.6 t -84.49 -35.5 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -58.59 -28.12 65.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.58 -18.84 61.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.3 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.48 -74.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.794 0.33 . . . . 0.0 111.769 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.422 HD13 ' CG ' ' A' ' 57' ' ' GLU . 4.5 tt -95.23 -56.72 2.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.83 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 61' ' ' PHE . 15.0 t -48.03 -26.43 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.94 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -15.68 61.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 0.0 111.311 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -76.08 5.18 7.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.769 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.46 4.54 58.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.394 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.821 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mt 64.46 76.32 0.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.165 0.507 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 176.91 103.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.822 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.902 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.07 148.55 36.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.31 153.05 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.28 127.9 44.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.03 147.13 64.11 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.94 120.54 8.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.422 2.081 . . . . 0.0 112.024 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.64 107.94 4.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.849 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 168.81 11.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.23 144.02 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.4 tt -82.13 -42.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.409 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -143.55 105.81 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.14 123.68 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.23 -35.03 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.174 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.08 -64.58 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.173 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.06 -26.34 8.74 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.789 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.75 -79.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 m -131.83 158.96 39.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.68 145.12 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.055 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.31 142.26 51.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mt -115.91 152.11 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 95.62 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -106.6 93.64 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 58.25 41.84 22.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.973 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.66 24.03 68.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.59 128.04 24.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.604 0.24 . . . . 0.0 110.803 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.82 90.41 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.367 2.045 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ttm -78.41 113.07 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 p -73.54 135.5 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 4.7 t80 -127.79 109.21 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.747 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 64.24 144.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.3 mp -91.05 172.01 8.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.48 99.43 10.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.55 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 11.1 mt-10 . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.672 0.273 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 52' ' ' GLU . 18.8 ptpt 139.96 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.346 1.058 . . . . 0.0 108.474 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.47 ' CG ' ' CB ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER 50.53 25.35 1.94 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 -178.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -109.47 1.85 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.252 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 2.36 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.678 2.252 . . . . 0.0 113.024 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -85.59 -62.97 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 53' ' ' LYS . . . -45.77 -48.92 15.39 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.723 0.296 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 13.0 t -48.53 -29.48 4.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -91.46 -38.19 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.605 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.2 -65.4 0.56 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.241 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -20.4 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -65.62 -33.4 75.81 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.628 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 2.4 mttp -92.16 -21.34 20.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.148 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.437 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -75.0 -5.32 43.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.011 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.41 ' HA ' ' CD1' ' A' ' 72' ' ' ILE . 22.6 m -123.39 -41.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.705 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.73 -66.8 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.903 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -92.83 5.39 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -98.96 92.07 5.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.487 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm 60.17 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.214 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mttt 166.95 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.7 mt 79.23 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.28 140.11 33.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.692 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.8 p -95.92 109.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HG3' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -124.84 -86.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.831 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.486 ' CE1' ' CD2' ' A' ' 91' ' ' TYR . 2.7 t80 59.75 117.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 111.163 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -86.03 57.17 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.454 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -166.73 -44.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.34 144.63 9.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HB2' ' HG ' ' A' ' 89' ' ' LEU . 5.7 pm0 -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.0 110.722 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -114.34 -55.72 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.565 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -141.4 -175.3 4.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.729 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 82' ' ' THR . 24.2 t70 104.02 -72.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.532 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.415 ' CB ' HD21 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -92.15 90.6 7.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.394 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 43.1 t80 64.86 11.35 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.921 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 58.75 30.79 66.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.465 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 165.35 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.464 0.306 . . . . 0.0 110.789 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.72 -12.87 36.57 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.062 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HG ' ' HB2' ' A' ' 80' ' ' GLN . 0.2 OUTLIER -83.7 109.77 17.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 34' ' ' PHE . . . -144.23 134.74 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.486 ' CD2' ' CE1' ' A' ' 76' ' ' PHE . 5.5 m-85 -112.11 119.92 40.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.24 136.07 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.604 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.413 ' CD2' ' HG3' ' A' ' 75' ' ' GLU . 74.5 m-85 -127.34 77.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.784 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.06 141.81 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.246 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 p30 48.88 31.23 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.651 0.739 . . . . 0.0 109.505 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.51 -47.01 2.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.059 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -161.7 111.69 1.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.764 0.282 . . . . 0.0 111.589 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.3 ttm -147.41 80.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.283 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -98.95 -59.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.111 0.482 . . . . 0.0 111.961 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 105' ' ' ARG . 5.8 p-10 -89.56 -57.21 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.215 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -40.56 -28.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.18 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.657 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 104' ' ' VAL . 1.3 tm? -114.42 -57.58 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.456 0.646 . . . . 0.0 111.469 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.444 ' N ' HD12 ' A' ' 103' ' ' LEU . 18.5 t -48.82 -16.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.012 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -49.93 -28.66 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.975 0.417 . . . . 0.0 110.486 179.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -98.41 23.04 8.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.068 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.85 38.65 65.28 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.0 mt 55.87 87.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.62 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.61 -6.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HA ' ' CD2' ' A' ' 54' ' ' TYR . 8.1 ptpt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.927 0.394 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -127.07 104.05 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.56 106.53 18.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.03 106.91 17.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -128.24 126.54 23.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.785 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.36 121.46 9.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.385 2.057 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.15 107.43 4.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -125.44 150.58 47.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.58 141.74 41.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.695 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.4 tt -88.64 -47.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.703 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -155.07 130.3 9.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 111.46 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.03 133.51 55.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.698 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 17.3 tt -54.66 -49.45 67.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.23 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER 166.93 -152.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.84 -10.52 4.79 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.449 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.15 -71.17 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.026 0.413 . . . . 0.0 111.129 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -147.0 159.05 44.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.45 117.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.978 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -83.34 124.9 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 2.4 mp -89.67 160.85 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.1 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.63 98.32 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt 57.57 43.42 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.32 22.56 76.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.597 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -114.31 133.64 22.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.576 0.226 . . . . 0.0 110.815 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.06 99.49 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.458 2.105 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 mtt -95.9 149.75 21.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.88 144.55 36.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.976 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -138.02 122.81 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 62.86 145.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.26 103.09 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.74 102.82 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.839 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER 64.81 4.67 2.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER 172.11 -25.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.736 0.303 . . . . 0.0 110.813 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.15 -102.07 2.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.371 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.96 -25.69 63.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.61 -36.93 65.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.89 -26.23 1.62 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -32.37 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.82 -47.14 74.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.512 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.429 ' CG ' ' N ' ' A' ' 62' ' ' THR . 0.1 OUTLIER -47.85 -47.87 31.26 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.885 0.374 . . . . 0.0 110.488 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.7 t -81.94 -26.15 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -26.77 65.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.747 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 69' ' ' ALA . 11.9 mttp -92.02 -24.86 19.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.574 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 24.6 ttp -57.21 -15.25 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.414 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.4 m -105.23 -42.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.6 -69.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.714 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.24 -20.49 62.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.592 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.574 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -93.08 -179.84 5.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.356 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -69.45 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.068 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 172.61 149.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.922 0.391 . . . . 0.0 110.924 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 1.8 mp -102.78 161.61 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.051 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -133.78 149.55 51.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.48 109.82 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.967 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -88.48 -178.54 5.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 75' ' ' GLU . 15.5 p90 46.94 117.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.04 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.08 32.02 6.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -59.26 -27.55 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.069 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.45 -84.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.21 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.27 110.82 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.601 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -110.11 -40.29 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.7 p -130.1 133.94 47.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.38 -8.31 58.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.087 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.59 70.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -177.19 -37.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.05 -10.27 34.03 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.536 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -123.21 -24.11 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.54 -84.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.736 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tp -89.08 116.22 27.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.335 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.04 141.88 30.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 1.5 m-85 -80.89 127.3 32.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.13 149.77 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -134.42 89.12 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.25 115.55 18.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.24 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 t70 67.57 26.64 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.13 -31.26 7.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.816 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -134.17 131.43 38.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 111.025 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.18 158.36 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.12 -8.64 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -63.06 -16.57 60.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -18.83 30.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.53 -84.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.517 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.64 -24.07 10.3 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.424 ' N ' HD22 ' A' ' 103' ' ' LEU . 63.6 t -58.93 -31.47 45.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -98.17 -16.01 19.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -83.87 -25.2 30.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.533 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.12 47.8 2.16 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.332 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.573 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 2.6 tt -147.98 6.16 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.403 ' N ' ' HB2' ' A' ' 53' ' ' LYS . . . 176.32 86.78 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 1.1 ttmt . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 76' ' ' PHE . 1.6 mm? -79.06 112.87 16.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.034 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -70.0 153.21 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -106.95 106.91 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -110.52 129.65 23.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.379 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.1 120.02 7.58 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.253 1.969 . . . . 0.0 112.486 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' CB ' HG22 ' A' ' 74' ' ' VAL . . . -146.0 107.81 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.472 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -117.49 163.41 16.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.021 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' CD1' ' HB ' ' A' ' 66' ' ' VAL . 1.6 pp -106.23 144.19 33.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 15' ' ' ILE . 38.3 mm -62.2 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.99 135.42 1.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.808 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.12 137.73 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tt -57.71 -46.36 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 166.45 -110.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.41 -10.62 59.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.54 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.17 -80.75 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.714 0.292 . . . . 0.0 111.435 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -131.48 157.76 42.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.378 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.466 ' CG1' ' CD1' ' A' ' 34' ' ' PHE . 7.5 p -147.96 107.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -83.5 111.37 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.514 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HA ' ' CB ' ' A' ' 14' ' ' LEU . 3.6 mt -89.74 161.71 15.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.634 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.2 ttp -106.41 109.04 20.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -126.1 92.67 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.02 41.04 5.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.86 37.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.644 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -124.74 114.86 26.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.519 0.2 . . . . 0.0 110.876 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.75 83.0 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.487 2.124 . . . . 0.0 112.275 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 mtm -80.94 123.46 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.693 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -110.23 148.08 32.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.466 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -88.83 -171.02 3.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HG2' ' CD2' ' A' ' 34' ' ' PHE . 6.9 ptt180 -46.68 148.42 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 172.12 9.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -94.41 156.15 16.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.93 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.682 0.754 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.87 2.12 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.521 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 76.7 t80 -83.47 0.97 43.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.224 0.535 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.55 -60.36 1.81 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -92.06 -48.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.674 2.916 . . . . 0.0 113.153 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -56.92 10.28 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 54' ' ' TYR . . . -45.95 -49.33 15.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 111.428 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' LYS . 4.2 m -60.06 -19.97 55.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.73 -58.12 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.128 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -72.85 -62.63 1.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.911 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.406 ' CA ' HD13 ' A' ' 103' ' ' LEU . 1.9 m -49.63 -27.58 4.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.219 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 59' ' ' SER . 37.3 ttmt -76.61 -21.77 55.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -88.3 -23.27 23.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.467 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 5.0 mmt -89.95 -1.03 57.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 15.9 m -123.3 -41.69 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -85.7 -72.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.58 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.49 -20.69 64.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -102.46 111.14 23.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.685 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.58 51.35 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 30.2 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 mp -80.87 149.73 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.67 168.43 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.403 HG22 ' CB ' ' A' ' 12' ' ' ALA . 9.7 t -106.2 109.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 5.3 mm-40 -91.45 82.24 5.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 7' ' ' LEU . 2.4 m-85 -168.66 117.8 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 2.9 t0 -65.65 -44.82 85.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.898 0.38 . . . . 0.0 110.804 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -169.49 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.378 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.18 149.45 0.88 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.873 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.8 160.99 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 mtt-85 -95.12 -55.29 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.9 p -140.19 157.55 45.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.184 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -98.79 -25.44 14.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.676 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -45.87 -29.33 1.34 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.452 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -176.28 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.38 25.72 6.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -160.73 -24.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.13 -80.27 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.7 mp -74.09 117.22 15.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.0 159.87 41.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.121 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 36.0 m-85 -103.35 142.17 34.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.502 HD12 HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -120.53 110.92 30.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 91' ' ' TYR . 17.3 m-85 -113.69 71.73 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.183 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.58 101.28 8.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.059 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 67.37 35.06 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 35.8 83.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.04 157.27 16.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.119 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.34 84.08 2.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.539 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 30.1 m -60.97 -47.24 94.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.273 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -49.19 -24.1 1.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.506 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -91.31 -63.12 1.3 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.15 -15.73 30.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 99' ' ' VAL . 4.9 tt -99.91 -49.04 4.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.416 ' CG2' HD23 ' A' ' 103' ' ' LEU . 22.9 t -90.12 -62.26 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.65 -24.53 61.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.692 0.282 . . . . 0.0 111.227 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -70.19 -17.67 63.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.342 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.32 47.17 2.24 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.474 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 mp -153.22 34.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . . . 167.7 42.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.767 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.789 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -136.21 132.85 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -104.01 152.2 22.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.17 130.44 43.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -119.65 101.03 7.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -127.66 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.3 mt -123.43 119.71 30.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -108.93 121.34 44.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.756 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -79.42 110.93 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.241 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.86 130.59 23.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.566 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.91 120.31 7.93 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.227 1.951 . . . . 0.0 112.544 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.66 107.7 4.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -125.27 141.58 52.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.249 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mp -67.04 144.05 56.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pt -87.21 -28.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -167.91 94.22 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.64 115.5 28.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.354 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mt -80.64 -31.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 68.22 -65.68 0.25 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.16 33.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.689 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -121.44 -77.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -146.13 159.07 43.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.89 148.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.199 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 132.51 41.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -99.14 160.55 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.4 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.797 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -122.63 109.12 13.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.07 29.06 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.75 -4.13 83.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -85.94 127.81 60.69 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.799 0.3 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.69 83.27 2.11 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.563 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.62 111.35 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -86.57 155.01 20.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -123.58 97.5 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 67.51 122.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.77 172.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.66 101.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.82 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.971 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.99 153.59 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.3 120.52 21.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.9 110.58 58.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.78 -25.74 39.33 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.418 2.079 . . . . 0.0 112.401 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -116.66 46.5 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.96 -45.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.949 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -58.36 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.39 146.68 34.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.789 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.43 -32.13 10.44 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.443 2.095 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.51 -55.84 15.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -83.73 -34.74 24.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.02 -49.8 1.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.144 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.514 ' CG2' ' H ' ' A' ' 52' ' ' GLU . 8.9 m -128.28 -63.64 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 117.425 0.612 . . . . 0.0 112.125 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.514 ' H ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 mm-40 -118.64 -65.99 1.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.848 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 49' ' ' LYS . 2.9 mmtt -120.26 -53.93 2.12 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -124.72 -25.35 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.18 -107.24 3.31 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.588 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 90.1 Cg_exo -44.93 -28.26 2.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.595 2.197 . . . . 0.0 112.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.47 -70.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.653 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.41 -27.86 17.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.734 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 63' ' ' LYS . 10.4 t -70.0 -44.9 68.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.71 97.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.97 -44.26 97.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.113 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 m -76.46 -26.72 55.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 59' ' ' SER . 4.2 mmtp -59.06 -27.87 65.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -91.46 -31.95 15.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.714 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.412 ' HA ' ' CB ' ' A' ' 69' ' ' ALA . 4.7 mmt -62.01 -13.68 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.308 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -117.16 -41.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.715 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -70.33 -67.53 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -45.11 12.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -80.71 60.66 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.81 58.42 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.3 31.66 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.748 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mt -89.31 151.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -146.27 161.79 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 76' ' ' PHE . 4.9 m -96.01 109.64 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -101.4 72.52 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 74' ' ' VAL . 20.9 p90 -177.38 118.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -114.03 30.32 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -59.15 -29.96 67.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.39 -33.67 5.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.14 126.04 30.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.2 -23.73 12.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 83' ' ' ASP . 1.3 t -140.18 133.56 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 82' ' ' THR . 6.5 t0 174.8 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.454 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -80.2 -66.97 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 88' ' ' GLY . 23.4 t80 -118.79 -10.69 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.377 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 102.35 40.6 2.55 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.132 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 4.0 ttp180 89.6 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 110.636 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 85' ' ' TYR . . . -103.0 -13.17 29.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.666 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.78 116.83 31.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.19 130.73 22.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' HB2' ' CD1' ' A' ' 76' ' ' PHE . 47.8 m-85 -61.97 122.0 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.1 pt -118.06 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 81.1 m-85 -121.81 79.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.53 124.47 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.83 47.93 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.629 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.49 21.0 40.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.339 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -146.57 153.92 40.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.068 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 mtm -81.3 148.37 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.19 -32.65 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -65.48 -24.89 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.022 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.16 -18.91 23.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.396 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.73 -84.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.743 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.6 -15.96 13.36 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.435 ' N ' HD11 ' A' ' 103' ' ' LEU . 15.1 t -70.36 -28.53 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -15.78 62.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.062 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.49 10.13 16.21 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.539 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 108' ' ' LEU . . . 97.51 34.58 5.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.622 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 6.2 mt 50.91 108.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 111.45 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 108' ' ' LEU . . . 88.57 -70.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.31 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.169 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.894 0.378 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 p -107.36 102.66 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.69 113.46 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -111.99 147.96 34.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.963 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.99 143.5 27.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.973 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -106.44 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.47 103.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.31 140.58 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 106.86 13.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -130.38 144.02 51.6 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.18 121.61 6.22 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.607 2.204 . . . . 0.0 112.552 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.05 107.62 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.82 163.38 14.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.7 pp -106.06 136.64 45.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.0 mt -74.48 -58.83 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 145.27 14.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.08 150.18 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 2.6 pt -63.11 -14.77 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 59' ' ' SER . 5.3 m-20 82.82 -8.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.2 -38.52 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.06 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 166.66 -18.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.643 0.222 . . . . 0.0 111.475 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 m -96.51 144.27 26.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 t -138.51 158.05 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.418 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -128.67 105.07 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.635 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -86.94 161.52 18.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.371 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.14 98.09 6.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.838 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -107.82 105.27 15.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 55.18 53.88 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.15 24.23 54.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -128.73 119.0 19.99 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.55 102.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.35 2.033 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.5 ttm -84.28 135.72 34.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 p -86.77 142.12 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.245 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 16.8 t80 -135.68 94.73 3.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.725 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 34.78 74.54 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.936 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mp -98.64 127.0 44.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.2 82.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.733 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.19 112.76 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -152.33 128.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.6 104.13 5.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.91 84.26 7.01 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.98 -25.45 22.11 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.668 2.245 . . . . 0.0 112.388 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.5 -31.07 42.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.4 m -150.33 116.41 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.94 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 -50.83 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -128.66 74.96 80.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.8 2.71 8.34 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.821 2.347 . . . . 0.0 113.099 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -91.76 0.46 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -38.3 5.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.867 0.365 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.26 -5.65 62.73 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.35 27.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.926 0.394 . . . . 0.0 111.3 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.459 ' C ' ' HB1' ' A' ' 109' ' ' ALA . 5.9 mt-10 -83.19 -38.0 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.453 ' CA ' ' HB2' ' A' ' 109' ' ' ALA . 4.5 pttp -143.84 13.53 1.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.833 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 54' ' ' TYR . 12.7 t80 -126.15 -25.28 3.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.416 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -48.34 174.37 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.156 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.47 2.51 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 113.509 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.61 ' CB ' ' HA ' ' A' ' 109' ' ' ALA . 3.4 mt-10 -96.65 -49.02 5.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.871 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -40.74 -52.39 2.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.948 0.34 . . . . 0.0 111.199 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 57.1 p -61.38 -47.76 84.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.392 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.12 -36.22 28.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.468 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 99' ' ' VAL . 89.0 t80 -51.95 -60.7 2.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.29 -30.98 48.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 1.6 tppp? -61.77 -21.87 64.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.011 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 15.6 ttmt -89.97 -33.48 16.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.509 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 2.2 mtm -58.31 -15.67 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.209 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.9 -41.38 2.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -74.48 -64.88 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 111.49 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.11 -43.56 21.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -70.26 -175.06 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.024 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -129.92 -54.92 1.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.045 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 3.7 mp -143.0 145.22 23.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' N ' HG23 ' A' ' 72' ' ' ILE . 1.8 pt-20 -117.1 164.92 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.2 p -110.94 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.216 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' PHE . 22.3 mt-10 -91.16 128.65 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 75' ' ' GLU . 5.1 p90 48.74 168.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.274 0.559 . . . . 0.0 112.013 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -93.54 -14.15 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.341 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.55 -8.6 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.656 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.54 -77.55 0.25 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -106.34 111.32 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -30.61 8.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.477 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 80.9 p -90.51 -175.71 4.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.4 t0 76.59 -61.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.71 -16.75 63.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -179.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.141 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 109.24 -10.54 33.65 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.348 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 1.1 tpp180 171.96 26.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.191 0.196 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.82 -49.95 4.12 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.906 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.91 109.76 7.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 111.129 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.3 122.51 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.977 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.1 111.97 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.779 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.98 124.72 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.26 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -134.91 88.2 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.775 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.72 91.03 5.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.95 51.26 7.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.19 24.8 56.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.246 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 130.39 56.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ttt -104.52 83.87 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 61' ' ' PHE . 6.5 m -68.22 -19.35 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.491 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 1.8 t-20 -56.3 -63.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 111.045 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -18.75 48.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.356 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.55 -46.55 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 tt -111.09 -50.79 2.91 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 59.7 t -58.76 -16.88 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -22.08 18.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.454 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.43 23.17 5.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.555 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 108' ' ' LEU . . . 94.55 -3.03 68.11 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.76 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 1.0 OUTLIER 99.24 22.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.698 0.799 . . . . 0.0 110.98 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . . . -177.73 -165.7 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.697 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.909 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.891 0.377 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 t -130.38 118.64 21.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 t -76.79 145.82 38.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 p -88.11 147.78 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -77.95 143.94 37.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -125.58 146.94 49.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -127.32 104.02 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.25 121.86 45.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.912 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -78.0 112.11 14.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.29 137.4 22.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 121.96 9.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.519 2.146 . . . . 0.0 112.351 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.24 107.78 4.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.538 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.04 135.41 54.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -68.18 113.42 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.852 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -31.76 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.39 91.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.545 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.64 106.18 18.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.9 mp -80.38 -53.9 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER 82.34 -19.8 0.39 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.543 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.38 -25.72 65.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.315 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -170.5 -40.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 m -128.27 159.07 36.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.903 0.382 . . . . 0.0 111.276 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.71 145.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -126.1 147.13 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -130.61 156.87 44.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ttp -113.18 97.94 6.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.582 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -103.78 106.16 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.382 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 48.57 36.9 8.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.229 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.05 -21.18 43.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -87.94 125.0 65.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 110.542 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.87 97.36 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.416 2.077 . . . . 0.0 112.462 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.94 129.65 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.4 m -81.2 133.24 35.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 111.294 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -139.24 34.95 2.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.009 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -61.19 127.46 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.57 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tp -134.93 81.69 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.3 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.12 100.1 11.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -136.15 105.47 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.339 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.2 t -153.21 159.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.85 89.78 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 p -113.93 85.18 9.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.445 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.18 -37.34 87.6 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.317 2.011 . . . . 0.0 111.53 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -165.54 20.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.121 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.9 m -167.91 141.01 3.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.53 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -77.86 -15.71 58.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.231 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -132.51 62.3 62.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.948 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -30.17 45.74 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.124 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -97.21 -101.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -107.66 -38.78 5.79 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.786 0.326 . . . . 0.0 111.164 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.49 38.74 95.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG23 ' CG ' ' A' ' 52' ' ' GLU . 21.0 m -127.03 -51.27 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.629 0.252 . . . . 0.0 111.669 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.534 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -116.8 -52.36 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.281 0.562 . . . . 0.0 109.739 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.424 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -24.69 -74.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.873 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -156.03 25.0 0.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.363 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.52 -132.56 2.84 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.148 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.59 -5.34 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.098 1.865 . . . . 0.0 111.133 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 3.5 mm-40 -93.12 -42.34 9.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.817 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 54' ' ' TYR . . . -39.42 -32.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -51.08 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 109.962 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -40.91 -44.1 2.23 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.381 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 3.1 t80 -43.79 -47.45 8.03 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.86 -47.02 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.212 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 67.7 mttt -50.71 -27.64 7.47 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 62.4 mttt -79.15 -32.73 44.43 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.424 ' C ' ' HB1' ' A' ' 69' ' ' ALA . 11.3 mtp -93.16 -0.52 56.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.231 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' THR . 93.2 t -117.69 -41.73 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.669 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.69 -79.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.735 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -57.63 -21.92 42.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.48 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -63.88 178.72 0.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 0.0 111.402 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -69.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.3 133.99 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 3.8 mp -96.06 161.66 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -146.1 139.84 26.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.641 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.74 109.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 3.5 pt-20 -112.31 106.62 15.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.7 p90 175.63 117.89 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.585 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.31 74.39 0.87 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.844 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 -54.98 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.15 -100.71 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.88 121.75 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -89.25 -30.89 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.45 151.1 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.2 -18.87 13.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.02 -78.65 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -108.44 -22.51 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.14 -10.05 70.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -129.93 -24.03 2.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.359 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.93 -78.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.748 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.85 115.09 12.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 0.0 111.069 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.08 158.91 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.051 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.68 142.09 28.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mt -117.05 116.46 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.419 ' C ' HG23 ' A' ' 72' ' ' ILE . 17.1 m-85 -114.61 78.22 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.065 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -78.99 93.25 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 63.99 44.61 4.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.203 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 25.69 58.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.863 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 155.36 44.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.91 0.386 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.0 mtt -120.67 99.16 6.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.79 -8.14 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.609 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.537 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 17.9 p30 -47.82 -30.8 4.32 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -91.2 -18.73 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.811 0.339 . . . . 0.0 111.537 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.98 -69.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -111.37 -32.18 6.81 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 100' ' ' ASN . 5.0 t -59.8 -20.67 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -77.56 -24.37 49.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -61.75 -17.41 55.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.033 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.18 34.5 5.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.425 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -156.52 -115.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.566 ' N ' HD22 ' A' ' 108' ' ' LEU . . . -178.03 16.77 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.233 -0.292 . . . . 0.0 111.706 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.983 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.825 0.345 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m -108.27 138.97 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.76 138.78 31.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 t -64.93 133.8 52.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -92.82 144.17 25.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -87.93 153.99 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.92 154.22 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.0 153.43 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.28 106.81 2.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.67 151.12 46.79 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.235 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.53 120.11 7.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.31 2.006 . . . . 0.0 112.215 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.15 107.83 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.089 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 71' ' ' LYS . 12.2 t -122.05 168.0 12.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.181 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 1.3 mt -78.56 143.96 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.2 mt -75.88 -47.81 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.15 86.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.706 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.14 117.92 13.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.182 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 29.2 mm -60.18 -61.26 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 7.2 p-10 172.43 -137.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.372 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.94 -10.2 58.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.439 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.59 -84.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.786 0.293 . . . . 0.0 111.435 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -125.4 159.12 32.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.366 . . . . 0.0 111.117 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.84 112.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -106.24 145.95 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -110.56 161.19 15.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.098 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 ttt -106.81 104.15 13.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -112.95 91.58 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.97 51.23 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.493 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 23.4 62.17 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.579 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -127.99 114.83 20.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.522 0.201 . . . . 0.0 110.816 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 97.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.443 2.095 . . . . 0.0 112.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.39 144.08 28.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.61 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.51 136.98 32.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.046 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -135.55 107.07 6.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 62.47 157.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.99 8.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 86.03 7.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.05 127.35 30.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.1 118.96 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -131.36 94.13 3.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -93.79 124.71 55.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.54 -24.47 8.96 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.405 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.53 -63.41 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -179.98 -54.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -132.25 -175.63 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.525 ' HB3' ' CD ' ' A' ' 47' ' ' PRO . 4.1 t60 -159.88 -61.68 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.525 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 9.9 Cg_endo -50.72 -21.1 7.55 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -44.51 -51.03 9.2 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.0 -38.56 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.83 -48.31 1.62 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.395 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 13.3 p -52.07 -18.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.62 -22.65 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.613 0.244 . . . . 0.0 111.231 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 110' ' ' LYS . 0.1 OUTLIER 173.11 -8.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 21.9 m-85 -135.79 25.23 3.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.673 0.273 . . . . 0.0 111.016 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.31 -133.15 6.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.97 -1.11 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.3 2.59 4.87 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.107 1.871 . . . . 0.0 111.584 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 8.6 mm-40 -94.92 -64.75 1.03 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.106 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' N ' ' HB3' ' A' ' 109' ' ' ALA . . . -40.25 -33.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.227 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.0 p -79.3 -48.14 14.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.108 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.71 96.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.458 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 30.1 t80 -44.95 -39.42 5.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.456 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -94.15 -29.07 15.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.331 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -26.33 68.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -91.99 -38.3 12.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.987 0.423 . . . . 0.0 110.289 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.493 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -57.43 -17.04 11.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -104.89 -40.5 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -76.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -55.1 -36.28 65.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.381 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -76.17 -170.22 1.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.154 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -71.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER 176.47 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.232 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.2 mt 83.92 146.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 110.948 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' N ' HG21 ' A' ' 72' ' ' ILE . 6.7 pm0 -129.71 147.01 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.068 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 p -97.12 109.64 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.744 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.79 -76.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.255 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 55.0 p90 -85.89 117.67 24.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.17 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.22 24.04 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.969 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -140.44 -55.12 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.44 99.66 0.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.51 157.23 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -96.92 -44.8 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.37 164.09 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -116.88 30.7 7.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.034 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -78.55 -66.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.742 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 93.7 t80 -137.93 11.2 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.35 40.11 97.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.093 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -174.43 -24.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.497 0.189 . . . . 0.0 111.356 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.7 -64.35 3.25 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.26 114.16 26.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 111.048 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.85 146.68 52.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.431 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -83.45 122.58 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.413 HG13 ' CG2' ' A' ' 72' ' ' ILE . 11.2 tt -121.07 110.02 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -129.7 107.6 9.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.954 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -84.74 92.48 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.9 40.06 5.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.16 33.32 69.19 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -103.53 129.93 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.91 84.95 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.75 -7.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.537 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 3.8 t-20 -56.52 -22.99 36.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -91.03 -18.87 23.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.91 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.871 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.43 -21.18 11.94 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.458 ' CG2' ' CD1' ' A' ' 61' ' ' PHE . 20.1 t -61.93 -23.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 0.0 111.499 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -15.58 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.39 23.14 1.66 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.08 47.18 87.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.685 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 57' ' ' GLU . 5.3 mp -122.83 -44.88 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.816 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB3' ' N ' ' A' ' 58' ' ' ALA . . . -134.33 37.31 3.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 15.2 mtmm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.849 0.357 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 m -90.86 114.49 26.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -101.43 135.38 43.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.4 p -97.09 118.91 34.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.0 113.34 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.685 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.6 150.58 47.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.21 155.14 19.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.778 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 113.3 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -67.67 106.93 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -96.1 152.08 38.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 119.1 6.07 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.668 1.579 . . . . 0.0 112.286 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.55 107.63 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.362 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 m -123.67 145.86 48.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.34 144.13 25.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.706 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 tp -86.1 -46.27 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.362 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.84 135.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.991 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.21 150.14 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.991 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -55.61 -47.64 78.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.678 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 19.9 t70 169.25 -110.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.809 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.73 -10.47 58.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.748 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -80.27 -90.04 0.06 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 m -97.14 159.09 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.064 0.459 . . . . 0.0 111.671 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.13 108.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.438 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 146.98 27.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.091 0.472 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD12 ' CE2' ' A' ' 34' ' ' PHE . 6.1 mt -124.22 130.92 53.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.681 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.6 tpp -85.45 100.71 12.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 29.8 t80 -126.06 112.47 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 27' ' ' TYR . 10.1 ptpt 47.44 29.05 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.31 -19.79 50.26 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.873 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -86.06 114.97 60.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.34 102.59 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.569 2.179 . . . . 0.0 112.408 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.5 mtt -99.28 127.7 45.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 t -105.55 140.42 38.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CE2' HD12 ' A' ' 25' ' ' LEU . 47.0 p90 -127.17 151.44 48.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 60.49 102.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -135.46 99.65 4.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.561 . . . . 0.0 111.327 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.25 126.88 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.842 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.69 118.94 26.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.69 123.86 62.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -116.31 116.07 27.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.89 129.28 8.97 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.729 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -52.45 8.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.365 2.043 . . . . 0.0 112.592 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -39.19 18.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.3 95.33 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.042 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -118.79 27.2 9.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.059 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 18.0 m80 -141.03 62.89 17.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 46' ' ' HIS . 3.4 Cg_exo -80.17 -61.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.979 2.453 . . . . 0.0 111.951 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.18 29.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.782 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.56 -10.86 60.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.307 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.586 ' C ' ' HA2' ' A' ' 55' ' ' GLY . . . 116.17 -48.11 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.548 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.548 ' HA ' ' N ' ' A' ' 55' ' ' GLY . 13.2 p -57.99 -11.78 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.32 -45.4 8.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.493 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HB3' ' N ' ' A' ' 110' ' ' LYS . 4.4 tptt -112.25 -28.51 7.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.645 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -169.61 -26.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.586 ' HA2' ' C ' ' A' ' 50' ' ' GLY . . . 85.58 -101.04 2.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.29 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 64.5 Cg_exo -40.77 -28.65 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.46 2.107 . . . . 0.0 112.724 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -73.11 -45.38 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.202 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB2' ' N ' ' A' ' 109' ' ' ALA . . . -51.49 -49.07 62.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -64.06 -37.63 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.91 -34.1 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.16 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER -53.54 -44.35 69.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.314 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.409 HG21 ' CZ ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -94.03 -28.39 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.417 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -69.42 -22.11 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 69' ' ' ALA . 6.3 mtpt -84.96 -33.15 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.032 0.444 . . . . 0.0 109.941 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.451 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -58.39 -14.37 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.431 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 67' ' ' GLU . 30.2 m -107.76 -41.68 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.8 mt-10 -95.47 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.39 -28.9 69.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.685 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -86.91 171.65 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.433 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.84 -60.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.71 169.72 24.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.408 HG22 ' C ' ' A' ' 93' ' ' TYR . 3.6 mp -141.51 157.11 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -134.65 171.2 14.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.84 115.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.356 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.7 85.69 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -108.89 130.35 55.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.908 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -63.64 -53.61 48.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.0 -35.83 16.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.64 78.47 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -117.7 110.72 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -28.15 7.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 7.6 p -89.95 -175.79 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 82' ' ' THR . 4.0 m-20 81.09 -57.5 0.28 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -69.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.674 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -153.5 11.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.566 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.45 24.03 71.73 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.221 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 167.99 -24.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.633 0.254 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.39 -39.16 5.5 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.11 109.58 21.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.59 28.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.082 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.424 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -105.28 126.22 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.1 pt -125.72 143.49 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 111.453 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.408 ' C ' HG22 ' A' ' 72' ' ' ILE . 73.3 m-85 -140.24 107.98 5.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.23 107.31 11.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.403 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.78 47.13 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.58 77.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -107.34 119.05 38.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -98.53 83.91 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.754 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.44 -27.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -56.46 -41.75 77.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -86.38 -18.71 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.331 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -24.86 20.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -111.22 -66.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.0 t -52.98 -37.31 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.692 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -15.9 63.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.379 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.58 5.87 26.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.53 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.14 29.08 8.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.529 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 5.6 mt 64.27 107.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.651 0.263 . . . . 0.0 111.112 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . 82.41 -117.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.439 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.6 p -103.34 100.14 10.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -62.85 160.01 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 p -91.85 115.88 28.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.19 137.83 47.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -91.84 109.62 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.01 131.42 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -120.0 110.18 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -101.13 107.36 18.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -138.44 152.42 71.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.795 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.68 120.85 8.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.517 2.144 . . . . 0.0 112.148 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.35 107.91 4.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -120.49 159.4 25.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.71 141.39 35.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -77.49 -58.96 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.239 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.72 124.03 36.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.99 111.29 21.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -94.84 -49.08 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 76.05 -54.89 0.61 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.18 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.39 -25.52 4.42 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.035 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -132.79 -79.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 m -140.82 158.82 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.3 t -132.58 155.27 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.208 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.52 134.28 44.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.12 155.99 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.1 ttp -102.77 101.24 11.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CG ' ' HE2' ' A' ' 32' ' ' MET . 43.2 t80 -114.5 94.79 4.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.011 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 tttm 56.18 29.86 15.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.56 56.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.714 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.81 126.69 65.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.54 0.209 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 95.92 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.428 2.086 . . . . 0.0 112.429 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.416 ' HE2' ' CG ' ' A' ' 27' ' ' TYR . 2.5 mtt -77.42 99.97 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -70.93 132.58 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.466 ' CD1' ' CB ' ' A' ' 90' ' ' ALA . 9.5 t80 -116.79 134.85 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 59.58 164.11 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -127.32 155.43 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.33 102.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.996 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.82 177.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.23 154.76 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.081 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -120.96 104.28 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -84.77 121.23 74.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.25 -27.82 23.68 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.44 2.093 . . . . 0.0 112.39 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -47.06 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.9 p -96.46 -77.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.79 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.12 30.39 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.486 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.49 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . 6.1 t60 -176.56 -61.29 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.234 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 66.4 Cg_endo -72.4 -3.75 13.97 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.497 2.131 . . . . 0.0 113.092 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.7 -43.0 2.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.694 0.283 . . . . 0.0 111.473 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 46' ' ' HIS . 4.2 ptpt -56.85 -38.05 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.348 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.95 7.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.752 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.413 ' O ' ' HA3' ' A' ' 55' ' ' GLY . 7.4 p -49.73 -26.17 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -57.04 -30.43 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.325 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.477 ' HA ' ' H ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -107.69 -41.22 5.07 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.532 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -108.11 21.38 17.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 111.704 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 51' ' ' VAL . . . -82.91 -107.78 0.48 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.161 -1.019 . . . . 0.0 110.954 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.9 2.54 7.01 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.55 2.167 . . . . 0.0 111.913 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' CB ' ' CB ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -97.23 -68.06 0.82 Allowed 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . . . -40.8 -56.43 2.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 0.0 111.953 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -57.37 -18.68 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.908 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -91.1 -40.51 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.443 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.436 ' CD1' HD12 ' A' ' 103' ' ' LEU . 11.0 t80 -62.35 -62.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 66' ' ' VAL . 39.1 p -53.29 -35.75 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.961 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 59' ' ' SER . 3.8 tppp? -48.88 -31.9 8.0 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.616 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 1.8 mmmp? -83.31 -36.93 24.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.473 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.08 -0.8 37.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.741 178.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -109.9 -41.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.386 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 13.3 tt0 -95.26 -72.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.922 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.43 -45.05 85.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -98.46 141.44 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.972 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.65 29.06 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.59 61.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.0 mp -110.16 146.59 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' HG22 ' A' ' 72' ' ' ILE . 7.0 pt-20 -130.68 162.28 29.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 m -95.97 117.26 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.86 166.13 15.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 60.68 163.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -66.68 -17.9 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -177.37 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 110.933 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.97 88.7 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.22 111.01 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.17 -36.0 5.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.028 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.403 HG22 ' HG3' ' A' ' 84' ' ' LYS . 1.9 m -105.95 -176.39 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -109.21 -18.3 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.672 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.403 ' HG3' HG22 ' A' ' 82' ' ' THR . 13.0 mttt -58.38 -161.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 87' ' ' ARG . 1.2 p90 -84.34 11.68 8.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.791 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 89' ' ' LEU . . . 108.13 35.93 2.43 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.486 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.472 ' HB2' ' CE1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -101.89 -24.11 14.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.163 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.88 60.38 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.207 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -107.89 113.08 26.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.251 0.526 . . . . 0.0 111.381 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' CB ' ' CD1' ' A' ' 34' ' ' PHE . . . -144.36 109.87 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.39 126.61 35.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.688 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.14 107.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.602 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -130.07 84.47 2.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.52 110.39 14.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.183 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t70 48.69 30.58 2.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.039 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.45 26.27 63.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.323 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 11.0 mmtt -79.75 164.05 23.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.934 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.89 83.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.7 m -91.4 -34.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -66.71 -33.21 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.29 -20.7 21.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.43 -84.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.55 0.215 . . . . 0.0 111.483 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.16 -24.23 9.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 53.4 t -57.99 -19.38 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.272 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -56.99 -34.86 68.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 110.423 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -98.61 21.97 10.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.684 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 108' ' ' LEU . . . 97.15 -4.59 62.69 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.178 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 58' ' ' ALA . 6.0 mt 140.9 -25.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.595 0.758 . . . . 0.0 111.156 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.471 ' CB ' ' CB ' ' A' ' 57' ' ' GLU . . . -168.57 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' H ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.692 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.75 126.37 54.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -67.7 125.3 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.959 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m -104.94 107.09 17.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.88 122.92 42.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 125.47 39.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.958 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 1.2 mm? -119.99 106.55 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.46 152.34 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -105.98 106.95 17.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -114.17 148.26 39.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.92 120.74 8.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.379 2.053 . . . . 0.0 112.463 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.35 107.84 4.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -115.94 158.73 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -106.04 142.06 36.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.612 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.4 tt -95.9 -47.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.822 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.22 132.87 11.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 111.344 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . . . -114.25 149.75 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.905 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 19' ' ' ASP . 2.8 tt -53.65 -44.24 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.126 0.488 . . . . 0.0 110.143 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.6 OUTLIER 169.1 -108.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.6 -10.05 59.49 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.123 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -95.52 -82.19 0.39 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 18' ' ' ILE . 14.6 t -96.45 159.37 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 3.8 p -148.1 133.17 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.721 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -82.79 143.83 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 3.0 mt -133.32 149.06 51.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.36 97.63 7.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -105.44 106.27 16.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.981 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 58.33 30.29 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.95 -12.86 66.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.789 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.94 125.38 68.77 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.613 0.244 . . . . 0.0 110.723 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 93.78 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.404 2.069 . . . . 0.0 112.321 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.6 tpt -80.73 120.64 24.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -91.85 121.51 33.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -105.14 61.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 85' ' ' TYR . 1.7 mtt-85 -66.65 93.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -110.04 81.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.809 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.92 127.77 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.33 -176.52 6.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.839 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.41 122.89 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.093 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.19 110.06 18.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.9 p -144.13 157.03 57.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.9 59.39 3.52 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.127 . . . . 0.0 112.321 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -164.03 -44.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.746 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 t -99.67 26.03 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -65.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.746 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.426 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 5.3 m-70 60.48 71.78 0.81 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.63 14.24 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.84 2.36 . . . . 0.0 112.876 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -84.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.629 0.252 . . . . 0.0 111.041 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -107.07 -38.23 6.08 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 55' ' ' GLY . . . 66.05 32.76 83.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.695 ' HA ' ' N ' ' A' ' 55' ' ' GLY . 12.7 p -86.1 27.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.692 0.282 . . . . 0.0 111.486 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -50.02 -32.55 15.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -125.93 -27.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.54 178.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.558 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.3 t80 -176.72 -25.56 0.01 OUTLIER 'General case' 0 C--N 1.345 0.4 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.666 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.695 ' N ' ' HA ' ' A' ' 51' ' ' VAL . . . 79.99 -104.81 2.26 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.601 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 2.2 Cg_endo -41.13 -28.07 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.912 2.408 . . . . 0.0 112.608 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 15.7 tp10 -78.56 -30.7 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.191 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.698 ' CB ' ' HA ' ' A' ' 109' ' ' ALA . . . -39.27 -60.16 0.95 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -84.09 -47.39 10.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.5 -31.35 6.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.381 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' CD2' ' HG ' ' A' ' 103' ' ' LEU . 54.8 t80 -56.85 -58.49 7.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.225 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.25 -23.39 43.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.557 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -25.26 63.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -87.13 -26.92 23.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.296 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.426 ' HA ' ' CB ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -70.16 -6.44 34.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.572 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -112.3 -41.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -87.92 -68.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.593 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -73.53 -32.54 64.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 0.0 111.251 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -113.97 149.39 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.086 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -165.35 70.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.86 84.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 94' ' ' ALA . 3.2 mp -135.65 150.73 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' N ' HG21 ' A' ' 72' ' ' ILE . 31.9 tt0 -137.22 149.96 47.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.645 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 76' ' ' PHE . 6.2 m -95.91 109.87 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.804 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.1 82.91 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.432 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.417 ' CE1' ' HB ' ' A' ' 74' ' ' VAL . 45.5 p90 -178.85 133.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.18 16.76 19.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -64.92 -34.67 78.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.51 27.53 68.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.95 110.8 20.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -4.66 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.405 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -89.78 -175.69 4.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.994 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 82' ' ' THR . 3.6 t0 84.94 -49.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -67.86 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.413 ' CZ ' ' HD2' ' A' ' 35' ' ' ARG . 70.5 t80 -149.32 11.4 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.72 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 70.44 18.08 75.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.532 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 169.19 -24.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.622 0.249 . . . . 0.0 111.186 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.87 -38.77 86.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.919 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.42 109.88 15.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.19 117.95 9.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.218 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 93.68 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.435 ' HB ' ' CG2' ' A' ' 72' ' ' ILE . 3.0 pt -112.71 158.18 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.43 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.66 89.56 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.759 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.487 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.87 141.25 36.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.571 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 49.18 31.25 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.434 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.1 -37.62 3.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.744 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -139.33 139.59 37.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.004 0.43 . . . . 0.0 111.235 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.31 94.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.112 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.33 -28.66 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -66.01 -37.4 85.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -29.73 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.3 -33.95 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.426 ' HG ' ' CD2' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -59.29 -58.15 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.66 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 t -66.09 -14.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.537 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -24.88 60.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -94.35 23.29 5.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.17 -3.32 61.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.596 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tt 69.55 86.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.504 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.698 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . . . -166.63 -41.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.088 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.447 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.903 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.51 113.77 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.7 t -106.56 153.32 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 m -80.63 139.33 36.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.851 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 100.86 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -123.87 139.25 54.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.9 112.91 14.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -82.04 109.64 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.644 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.7 111.09 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -129.25 143.05 47.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.07 120.86 7.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.491 2.127 . . . . 0.0 112.52 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 107.94 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.04 149.87 45.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HB3' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -98.56 139.6 34.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.58 -34.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -137.87 93.27 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.58 111.06 23.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.527 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 mt -101.07 -46.9 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.7 -61.62 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.235 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.33 -27.7 2.92 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.834 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -127.42 -76.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.929 0.395 . . . . 0.0 110.781 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.24 146.82 39.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 t -120.77 143.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -128.65 109.47 11.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -101.88 154.26 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.689 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 tpp -85.62 94.92 9.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -120.71 93.66 4.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 tttm 54.54 41.17 32.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.9 16.03 78.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -118.0 142.29 30.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.643 0.259 . . . . 0.0 110.761 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.15 97.98 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 107.75 7.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 p -72.05 125.94 28.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -115.23 95.94 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.76 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 62.07 89.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 171.95 12.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.32 103.12 10.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.57 158.96 36.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.78 112.1 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -154.9 87.74 1.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.03 75.78 10.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.21 82.67 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.715 2.277 . . . . 0.0 112.418 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.33 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.992 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.5 -28.05 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.323 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 pttm 44.22 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.549 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 86.7 t60 -122.22 50.89 2.78 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.297 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 46' ' ' HIS . 95.5 Cg_endo -77.47 -1.8 11.97 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.548 2.165 . . . . 0.0 112.668 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -73.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -90.83 -38.2 13.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.22 42.03 94.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.418 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 t -96.26 23.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 0.0 111.278 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.3 mt-10 -111.11 13.17 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.989 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' GLU . 0.3 OUTLIER 161.34 -2.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.465 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 8.2 m-85 -131.11 -1.53 4.06 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.12 -140.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.443 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 2.41 7.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.551 2.167 . . . . 0.0 112.864 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HB2' ' CA ' ' A' ' 109' ' ' ALA . 9.9 mt-10 -95.98 -63.8 1.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.105 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . . . -40.43 -33.35 0.25 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.789 0.328 . . . . 0.0 111.517 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -81.65 -57.95 3.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.481 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.05 -28.39 7.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.503 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.468 ' CE1' ' CG2' ' A' ' 104' ' ' VAL . 61.4 t80 -57.64 -65.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.64 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 61' ' ' PHE . 67.6 p -79.58 -26.49 41.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 22.7 ttmt -60.16 -24.73 64.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -92.07 -25.09 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.919 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.586 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -63.7 -9.23 13.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.527 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' CG1' ' CD1' ' A' ' 14' ' ' LEU . 28.3 m -114.72 -41.31 3.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.12 -68.87 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.345 . . . . 0.0 111.912 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.58 -29.96 68.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.355 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -72.29 170.47 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.185 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -108.61 -55.92 2.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.51 163.74 17.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 1.6 mp -142.4 162.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.04 137.44 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.43 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.2 p -95.83 109.81 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 4.5 pt-20 -129.62 139.79 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -166.99 132.01 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.0 -30.28 71.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.983 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -107.81 -47.35 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.838 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.86 -40.66 2.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.75 116.52 32.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.18 -55.04 4.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.515 ' HB ' ' CD ' ' A' ' 84' ' ' LYS . 96.4 m -121.96 158.02 30.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.027 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.89 47.06 0.98 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.761 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.515 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -92.21 -38.79 11.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.723 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.487 ' N ' ' HG2' ' A' ' 84' ' ' LYS . 4.9 t80 -158.3 11.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.415 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.94 32.05 78.5 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.365 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.88 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.559 0.219 . . . . 0.0 111.234 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -45.43 -79.66 0.06 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.945 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.86 122.13 26.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.865 0.365 . . . . 0.0 110.78 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.13 148.35 34.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -72.35 142.07 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.784 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.402 ' CG2' HG21 ' A' ' 72' ' ' ILE . 17.6 mm -128.53 120.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.187 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 91' ' ' TYR . 1.1 m-85 -116.64 78.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.6 111.19 15.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 68.4 45.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.326 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.24 24.64 52.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.062 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -134.19 150.44 51.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.283 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.22 107.19 15.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.7 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.5 -7.9 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.774 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.439 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 4.9 m-80 -58.66 -20.32 47.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.19 -18.72 24.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.394 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.71 -84.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.14 -22.23 11.08 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.468 ' CG2' ' CE1' ' A' ' 61' ' ' PHE . 14.6 t -54.83 -23.29 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -57.72 -24.12 55.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.963 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -103.76 19.12 20.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.29 -3.2 82.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.854 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.62 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER 78.38 74.0 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.584 0.231 . . . . 0.0 110.874 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.62 ' CB ' ' O ' ' A' ' 108' ' ' LEU . . . 131.15 -71.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.638 0.775 . . . . 0.0 110.226 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.985 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.838 0.352 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 t -115.82 139.96 49.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -103.59 126.91 51.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -67.82 126.07 28.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -81.81 125.85 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.929 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.49 110.75 18.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 mt -127.06 103.96 7.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -94.55 128.8 41.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.732 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -81.21 115.73 20.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.87 129.29 18.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.443 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.67 120.52 8.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.368 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.42 107.39 4.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -116.99 164.08 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -96.92 144.04 27.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.896 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -40.61 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.57 126.02 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.985 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 23' ' ' VAL . . . -103.84 148.59 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 4.2 pt -51.12 -40.36 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 4.5 p30 165.11 -113.66 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.37 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.31 -10.12 59.77 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.618 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -82.46 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.4 m -130.14 159.43 36.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.418 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 22.9 m -124.8 154.4 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.229 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.99 135.33 54.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 mp -110.95 159.89 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.9 94.91 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.33 95.35 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.11 30.16 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.01 43.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.685 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -85.81 114.99 59.9 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.518 0.199 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.88 102.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.504 2.136 . . . . 0.0 112.337 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ttp -87.6 150.04 23.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -104.84 140.01 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.935 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.41 ' HB2' ' CD1' ' A' ' 25' ' ' LEU . 13.6 t80 -124.56 112.85 17.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.73 87.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.211 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.75 81.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tp -125.53 145.7 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.01 105.22 12.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.674 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 m -153.75 142.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -145.8 87.38 1.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 110.875 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.51 75.44 10.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 75.6 Cg_endo -88.1 -14.22 3.47 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.806 2.338 . . . . 0.0 112.438 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.1 tm-20 165.89 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.528 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -154.09 -64.45 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.498 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.84 -55.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.7 p80 178.32 83.34 0.15 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.53 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.52 -26.35 12.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 111.876 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 pttt 175.83 -53.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.396 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' O ' ' CA ' ' A' ' 55' ' ' GLY . 4.5 mtmp? -107.81 -38.81 5.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' GLY . . . 106.89 35.32 2.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.312 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 18.4 t -66.56 1.41 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.402 ' CB ' ' HB2' ' A' ' 42' ' ' PRO . 5.8 mm-40 -89.54 15.01 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 8.3 tttt -167.06 -45.8 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.572 ' CG ' ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 169.81 -22.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.14 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . 46.78 -111.75 0.77 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.214 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.42 -19.79 45.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.002 1.801 . . . . 0.0 111.011 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -88.56 -20.82 24.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.572 ' HA ' ' CG ' ' A' ' 54' ' ' TYR . . . -39.98 -35.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.452 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -79.21 -43.32 24.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 0.0 109.719 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' GLU . . . -50.71 -40.37 53.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.527 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.44 ' CD1' HG23 ' A' ' 104' ' ' VAL . 10.6 t80 -40.23 -61.58 0.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.948 0.404 . . . . 0.0 110.427 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 65' ' ' MET . 2.4 m -88.19 -49.74 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.114 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' HA ' ' CG1' ' A' ' 66' ' ' VAL . 34.1 ttmt -40.34 -29.32 0.08 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 2.9 tttm -85.8 -33.25 21.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.0 110.421 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 62' ' ' THR . 6.7 tpp -94.15 -0.67 55.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.011 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.482 ' CG1' ' HA ' ' A' ' 63' ' ' LYS . 7.4 p -123.48 -41.72 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -95.59 -55.2 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 111.828 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -87.06 5.26 38.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.791 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.452 ' HB1' ' CA ' ' A' ' 65' ' ' MET . . . -99.54 173.53 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.403 . . . . 0.0 111.482 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 -66.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.83 -176.72 3.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 73' ' ' GLU . 4.1 mp -143.68 145.58 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' HG21 ' A' ' 72' ' ' ILE . 14.8 pt-20 -113.72 133.14 55.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.403 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 4.2 m -95.67 118.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 111.207 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -94.61 78.58 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.285 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 74' ' ' VAL . 8.0 p90 -171.21 136.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.75 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -63.92 -60.86 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.471 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.31 -30.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.281 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -41.73 134.75 3.4 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.26 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 142.49 55.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -34.08 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 p -122.09 147.16 46.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.42 -9.9 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -27.77 6.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -178.13 -37.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.06 -10.23 34.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.633 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.22 -5.6 6.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.508 0.194 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.54 -76.28 0.64 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.545 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.01 110.08 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.829 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.92 139.82 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.39 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -109.37 156.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -141.99 83.56 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.981 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.9 106.81 12.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 64.77 42.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.801 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 21.75 74.43 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.669 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -158.0 156.66 31.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 166.75 22.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.41 HG13 ' CE1' ' A' ' 61' ' ' PHE . 19.6 t -84.49 -35.5 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -58.59 -28.12 65.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.58 -18.84 61.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.3 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.48 -74.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.794 0.33 . . . . 0.0 111.769 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.422 HD13 ' CG ' ' A' ' 57' ' ' GLU . 4.5 tt -95.23 -56.72 2.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.83 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 61' ' ' PHE . 15.0 t -48.03 -26.43 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.94 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -15.68 61.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 0.0 111.311 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -76.08 5.18 7.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.769 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.46 4.54 58.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.394 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.821 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mt 64.46 76.32 0.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.165 0.507 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . 176.91 103.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.822 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.902 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.923 0.392 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.1 p -136.23 127.94 29.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 t -98.13 150.1 21.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -63.11 145.22 55.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 106.49 18.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 131.56 46.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.07 148.55 36.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.31 153.05 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.28 127.9 44.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.03 147.13 64.11 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.94 120.54 8.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.422 2.081 . . . . 0.0 112.024 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.64 107.94 4.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.849 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 168.81 11.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.23 144.02 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.4 tt -82.13 -42.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.409 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -143.55 105.81 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.14 123.68 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.23 -35.03 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.174 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.08 -64.58 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.173 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.06 -26.34 8.74 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.789 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.75 -79.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 m -131.83 158.96 39.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.68 145.12 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.055 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.31 142.26 51.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mt -115.91 152.11 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 95.62 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -106.6 93.64 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 58.25 41.84 22.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.973 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.66 24.03 68.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.59 128.04 24.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.604 0.24 . . . . 0.0 110.803 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.82 90.41 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.367 2.045 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ttm -78.41 113.07 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 p -73.54 135.5 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 4.7 t80 -127.79 109.21 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.747 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 64.24 144.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.3 mp -91.05 172.01 8.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.48 99.43 10.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.7 tp -132.38 106.44 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -136.38 159.23 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -92.87 127.2 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 t -124.05 85.78 54.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.82 -55.14 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.502 2.135 . . . . 0.0 112.38 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -24.63 9.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.3 -54.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -48.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.711 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.68 143.8 49.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.717 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -86.6 26.23 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.851 2.368 . . . . 0.0 112.687 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 mttm 59.3 27.89 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -107.12 -38.16 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.2 95.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.252 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -117.3 16.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.709 0.29 . . . . 0.0 111.454 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.55 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 11.1 mt-10 -116.0 13.31 15.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.412 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 52' ' ' GLU . 18.8 ptpt 139.96 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.346 1.058 . . . . 0.0 108.474 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.47 ' CG ' ' CB ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER 50.53 25.35 1.94 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 -178.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -109.47 1.85 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.252 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 2.36 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.678 2.252 . . . . 0.0 113.024 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -85.59 -62.97 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 53' ' ' LYS . . . -45.77 -48.92 15.39 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.723 0.296 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 13.0 t -48.53 -29.48 4.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -91.46 -38.19 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.605 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.2 -65.4 0.56 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.241 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -20.4 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -65.62 -33.4 75.81 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.628 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 2.4 mttp -92.16 -21.34 20.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.148 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.437 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -75.0 -5.32 43.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.011 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.41 ' HA ' ' CD1' ' A' ' 72' ' ' ILE . 22.6 m -123.39 -41.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.705 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.73 -66.8 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.903 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -92.83 5.39 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -98.96 92.07 5.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.487 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm 60.17 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.214 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mttt 166.95 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.7 mt 79.23 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.28 140.11 33.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.692 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.8 p -95.92 109.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HG3' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -124.84 -86.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.831 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.486 ' CE1' ' CD2' ' A' ' 91' ' ' TYR . 2.7 t80 59.75 117.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 111.163 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -86.03 57.17 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.454 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -166.73 -44.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.34 144.63 9.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HB2' ' HG ' ' A' ' 89' ' ' LEU . 5.7 pm0 -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.0 110.722 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -114.34 -55.72 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.565 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -141.4 -175.3 4.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.729 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 82' ' ' THR . 24.2 t70 104.02 -72.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.532 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.415 ' CB ' HD21 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -92.15 90.6 7.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.394 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 43.1 t80 64.86 11.35 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.921 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 58.75 30.79 66.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.465 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 165.35 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.464 0.306 . . . . 0.0 110.789 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.72 -12.87 36.57 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.062 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HG ' ' HB2' ' A' ' 80' ' ' GLN . 0.2 OUTLIER -83.7 109.77 17.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 34' ' ' PHE . . . -144.23 134.74 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.486 ' CD2' ' CE1' ' A' ' 76' ' ' PHE . 5.5 m-85 -112.11 119.92 40.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.24 136.07 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.604 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.413 ' CD2' ' HG3' ' A' ' 75' ' ' GLU . 74.5 m-85 -127.34 77.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.784 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.06 141.81 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.246 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 p30 48.88 31.23 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.651 0.739 . . . . 0.0 109.505 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.51 -47.01 2.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.059 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -161.7 111.69 1.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.764 0.282 . . . . 0.0 111.589 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.3 ttm -147.41 80.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.283 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -98.95 -59.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.111 0.482 . . . . 0.0 111.961 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 105' ' ' ARG . 5.8 p-10 -89.56 -57.21 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.215 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -40.56 -28.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.18 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.657 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 104' ' ' VAL . 1.3 tm? -114.42 -57.58 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.456 0.646 . . . . 0.0 111.469 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.444 ' N ' HD12 ' A' ' 103' ' ' LEU . 18.5 t -48.82 -16.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.012 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -49.93 -28.66 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.975 0.417 . . . . 0.0 110.486 179.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -98.41 23.04 8.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.068 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.85 38.65 65.28 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.0 mt 55.87 87.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.62 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.61 -6.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HA ' ' CD2' ' A' ' 54' ' ' TYR . 8.1 ptpt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 p -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.932 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 p -71.93 116.95 12.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.3 m -101.6 147.58 26.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -84.14 134.22 34.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 105.41 17.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -127.07 104.05 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.56 106.53 18.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.03 106.91 17.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -128.24 126.54 23.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.785 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.36 121.46 9.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.385 2.057 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.15 107.43 4.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -125.44 150.58 47.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.58 141.74 41.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.695 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.4 tt -88.64 -47.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.703 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -155.07 130.3 9.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 111.46 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.03 133.51 55.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.698 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 17.3 tt -54.66 -49.45 67.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.23 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER 166.93 -152.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.84 -10.52 4.79 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.449 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.15 -71.17 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.026 0.413 . . . . 0.0 111.129 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -147.0 159.05 44.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.45 117.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.978 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -83.34 124.9 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 2.4 mp -89.67 160.85 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.1 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.63 98.32 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt 57.57 43.42 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.32 22.56 76.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.597 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -114.31 133.64 22.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.576 0.226 . . . . 0.0 110.815 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.06 99.49 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.458 2.105 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 mtt -95.9 149.75 21.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.88 144.55 36.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.976 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -138.02 122.81 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 62.86 145.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.26 103.09 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.74 102.82 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.839 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.97 107.76 17.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.61 140.26 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -141.72 89.73 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -62.65 145.84 94.92 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.99 -50.65 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.418 2.079 . . . . 0.0 112.371 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -159.3 28.51 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.802 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 t -150.77 -168.28 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.444 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -70.2 -62.35 2.29 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.683 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 46' ' ' HIS . 3.3 Cg_endo -46.38 -44.7 20.1 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.817 2.345 . . . . 0.0 112.548 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -28.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -73.39 -30.08 63.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.1 42.08 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.625 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.4 m -95.8 -30.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.054 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -92.71 13.56 19.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER 64.81 4.67 2.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER 172.11 -25.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.736 0.303 . . . . 0.0 110.813 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.15 -102.07 2.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.371 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.96 -25.69 63.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.61 -36.93 65.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.89 -26.23 1.62 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -32.37 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.82 -47.14 74.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.512 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.429 ' CG ' ' N ' ' A' ' 62' ' ' THR . 0.1 OUTLIER -47.85 -47.87 31.26 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.885 0.374 . . . . 0.0 110.488 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.7 t -81.94 -26.15 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -26.77 65.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.747 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 69' ' ' ALA . 11.9 mttp -92.02 -24.86 19.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.574 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 24.6 ttp -57.21 -15.25 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.414 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.4 m -105.23 -42.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.6 -69.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.714 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.24 -20.49 62.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.592 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.574 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -93.08 -179.84 5.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.356 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -69.45 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.068 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 172.61 149.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.922 0.391 . . . . 0.0 110.924 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 1.8 mp -102.78 161.61 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.051 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -133.78 149.55 51.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.48 109.82 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.967 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -88.48 -178.54 5.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 75' ' ' GLU . 15.5 p90 46.94 117.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.04 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.08 32.02 6.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -59.26 -27.55 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.069 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.45 -84.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.21 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.27 110.82 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.601 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -110.11 -40.29 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.7 p -130.1 133.94 47.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.38 -8.31 58.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.087 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.59 70.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -177.19 -37.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.05 -10.27 34.03 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.536 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -123.21 -24.11 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.54 -84.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.736 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tp -89.08 116.22 27.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.335 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.04 141.88 30.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 1.5 m-85 -80.89 127.3 32.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.13 149.77 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -134.42 89.12 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.25 115.55 18.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.24 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 t70 67.57 26.64 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.13 -31.26 7.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.816 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -134.17 131.43 38.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 111.025 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.18 158.36 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 t -95.12 -8.64 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -63.06 -16.57 60.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -18.83 30.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.53 -84.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.517 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.64 -24.07 10.3 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.424 ' N ' HD22 ' A' ' 103' ' ' LEU . 63.6 t -58.93 -31.47 45.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -98.17 -16.01 19.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -83.87 -25.2 30.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.533 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.12 47.8 2.16 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.332 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.573 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 2.6 tt -147.98 6.16 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' N ' ' HB2' ' A' ' 53' ' ' LYS . . . 176.32 86.78 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.829 0.347 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -111.33 95.15 5.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 p -90.41 119.05 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.6 p -74.44 128.31 35.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.03 138.44 52.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.826 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 1.1 ttmt -103.14 138.57 39.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 76' ' ' PHE . 1.6 mm? -79.06 112.87 16.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.034 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -70.0 153.21 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -106.95 106.91 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -110.52 129.65 23.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.379 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.1 120.02 7.58 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.253 1.969 . . . . 0.0 112.486 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' CB ' HG22 ' A' ' 74' ' ' VAL . . . -146.0 107.81 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.472 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -117.49 163.41 16.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.021 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' CD1' ' HB ' ' A' ' 66' ' ' VAL . 1.6 pp -106.23 144.19 33.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 15' ' ' ILE . 38.3 mm -62.2 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.99 135.42 1.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.808 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.12 137.73 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tt -57.71 -46.36 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 166.45 -110.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.41 -10.62 59.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.54 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.17 -80.75 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.714 0.292 . . . . 0.0 111.435 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -131.48 157.76 42.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.378 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.466 ' CG1' ' CD1' ' A' ' 34' ' ' PHE . 7.5 p -147.96 107.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -83.5 111.37 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.514 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HA ' ' CB ' ' A' ' 14' ' ' LEU . 3.6 mt -89.74 161.71 15.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.634 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.2 ttp -106.41 109.04 20.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -126.1 92.67 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.02 41.04 5.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.86 37.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.644 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -124.74 114.86 26.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.519 0.2 . . . . 0.0 110.876 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.75 83.0 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.487 2.124 . . . . 0.0 112.275 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 mtm -80.94 123.46 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.693 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -110.23 148.08 32.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.466 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -88.83 -171.02 3.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HG2' ' CD2' ' A' ' 34' ' ' PHE . 6.9 ptt180 -46.68 148.42 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 172.12 9.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -94.41 156.15 16.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.93 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.44 -178.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.3 138.44 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.66 96.17 7.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.0 p -123.71 156.18 65.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.32 -14.71 45.6 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.605 2.203 . . . . 0.0 112.425 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.38 -28.41 65.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.11 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 m -161.0 78.94 0.6 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -74.54 154.14 38.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 46' ' ' HIS . 13.1 m170 -96.86 101.82 10.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.1 -43.84 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.415 2.077 . . . . 0.0 112.201 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -145.01 -55.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.695 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 67.9 mttt -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.352 0.596 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.23 -51.9 0.79 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.574 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.43 -67.37 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.214 1.007 . . . . 0.0 112.216 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -121.29 -78.11 0.59 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.682 0.754 . . . . 0.0 111.317 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.87 2.12 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.521 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 76.7 t80 -83.47 0.97 43.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.224 0.535 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.55 -60.36 1.81 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.695 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 85.7 Cg_endo -92.06 -48.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.674 2.916 . . . . 0.0 113.153 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -56.92 10.28 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 54' ' ' TYR . . . -45.95 -49.33 15.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 111.428 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' LYS . 4.2 m -60.06 -19.97 55.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.73 -58.12 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.128 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -72.85 -62.63 1.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.911 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.406 ' CA ' HD13 ' A' ' 103' ' ' LEU . 1.9 m -49.63 -27.58 4.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.219 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 59' ' ' SER . 37.3 ttmt -76.61 -21.77 55.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -88.3 -23.27 23.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.467 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 5.0 mmt -89.95 -1.03 57.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 15.9 m -123.3 -41.69 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -85.7 -72.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.58 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.49 -20.69 64.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -102.46 111.14 23.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.685 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.58 51.35 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 30.2 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 mp -80.87 149.73 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.67 168.43 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.403 HG22 ' CB ' ' A' ' 12' ' ' ALA . 9.7 t -106.2 109.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 5.3 mm-40 -91.45 82.24 5.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 7' ' ' LEU . 2.4 m-85 -168.66 117.8 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 2.9 t0 -65.65 -44.82 85.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.898 0.38 . . . . 0.0 110.804 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -169.49 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.378 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.18 149.45 0.88 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.873 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.8 160.99 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 mtt-85 -95.12 -55.29 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.9 p -140.19 157.55 45.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.184 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -98.79 -25.44 14.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.676 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -45.87 -29.33 1.34 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.452 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -176.28 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.38 25.72 6.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -160.73 -24.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.13 -80.27 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.7 mp -74.09 117.22 15.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.0 159.87 41.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.121 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 36.0 m-85 -103.35 142.17 34.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.502 HD12 HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -120.53 110.92 30.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 91' ' ' TYR . 17.3 m-85 -113.69 71.73 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.183 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.58 101.28 8.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.059 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 67.37 35.06 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 35.8 83.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.04 157.27 16.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.119 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.34 84.08 2.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.539 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 30.1 m -60.97 -47.24 94.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.273 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -49.19 -24.1 1.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.506 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -91.31 -63.12 1.3 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.15 -15.73 30.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 99' ' ' VAL . 4.9 tt -99.91 -49.04 4.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.416 ' CG2' HD23 ' A' ' 103' ' ' LEU . 22.9 t -90.12 -62.26 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.65 -24.53 61.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.692 0.282 . . . . 0.0 111.227 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -70.19 -17.67 63.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.342 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.32 47.17 2.24 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.474 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 mp -153.22 34.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . . . 167.7 42.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.767 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.789 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 pttt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.83 0.348 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 76' ' ' PHE . 24.3 mt -123.43 119.71 30.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -108.93 121.34 44.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.756 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -79.42 110.93 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.241 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.86 130.59 23.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.566 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.91 120.31 7.93 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.227 1.951 . . . . 0.0 112.544 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.66 107.7 4.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -125.27 141.58 52.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.249 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.808 HD22 ' HB2' ' A' ' 17' ' ' ALA . 3.5 mp -67.04 144.05 56.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pt -87.21 -28.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -167.91 94.22 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -98.64 115.5 28.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.354 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mt -80.64 -31.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 59' ' ' SER . 20.4 m-20 68.22 -65.68 0.25 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.079 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.16 33.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.689 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.422 ' O ' HD12 ' A' ' 37' ' ' LEU . 85.9 m-20 -121.44 -77.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -146.13 159.07 43.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 HG12 ' HB1' ' A' ' 17' ' ' ALA . 18.4 m -134.89 148.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.199 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 132.51 41.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -99.14 160.55 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.4 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.797 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -122.63 109.12 13.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.07 29.06 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.75 -4.13 83.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -85.94 127.81 60.69 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.799 0.3 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.69 83.27 2.11 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.563 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.62 111.35 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.679 ' CG2' HD11 ' A' ' 36' ' ' LEU . 8.9 t -86.57 155.01 20.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -123.58 97.5 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.473 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER 67.51 122.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD11 ' CG2' ' A' ' 33' ' ' THR . 5.9 mp -115.77 172.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 21' ' ' ASP . 1.8 mp -54.66 101.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.971 179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.68 ' HG3' HD12 ' A' ' 108' ' ' LEU . 1.4 mm-40 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.9 mmtt -120.26 -53.93 2.12 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.588 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -124.72 -25.35 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.18 -107.24 3.31 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.588 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 90.1 Cg_exo -44.93 -28.26 2.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.595 2.197 . . . . 0.0 112.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.47 -70.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.653 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.843 ' HB2' ' N ' ' A' ' 109' ' ' ALA . . . -52.41 -27.86 17.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.734 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 63' ' ' LYS . 10.4 t -70.0 -44.9 68.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.71 97.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.487 ' CD2' HD12 ' A' ' 103' ' ' LEU . 17.0 t80 -60.97 -44.26 97.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.113 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.421 HG23 HG11 ' A' ' 99' ' ' VAL . 1.9 m -76.46 -26.72 55.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 59' ' ' SER . 4.2 mmtp -59.06 -27.87 65.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -31.95 15.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.714 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.836 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 4.7 mmt -62.01 -13.68 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.308 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 17' ' ' ALA . 30.1 m -117.16 -41.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.715 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.5 tt0 -70.33 -67.53 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -45.11 12.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -80.71 60.66 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.81 58.42 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.3 31.66 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.748 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.723 HG12 ' HB2' ' A' ' 94' ' ' ALA . 2.1 mt -89.31 151.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -146.27 161.79 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 10' ' ' GLU . 4.9 m -96.01 109.64 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.455 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -101.4 72.52 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.54 ' HA ' HD22 ' A' ' 7' ' ' LEU . 20.9 p90 -177.38 118.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -114.03 30.32 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -59.15 -29.96 67.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.39 -33.67 5.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.14 126.04 30.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.2 -23.73 12.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 83' ' ' ASP . 1.3 t -140.18 133.56 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 82' ' ' THR . 6.5 t0 174.8 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.454 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -80.2 -66.97 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.535 ' CE1' HD13 ' A' ' 36' ' ' LEU . 23.4 t80 -118.79 -10.69 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.377 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 102.35 40.6 2.55 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.132 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 4.0 ttp180 89.6 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 110.636 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.44 ' HA3' ' CD1' ' A' ' 85' ' ' TYR . . . -103.0 -13.17 29.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.666 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.78 116.83 31.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.19 130.73 22.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' HB2' ' CD1' ' A' ' 76' ' ' PHE . 47.8 m-85 -61.97 122.0 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.581 HD11 ' OD1' ' A' ' 100' ' ' ASN . 8.1 pt -118.06 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 81.1 m-85 -121.81 79.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.53 124.47 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.83 47.93 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.629 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.49 21.0 40.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.339 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -146.57 153.92 40.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.068 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 mtm -81.3 148.37 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.421 HG11 HG23 ' A' ' 62' ' ' THR . 21.4 t -93.19 -32.65 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.581 ' OD1' HD11 ' A' ' 92' ' ' ILE . 11.2 m120 -65.48 -24.89 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.16 -18.91 23.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.396 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.73 -84.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.743 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.705 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.6 -15.96 13.36 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' HD13 ' A' ' 103' ' ' LEU . 15.1 t -70.36 -28.53 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -15.78 62.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.062 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -86.49 10.13 16.21 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.539 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 108' ' ' LEU . . . 97.51 34.58 5.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.622 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' HG3' ' A' ' 52' ' ' GLU . 6.2 mt 50.91 108.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 111.45 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.843 ' N ' ' HB2' ' A' ' 58' ' ' ALA . . . 88.57 -70.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.31 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 106' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mttm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.47 103.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.31 140.58 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 106.86 13.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 74' ' ' VAL . 6.0 mt-10 -130.38 144.02 51.6 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.18 121.61 6.22 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.607 2.204 . . . . 0.0 112.552 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.05 107.62 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.777 HG23 HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -111.82 163.38 14.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.7 pp -106.06 136.64 45.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.0 mt -74.48 -58.83 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 145.27 14.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB2' HG13 ' A' ' 23' ' ' VAL . . . -110.08 150.18 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 ' H ' ' A' ' 22' ' ' THR . 2.6 pt -63.11 -14.77 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 59' ' ' SER . 5.3 m-20 82.82 -8.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.2 -38.52 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.06 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 166.66 -18.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.643 0.222 . . . . 0.0 111.475 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.745 ' CG2' HD23 ' A' ' 36' ' ' LEU . 46.8 m -96.51 144.27 26.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' HB2' ' A' ' 17' ' ' ALA . 3.1 t -138.51 158.05 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -128.67 105.07 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.635 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -86.94 161.52 18.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.371 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.14 98.09 6.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.838 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -107.82 105.27 15.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 55.18 53.88 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.15 24.23 54.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -128.73 119.0 19.99 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.55 102.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.35 2.033 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.5 ttm -84.28 135.72 34.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 36' ' ' LEU . 1.9 p -86.77 142.12 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.514 ' HB2' HD12 ' A' ' 25' ' ' LEU . 16.8 t80 -135.68 94.73 3.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.725 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 34.78 74.54 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.936 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.745 HD23 ' CG2' ' A' ' 22' ' ' THR . 2.7 mp -98.64 127.0 44.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.2 82.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.733 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.645 ' C ' ' HB3' ' A' ' 109' ' ' ALA . 5.9 mt-10 . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 121.233 0.54 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HA ' ' C ' ' A' ' 108' ' ' LEU . 4.5 pttp -143.84 13.53 1.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.833 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 54' ' ' TYR . 12.7 t80 -126.15 -25.28 3.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.416 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -48.34 174.37 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.156 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.415 ' HD2' ' OXT' ' A' ' 110' ' ' LYS . 47.9 Cg_exo -56.47 2.51 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 113.509 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 109' ' ' ALA . 3.4 mt-10 -96.65 -49.02 5.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.871 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . -40.74 -52.39 2.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.948 0.34 . . . . 0.0 111.199 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 57.1 p -61.38 -47.76 84.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.392 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.12 -36.22 28.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.468 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.889 ' CE1' HG23 ' A' ' 99' ' ' VAL . 89.0 t80 -51.95 -60.7 2.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.509 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.8 OUTLIER -78.29 -30.98 48.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 1.6 tppp? -61.77 -21.87 64.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.011 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -89.97 -33.48 16.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.588 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 2.2 mtm -58.31 -15.67 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.209 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 67' ' ' GLU . 33.2 m -116.9 -41.38 2.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' HG23 ' A' ' 66' ' ' VAL . 10.8 tt0 -74.48 -64.88 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 111.49 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.11 -43.56 21.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.588 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -70.26 -175.06 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.024 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -129.92 -54.92 1.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.045 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 93' ' ' TYR . 3.7 mp -143.0 145.22 23.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.1 164.92 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.2 p -110.94 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.216 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' PHE . 22.3 mt-10 -91.16 128.65 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 75' ' ' GLU . 5.1 p90 48.74 168.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.274 0.559 . . . . 0.0 112.013 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -93.54 -14.15 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.341 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.55 -8.6 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.656 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.54 -77.55 0.25 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -106.34 111.32 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -30.61 8.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.476 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 80.9 p -90.51 -175.71 4.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.4 t0 76.59 -61.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.825 ' HD3' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.71 -16.75 63.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -179.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.141 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 109.24 -10.54 33.65 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.348 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 1.1 tpp180 171.96 26.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.191 0.196 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.82 -49.95 4.12 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.906 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.825 HD13 ' HD3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -73.91 109.76 7.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 111.129 -179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.3 122.51 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.977 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.1 111.97 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.779 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.698 HG13 HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -84.98 124.72 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.26 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.79 ' C ' HG23 ' A' ' 72' ' ' ILE . 12.1 m-85 -134.91 88.2 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.775 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.588 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.72 91.03 5.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.95 51.26 7.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.19 24.8 56.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.246 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 130.39 56.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ttt -104.52 83.87 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.889 HG23 ' CE1' ' A' ' 61' ' ' PHE . 6.5 m -68.22 -19.35 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.491 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 1.8 t-20 -56.3 -63.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 111.045 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -18.75 48.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.356 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.55 -46.55 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' A' ' 61' ' ' PHE . 8.7 tt -111.09 -50.79 2.91 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 59.7 t -58.76 -16.88 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -22.08 18.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.454 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.43 23.17 5.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.555 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 108' ' ' LEU . . . 94.55 -3.03 68.11 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.76 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 1.0 OUTLIER 99.24 22.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.698 0.799 . . . . 0.0 110.98 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.645 ' HB3' ' C ' ' A' ' 52' ' ' GLU . . . -177.73 -165.7 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.697 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.415 ' OXT' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.909 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' HD22 ' A' ' 7' ' ' LEU . 66.4 mttt . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.878 0.371 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 76' ' ' PHE . 1.4 mm? -127.32 104.02 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.25 121.86 45.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.912 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -78.0 112.11 14.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.29 137.4 22.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 121.96 9.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.519 2.146 . . . . 0.0 112.351 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.507 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -145.24 107.78 4.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.538 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.04 135.41 54.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.978 HD13 HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -68.18 113.42 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.852 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -31.76 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.39 91.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.545 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.98 ' HB3' HG21 ' A' ' 66' ' ' VAL . . . -95.64 106.18 18.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 20' ' ' GLY . 1.9 mp -80.38 -53.9 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER 82.34 -19.8 0.39 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.543 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 18' ' ' ILE . . . -61.38 -25.72 65.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.315 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -170.5 -40.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.718 HG23 ' HG3' ' A' ' 35' ' ' ARG . 1.1 m -128.27 159.07 36.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.903 0.382 . . . . 0.0 111.276 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 17' ' ' ALA . 2.9 t -150.71 145.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -126.1 147.13 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -130.61 156.87 44.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ttp -113.18 97.94 6.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.582 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -103.78 106.16 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.382 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 48.57 36.9 8.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.229 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.05 -21.18 43.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -87.94 125.0 65.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 110.542 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.0 Cg_endo -66.87 97.36 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.416 2.077 . . . . 0.0 112.462 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.94 129.65 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 87' ' ' ARG . 29.4 m -81.2 133.24 35.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 111.294 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.536 ' HB2' HD12 ' A' ' 25' ' ' LEU . 49.2 t80 -139.24 34.95 2.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.009 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.718 ' HG3' HG23 ' A' ' 22' ' ' THR . 67.7 ttp85 -61.19 127.46 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.57 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tp -134.93 81.69 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.3 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.721 ' O ' HD22 ' A' ' 38' ' ' LEU . 5.7 tt -85.12 100.1 11.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.721 HD22 ' O ' ' A' ' 37' ' ' LEU . 2.1 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.339 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER . . . . . 0 CA--C 1.52 -0.198 0 CA-C-O 121.281 0.562 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -24.69 -74.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.873 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.055 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -156.03 25.0 0.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.363 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.52 -132.56 2.84 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.148 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.59 -5.34 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.098 1.865 . . . . 0.0 111.133 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 3.5 mm-40 -93.12 -42.34 9.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.817 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.055 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . . . -39.42 -32.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -51.08 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 109.962 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -40.91 -44.1 2.23 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.381 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.756 ' HB2' HD21 ' A' ' 103' ' ' LEU . 3.1 t80 -43.79 -47.45 8.03 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.86 -47.02 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.212 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 67.7 mttt -50.71 -27.64 7.47 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 62.4 mttt -79.15 -32.73 44.43 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.769 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 mtp -93.16 -0.52 56.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.231 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.98 HG21 ' HB3' ' A' ' 17' ' ' ALA . 93.2 t -117.69 -41.73 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.669 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.69 -79.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.735 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -57.63 -21.92 42.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.48 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.769 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -63.88 178.72 0.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 0.0 111.402 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -69.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.3 133.99 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 65' ' ' MET . 3.8 mp -96.06 161.66 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 72' ' ' ILE . 1.4 pt-20 -146.1 139.84 26.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.641 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 12' ' ' ALA . 26.0 t -95.74 109.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 3.5 pt-20 -112.31 106.62 15.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.7 p90 175.63 117.89 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.585 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.31 74.39 0.87 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.844 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 -54.98 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.15 -100.71 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.88 121.75 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.471 ' CZ ' ' HB1' ' A' ' 90' ' ' ALA . 6.4 ptt180 -89.25 -30.89 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.5 HG22 ' HG3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -104.45 151.1 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.014 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.2 -18.87 13.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HG3' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -71.02 -78.65 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -108.44 -22.51 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.14 -10.05 70.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.402 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 20.8 mmt85 -129.93 -24.03 2.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.359 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.93 -78.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.748 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.85 115.09 12.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 0.0 111.069 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.471 ' HB1' ' CZ ' ' A' ' 81' ' ' ARG . . . -144.08 158.91 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.051 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.68 142.09 28.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.457 HG23 HG21 ' A' ' 72' ' ' ILE . 27.5 mt -117.05 116.46 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' C ' HG23 ' A' ' 72' ' ' ILE . 17.1 m-85 -114.61 78.22 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.065 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -78.99 93.25 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 63.99 44.61 4.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.203 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 25.69 58.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.863 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 155.36 44.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.91 0.386 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.0 mtt -120.67 99.16 6.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.637 HG12 ' HB3' ' A' ' 102' ' ' ALA . 5.1 t -72.79 -8.14 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.554 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 17.9 p30 -47.82 -30.8 4.32 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -91.2 -18.73 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.811 0.339 . . . . 0.0 111.537 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.637 ' HB3' HG12 ' A' ' 99' ' ' VAL . . . -48.98 -69.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.888 HD22 ' N ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -111.37 -32.18 6.81 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.888 ' N ' HD22 ' A' ' 103' ' ' LEU . 5.0 t -59.8 -20.67 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -77.56 -24.37 49.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.706 ' HB2' HD21 ' A' ' 108' ' ' LEU . 6.8 mt-30 -61.75 -17.41 55.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.033 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.681 ' C ' HD13 ' A' ' 108' ' ' LEU . . . 98.18 34.5 5.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.425 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.706 HD21 ' HB2' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -156.52 -115.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 58' ' ' ALA . . . -178.03 16.77 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.233 -0.292 . . . . 0.0 111.706 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.983 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.824 0.345 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.92 154.22 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.0 153.43 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.28 106.81 2.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.67 151.12 46.79 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.235 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.53 120.11 7.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.31 2.006 . . . . 0.0 112.215 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 74' ' ' VAL . . . -146.15 107.83 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.615 HG21 ' CE ' ' A' ' 71' ' ' LYS . 12.2 t -122.05 168.0 12.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.181 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.791 HD13 ' OG1' ' A' ' 62' ' ' THR . 1.3 mt -78.56 143.96 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.741 HG22 ' HD3' ' A' ' 16' ' ' LYS . 16.2 mt -75.88 -47.81 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.741 ' HD3' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -177.15 86.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.706 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.625 ' CB ' HG13 ' A' ' 23' ' ' VAL . . . -71.14 117.92 13.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.182 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.794 HG22 ' OD1' ' A' ' 19' ' ' ASP . 29.2 mm -60.18 -61.26 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.794 ' OD1' HG22 ' A' ' 18' ' ' ILE . 7.2 p-10 172.43 -137.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.372 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.94 -10.2 58.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.439 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.59 -84.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.786 0.293 . . . . 0.0 111.435 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -125.4 159.12 32.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.366 . . . . 0.0 111.117 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.625 HG13 ' CB ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.84 112.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -106.24 145.95 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -110.56 161.19 15.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.098 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 ttt -106.81 104.15 13.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' CE1' HG11 ' A' ' 74' ' ' VAL . 18.3 t80 -112.95 91.58 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.97 51.23 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.493 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 23.4 62.17 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.579 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -127.99 114.83 20.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.522 0.201 . . . . 0.0 110.816 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 97.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.443 2.095 . . . . 0.0 112.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.39 144.08 28.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.61 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.51 136.98 32.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.046 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.664 ' CD2' ' HB3' ' A' ' 90' ' ' ALA . 32.8 t80 -135.55 107.07 6.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 62.47 157.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.99 8.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 86.03 7.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.776 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.613 0.244 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 173.11 -8.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -135.79 25.23 3.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.673 0.273 . . . . 0.0 111.016 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.31 -133.15 6.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.97 -1.11 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.3 2.59 4.87 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.107 1.871 . . . . 0.0 111.584 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.676 ' CD ' HD23 ' A' ' 108' ' ' LEU . 8.6 mm-40 -94.92 -64.75 1.03 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.106 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.614 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . . . -40.25 -33.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.227 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 19' ' ' ASP . 40.0 p -79.3 -48.14 14.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.108 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.71 96.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 104' ' ' VAL . 30.1 t80 -44.95 -39.42 5.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.456 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.791 ' OG1' HD13 ' A' ' 14' ' ' LEU . 3.9 t -94.15 -29.07 15.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.331 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -26.33 68.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 68' ' ' ASN . 2.2 tttt -91.99 -38.3 12.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.987 0.423 . . . . 0.0 110.289 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.435 ' HA ' ' CB ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -57.43 -17.04 11.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 14' ' ' LEU . 4.6 m -104.89 -40.5 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -76.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 6.3 t30 -55.1 -36.28 65.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.381 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -76.17 -170.22 1.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.154 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -71.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.615 ' CE ' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER 176.47 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.232 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.949 HG21 HG13 ' A' ' 92' ' ' ILE . 2.2 mt 83.92 146.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 110.948 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -129.71 147.01 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.0 p -97.12 109.64 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.79 -76.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.255 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 55.0 p90 -85.89 117.67 24.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.17 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.22 24.04 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.969 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -140.44 -55.12 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.44 99.66 0.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.51 157.23 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.445 ' HB3' HD23 ' A' ' 89' ' ' LEU . 2.8 tpt85 -96.92 -44.8 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.413 ' CG2' ' HG3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -104.37 164.09 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -116.88 30.7 7.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.034 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 1.3 mttm -78.55 -66.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.742 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 93.7 t80 -137.93 11.2 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.35 40.11 97.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.093 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -174.43 -24.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.497 0.189 . . . . 0.0 111.356 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.7 -64.35 3.25 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 81' ' ' ARG . 2.6 tp -93.26 114.16 26.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.664 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . . . -131.85 146.68 52.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -83.45 122.58 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.949 HG13 HG21 ' A' ' 72' ' ' ILE . 11.2 tt -121.07 110.02 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.542 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -129.7 107.6 9.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.954 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB2' HG13 ' A' ' 72' ' ' ILE . . . -84.74 92.48 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.9 40.06 5.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.16 33.32 69.19 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -103.53 129.93 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.91 84.95 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 99' ' ' VAL . 21.6 t -75.75 -7.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 3.8 t-20 -56.52 -22.99 36.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -91.03 -18.87 23.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.91 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.871 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.701 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.43 -21.18 11.94 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.602 ' N ' HD22 ' A' ' 103' ' ' LEU . 20.1 t -61.93 -23.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 0.0 111.499 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -15.58 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.39 23.14 1.66 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.08 47.18 87.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.685 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.676 HD23 ' CD ' ' A' ' 57' ' ' GLU . 5.3 mp -122.83 -44.88 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.816 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 58' ' ' ALA . . . -134.33 37.31 3.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 15.2 mtmm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 121.026 0.441 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 76' ' ' PHE . 10.9 tp -88.21 155.14 19.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 113.3 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -67.67 106.93 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -96.1 152.08 38.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 119.1 6.07 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.668 1.579 . . . . 0.0 112.286 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 74' ' ' VAL . . . -146.55 107.63 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.362 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 m -123.67 145.86 48.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -91.34 144.13 25.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.706 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 16' ' ' LYS . 3.9 tp -86.1 -46.27 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.362 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' N ' HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.84 135.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.719 ' HB2' HG13 ' A' ' 23' ' ' VAL . . . -114.21 150.14 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -55.61 -47.64 78.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.678 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 19.9 t70 169.25 -110.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.809 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.73 -10.47 58.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.748 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -80.27 -90.04 0.06 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 m -97.14 159.09 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.064 0.459 . . . . 0.0 111.671 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -147.13 108.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.438 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 146.98 27.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.091 0.472 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 6.1 mt -124.22 130.92 53.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.681 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.403 ' CE ' HD13 ' A' ' 15' ' ' ILE . 1.6 tpp -85.45 100.71 12.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 29.8 t80 -126.06 112.47 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 27' ' ' TYR . 10.1 ptpt 47.44 29.05 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.31 -19.79 50.26 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.873 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -86.06 114.97 60.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.34 102.59 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.569 2.179 . . . . 0.0 112.408 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.5 mtt -99.28 127.7 45.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.485 HG22 ' HD2' ' A' ' 87' ' ' ARG . 1.5 t -105.55 140.42 38.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.17 151.44 48.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 60.49 102.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -135.46 99.65 4.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.561 . . . . 0.0 111.327 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.25 126.88 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.842 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.928 0.394 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HB3' ' N ' ' A' ' 110' ' ' LYS . 4.4 tptt -112.25 -28.51 7.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.67 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -169.61 -26.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -101.04 2.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.29 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 64.5 Cg_exo -40.77 -28.65 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.46 2.107 . . . . 0.0 112.724 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -73.11 -45.38 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.202 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . . . -51.49 -49.07 62.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -64.06 -37.63 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' GLU . . . -47.91 -34.1 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.16 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.816 ' CZ ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -53.54 -44.35 69.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.314 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.816 HG23 ' CZ ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -94.03 -28.39 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.417 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -69.42 -22.11 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ALA . 6.3 mtpt -84.96 -33.15 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.032 0.444 . . . . 0.0 109.941 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.575 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.39 -14.37 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.431 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 14' ' ' LEU . 30.2 m -107.76 -41.68 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.8 mt-10 -95.47 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.39 -28.9 69.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.685 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -86.91 171.65 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.433 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.84 -60.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.71 169.72 24.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.668 HG21 ' HB ' ' A' ' 92' ' ' ILE . 3.6 mp -141.51 157.11 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.8 mt-10 -134.65 171.2 14.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.968 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 12' ' ' ALA . 21.5 t -107.84 115.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.356 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.7 85.69 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.75 ' O ' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.89 130.35 55.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.908 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -63.64 -53.61 48.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.0 -35.83 16.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.64 78.47 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -117.7 110.72 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -28.15 7.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 7.6 p -89.95 -175.79 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 82' ' ' THR . 4.0 m-20 81.09 -57.5 0.28 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -69.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.674 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -153.5 11.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.566 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.45 24.03 71.73 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.221 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HD2' HG22 ' A' ' 33' ' ' THR . 2.6 ptt180 167.99 -24.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.633 0.254 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.39 -39.16 5.5 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.11 109.58 21.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.59 28.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.082 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.424 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -105.28 126.22 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 72' ' ' ILE . 16.1 pt -125.72 143.49 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 111.453 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.61 ' C ' HG23 ' A' ' 72' ' ' ILE . 73.3 m-85 -140.24 107.98 5.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 65' ' ' MET . . . -79.23 107.31 11.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.403 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.78 47.13 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.58 77.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -107.34 119.05 38.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -98.53 83.91 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.754 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.44 -27.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.555 ' OD1' HG21 ' A' ' 104' ' ' VAL . 32.3 t30 -56.46 -41.75 77.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 105' ' ' ARG . 8.8 mt-10 -86.38 -18.71 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.331 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -24.86 20.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 103' ' ' LEU . 2.8 tm? -111.22 -66.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.555 HG21 ' OD1' ' A' ' 100' ' ' ASN . 15.0 t -52.98 -37.31 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.692 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -69.77 -15.9 63.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.379 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.58 5.87 26.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.53 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.14 29.08 8.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.529 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 5.6 mt 64.27 107.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.651 0.263 . . . . 0.0 111.112 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 58' ' ' ALA . . . 82.41 -117.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.439 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.473 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 mttm . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -127.01 131.42 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.919 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -120.0 110.18 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -101.13 107.36 18.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -138.44 152.42 71.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.795 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.68 120.85 8.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.517 2.144 . . . . 0.0 112.148 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' CB ' HG13 ' A' ' 74' ' ' VAL . . . -145.35 107.91 4.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -120.49 159.4 25.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.997 HD13 HG23 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -102.71 141.39 35.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.9 mt -77.49 -58.96 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.239 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.72 124.03 36.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.81 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . -113.99 111.29 21.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -94.84 -49.08 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.514 ' OD2' HG21 ' A' ' 62' ' ' THR . 3.2 m-20 76.05 -54.89 0.61 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.18 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.39 -25.52 4.42 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.035 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -132.79 -79.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 m -140.82 158.82 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 17' ' ' ALA . 3.3 t -132.58 155.27 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.52 134.28 44.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.12 155.99 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.1 ttp -102.77 101.24 11.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.712 ' HE2' HG21 ' A' ' 74' ' ' VAL . 43.2 t80 -114.5 94.79 4.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.011 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 tttm 56.18 29.86 15.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.56 56.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.714 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.81 126.69 65.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.54 0.209 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 95.92 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.428 2.086 . . . . 0.0 112.429 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.5 mtt -77.42 99.97 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.59 HG23 ' HG2' ' A' ' 87' ' ' ARG . 1.8 t -70.93 132.58 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.728 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 9.5 t80 -116.79 134.85 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 59.58 164.11 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -127.32 155.43 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.33 102.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.996 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 54' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HG2' ' HD3' ' A' ' 53' ' ' LYS . 2.2 pt-20 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.448 0.166 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -107.69 -41.22 5.07 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.549 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -108.11 21.38 17.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 111.704 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.91 -107.78 0.48 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.161 -1.019 . . . . 0.0 110.954 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.9 2.54 7.01 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.55 2.167 . . . . 0.0 111.913 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -97.23 -68.06 0.82 Allowed 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.836 ' CB ' HD22 ' A' ' 108' ' ' LEU . . . -40.8 -56.43 2.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 0.0 111.953 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -57.37 -18.68 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.908 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -91.1 -40.51 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.443 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.555 ' CD2' HD11 ' A' ' 103' ' ' LEU . 11.0 t80 -62.35 -62.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.514 HG21 ' OD2' ' A' ' 19' ' ' ASP . 39.1 p -53.29 -35.75 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.961 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 59' ' ' SER . 3.8 tppp? -48.88 -31.9 8.0 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.616 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -83.31 -36.93 24.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.996 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.08 -0.8 37.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.741 178.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.997 HG23 HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -109.9 -41.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.386 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 13.3 tt0 -95.26 -72.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.922 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.43 -45.05 85.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.996 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -98.46 141.44 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.972 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.65 29.06 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.59 61.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.0 mp -110.16 146.59 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.68 162.28 29.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.712 HG21 ' HE2' ' A' ' 27' ' ' TYR . 7.2 m -95.97 117.26 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.86 166.13 15.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.715 ' H ' HD23 ' A' ' 7' ' ' LEU . 16.0 m-85 60.68 163.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -66.68 -17.9 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -177.37 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 110.933 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.97 88.7 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.22 111.01 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.17 -36.0 5.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.028 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.759 ' H ' HD12 ' A' ' 89' ' ' LEU . 1.9 m -105.95 -176.39 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 82' ' ' THR . 2.4 m-20 -109.21 -18.3 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.672 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -58.38 -161.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.483 ' CE1' ' HB2' ' A' ' 87' ' ' ARG . 1.2 p90 -84.34 11.68 8.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.791 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 89' ' ' LEU . . . 108.13 35.93 2.43 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.486 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.59 ' HG2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -101.89 -24.11 14.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.163 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.88 60.38 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.207 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -107.89 113.08 26.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.251 0.526 . . . . 0.0 111.381 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB3' ' CD1' ' A' ' 34' ' ' PHE . . . -144.36 109.87 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.39 126.61 35.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.688 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.599 HG22 ' CE ' ' A' ' 65' ' ' MET . 3.2 mp -116.14 107.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.602 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.453 ' C ' HG23 ' A' ' 72' ' ' ILE . 48.1 m-85 -130.07 84.47 2.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.52 110.39 14.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.183 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t70 48.69 30.58 2.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.039 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.45 26.27 63.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.323 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -79.75 164.05 23.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.89 83.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.666 HG11 ' HE3' ' A' ' 65' ' ' MET . 9.7 m -91.4 -34.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 2.1 p-10 -66.71 -33.21 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.29 -20.7 21.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.5 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -58.43 -84.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.55 0.215 . . . . 0.0 111.483 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -112.16 -24.23 9.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.69 ' N ' HD22 ' A' ' 103' ' ' LEU . 53.4 t -57.99 -19.38 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.272 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -56.99 -34.86 68.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 110.423 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -98.61 21.97 10.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.684 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 108' ' ' LEU . . . 97.15 -4.59 62.69 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.178 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.836 HD22 ' CB ' ' A' ' 58' ' ' ALA . 6.0 mt 140.9 -25.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.595 0.758 . . . . 0.0 111.156 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . . . -168.57 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' H ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.692 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.433 ' C ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.861 0.362 . . . . 0.0 110.958 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 7' ' ' LEU . 1.2 mm? -119.99 106.55 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.46 152.34 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -105.98 106.95 17.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.528 ' O ' HG22 ' A' ' 74' ' ' VAL . 3.4 mt-10 -114.17 148.26 39.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.92 120.74 8.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.379 2.053 . . . . 0.0 112.463 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.671 ' CB ' HG13 ' A' ' 74' ' ' VAL . . . -145.35 107.84 4.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.649 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -115.94 158.73 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.06 HD13 HG12 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.04 142.06 36.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.612 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 16' ' ' LYS . 3.4 tt -95.9 -47.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.822 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' N ' HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -155.22 132.87 11.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 111.344 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.916 ' HB2' HG23 ' A' ' 23' ' ' VAL . . . -114.25 149.75 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.905 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.699 ' CG2' HG22 ' A' ' 22' ' ' THR . 2.8 tt -53.65 -44.24 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.126 0.488 . . . . 0.0 110.143 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.6 OUTLIER 169.1 -108.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.708 ' HA3' HD21 ' A' ' 108' ' ' LEU . . . -93.6 -10.05 59.49 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.123 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -95.52 -82.19 0.39 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.699 HG22 ' CG2' ' A' ' 18' ' ' ILE . 14.6 t -96.45 159.37 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.916 HG23 ' HB2' ' A' ' 17' ' ' ALA . 3.8 p -148.1 133.17 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.721 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -82.79 143.83 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 3.0 mt -133.32 149.06 51.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.36 97.63 7.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 74' ' ' VAL . 31.8 t80 -105.44 106.27 16.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.981 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 58.33 30.29 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.95 -12.86 66.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.789 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.94 125.38 68.77 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.613 0.244 . . . . 0.0 110.723 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 93.78 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.404 2.069 . . . . 0.0 112.321 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.574 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 5.6 tpt -80.73 120.64 24.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -91.85 121.51 33.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 17.8 t80 -105.14 61.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 85' ' ' TYR . 1.7 mtt-85 -66.65 93.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -110.04 81.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.809 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.92 127.77 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.839 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.898 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -125.93 -27.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.54 178.47 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.601 ' H ' ' HB1' ' A' ' 109' ' ' ALA . 1.3 t80 -176.72 -25.56 0.01 OUTLIER 'General case' 0 C--N 1.345 0.4 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.666 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.593 ' H ' ' HB1' ' A' ' 109' ' ' ALA . . . 79.99 -104.81 2.26 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.601 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 2.2 Cg_endo -41.13 -28.07 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.912 2.408 . . . . 0.0 112.608 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 15.7 tp10 -78.56 -30.7 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.191 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . . . -39.27 -60.16 0.95 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -84.09 -47.39 10.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -48.5 -31.35 6.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.381 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' HG ' ' A' ' 103' ' ' LEU . 54.8 t80 -56.85 -58.49 7.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.225 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.25 -23.39 43.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.557 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -25.26 63.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -87.13 -26.92 23.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.296 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.959 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -70.16 -6.44 34.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.572 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 1.06 HG12 HD13 ' A' ' 14' ' ' LEU . 20.7 m -112.3 -41.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.6 mt-10 -87.92 -68.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.593 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -73.53 -32.54 64.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 0.0 111.251 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.959 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -113.97 149.39 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.086 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -165.35 70.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.86 84.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 94' ' ' ALA . 3.2 mp -135.65 150.73 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.22 149.96 47.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.645 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.671 HG13 ' CB ' ' A' ' 12' ' ' ALA . 6.2 m -95.91 109.87 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.804 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.1 82.91 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.432 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 7' ' ' LEU . 45.5 p90 -178.85 133.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.18 16.76 19.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -64.92 -34.67 78.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.51 27.53 68.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.95 110.8 20.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -4.66 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.405 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -89.78 -175.69 4.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.994 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 82' ' ' THR . 3.6 t0 84.94 -49.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.474 ' CD ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -85.03 -67.86 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.868 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 35' ' ' ARG . 70.5 t80 -149.32 11.4 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.72 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 70.44 18.08 75.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.532 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 169.19 -24.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.622 0.249 . . . . 0.0 111.186 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.87 -38.77 86.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.919 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD23 ' CD ' ' A' ' 84' ' ' LYS . 1.5 tm? -80.42 109.88 15.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.574 ' HB2' ' HE2' ' A' ' 32' ' ' MET . . . -144.19 117.95 9.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 93.68 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.464 HG22 HG12 ' A' ' 74' ' ' VAL . 3.0 pt -112.71 158.18 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.43 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.66 89.56 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.759 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.87 141.25 36.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.571 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 49.18 31.25 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.434 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.1 -37.62 3.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.744 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -139.33 139.59 37.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.004 0.43 . . . . 0.0 111.235 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.31 94.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.112 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.33 -28.66 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -66.01 -37.4 85.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -29.73 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.3 -33.95 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -59.29 -58.15 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.66 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.82 HG13 HD12 ' A' ' 108' ' ' LEU . 33.9 t -66.09 -14.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.537 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -24.88 60.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -94.35 23.29 5.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.17 -3.32 61.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.596 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.82 HD12 HG13 ' A' ' 104' ' ' VAL . 2.6 tt 69.55 86.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.945 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . . . -166.63 -41.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.088 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' C ' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.903 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.886 0.374 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.9 112.91 14.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -82.04 109.64 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.644 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.7 111.09 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -129.25 143.05 47.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.07 120.86 7.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.491 2.127 . . . . 0.0 112.52 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 107.94 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.649 HG21 ' HG2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -124.04 149.87 45.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.924 HD12 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -98.56 139.6 34.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.58 -34.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -137.87 93.27 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.563 ' HB1' ' CB ' ' A' ' 62' ' ' THR . . . -99.58 111.06 23.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.527 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 22' ' ' THR . 7.3 mt -101.07 -46.9 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.677 ' H ' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER 69.7 -61.62 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.235 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.33 -27.7 2.92 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.834 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -127.42 -76.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.929 0.395 . . . . 0.0 110.781 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -140.24 146.82 39.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.677 HG22 ' H ' ' A' ' 19' ' ' ASP . 10.7 t -120.77 143.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -128.65 109.47 11.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.774 HD21 ' CD2' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -101.88 154.26 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.689 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 tpp -85.62 94.92 9.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.547 ' CE1' HG11 ' A' ' 74' ' ' VAL . 53.1 t80 -120.71 93.66 4.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 tttm 54.54 41.17 32.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.9 16.03 78.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -118.0 142.29 30.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.643 0.259 . . . . 0.0 110.761 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.15 97.98 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 107.75 7.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 p -72.05 125.94 28.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -115.23 95.94 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.76 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 62.07 89.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 171.95 12.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.32 103.12 10.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.3 mt-10 . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.741 0.305 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.827 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER 161.34 -2.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.465 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 8.2 m-85 -131.11 -1.53 4.06 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.12 -140.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.443 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 2.41 7.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.551 2.167 . . . . 0.0 112.864 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HB2' ' CA ' ' A' ' 109' ' ' ALA . 9.9 mt-10 -95.98 -63.8 1.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.105 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 53' ' ' LYS . . . -40.43 -33.35 0.25 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.789 0.328 . . . . 0.0 111.517 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -81.65 -57.95 3.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.481 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.05 -28.39 7.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.503 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.66 ' HD2' HG23 ' A' ' 62' ' ' THR . 61.4 t80 -57.64 -65.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.64 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.66 HG23 ' HD2' ' A' ' 61' ' ' PHE . 67.6 p -79.58 -26.49 41.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 22.7 ttmt -60.16 -24.73 64.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG2' ' CB ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -92.07 -25.09 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.919 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.584 ' HB2' HD11 ' A' ' 14' ' ' LEU . 0.7 OUTLIER -63.7 -9.23 13.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.527 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.924 HG13 HD12 ' A' ' 14' ' ' LEU . 28.3 m -114.72 -41.31 3.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.6 mt-10 -88.12 -68.87 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.345 . . . . 0.0 111.912 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' CB ' ' HG2' ' A' ' 64' ' ' LYS . 1.0 OUTLIER -68.58 -29.96 68.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -72.29 170.47 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.185 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -108.61 -55.92 2.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.649 ' HG2' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER -166.51 163.74 17.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.705 HG21 ' CG2' ' A' ' 92' ' ' ILE . 1.6 mp -142.4 162.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -135.04 137.44 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.43 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.2 p -95.83 109.81 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 4.5 pt-20 -129.62 139.79 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -166.99 132.01 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.0 -30.28 71.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.983 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -107.81 -47.35 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.838 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.86 -40.66 2.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.75 116.52 32.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.18 -55.04 4.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.549 ' HB ' ' CD ' ' A' ' 84' ' ' LYS . 96.4 m -121.96 158.02 30.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.027 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.89 47.06 0.98 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.761 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.549 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -92.21 -38.79 11.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.723 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.483 ' N ' ' HG2' ' A' ' 84' ' ' LYS . 4.9 t80 -158.3 11.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.415 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.94 32.05 78.5 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.365 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.88 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.559 0.219 . . . . 0.0 111.234 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -45.43 -79.66 0.06 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.945 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.431 ' H ' ' HD2' ' A' ' 84' ' ' LYS . 0.3 OUTLIER -80.86 122.13 26.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.865 0.365 . . . . 0.0 110.78 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.13 148.35 34.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.483 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -72.35 142.07 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.784 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.705 ' CG2' HG21 ' A' ' 72' ' ' ILE . 17.6 mm -128.53 120.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.187 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 75' ' ' GLU . 1.1 m-85 -116.64 78.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.691 ' CA ' HG23 ' A' ' 72' ' ' ILE . . . -79.6 111.19 15.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 68.4 45.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.326 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.24 24.64 52.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.062 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -134.19 150.44 51.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.283 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.22 107.19 15.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.7 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' VAL . 11.9 t -72.5 -7.9 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.774 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 4.9 m-80 -58.66 -20.32 47.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.19 -18.72 24.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.394 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -61.71 -84.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.14 -22.23 11.08 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.716 HG22 ' CD2' ' A' ' 108' ' ' LEU . 14.6 t -54.83 -23.29 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -57.72 -24.12 55.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.963 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -103.76 19.12 20.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.69 ' O ' HD12 ' A' ' 108' ' ' LEU . . . 82.29 -3.2 82.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.854 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.716 ' CD2' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER 78.38 74.0 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.584 0.231 . . . . 0.0 110.874 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.62 ' CB ' ' O ' ' A' ' 108' ' ' LEU . . . 131.15 -71.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.638 0.775 . . . . 0.0 110.226 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.985 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 mt -127.06 103.96 7.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -94.55 128.8 41.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.732 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -81.21 115.73 20.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -135.87 129.29 18.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.443 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.67 120.52 8.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.368 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB3' HG13 ' A' ' 74' ' ' VAL . . . -145.42 107.39 4.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -116.99 164.08 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.907 ' HB2' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -96.92 144.04 27.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.896 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -90.21 -40.61 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.5 OUTLIER 178.57 126.02 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.985 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.789 ' CB ' HG12 ' A' ' 23' ' ' VAL . . . -103.84 148.59 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 21' ' ' ASP . 4.2 pt -51.12 -40.36 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 4.5 p30 165.11 -113.66 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.37 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.31 -10.12 59.77 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.618 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.534 ' HB3' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -72.64 -82.46 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.489 ' H ' HD11 ' A' ' 18' ' ' ILE . 91.4 m -130.14 159.43 36.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.418 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.024 HG11 HG21 ' A' ' 62' ' ' THR . 22.9 m -124.8 154.4 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.229 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.99 135.33 54.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 mp -110.95 159.89 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.9 94.91 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.33 95.35 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.11 30.16 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.01 43.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.685 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -85.81 114.99 59.9 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.518 0.199 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.88 102.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.504 2.136 . . . . 0.0 112.337 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.414 ' HE1' HD22 ' A' ' 25' ' ' LEU . 4.2 ttp -87.6 150.04 23.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.911 HG21 HD23 ' A' ' 36' ' ' LEU . 3.5 m -104.84 140.01 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' HB2' HD13 ' A' ' 25' ' ' LEU . 13.6 t80 -124.56 112.85 17.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.73 87.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.211 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.911 HD23 HG21 ' A' ' 33' ' ' THR . 0.3 OUTLIER -105.75 81.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tp -125.53 145.7 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.674 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.836 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 8.3 tttt -167.06 -45.8 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 169.81 -22.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.14 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.78 -111.75 0.77 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.214 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.42 -19.79 45.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.002 1.801 . . . . 0.0 111.011 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.882 ' HB3' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -88.56 -20.82 24.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.657 ' HB2' ' CD1' ' A' ' 54' ' ' TYR . . . -39.98 -35.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.452 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -79.21 -43.32 24.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 0.0 109.719 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' GLU . . . -50.71 -40.37 53.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.527 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CE1' HG12 ' A' ' 99' ' ' VAL . 10.6 t80 -40.23 -61.58 0.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.948 0.404 . . . . 0.0 110.427 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 1.024 HG21 HG11 ' A' ' 23' ' ' VAL . 2.4 m -88.19 -49.74 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.114 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CG1' ' A' ' 66' ' ' VAL . 34.1 ttmt -40.34 -29.32 0.08 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 2.9 tttm -85.8 -33.25 21.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.0 110.421 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.895 ' HG2' HG22 ' A' ' 99' ' ' VAL . 6.7 tpp -94.15 -0.67 55.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.011 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 62' ' ' THR . 7.4 p -123.48 -41.72 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -95.59 -55.2 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 111.828 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -87.06 5.26 38.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.791 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -99.54 173.53 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.403 . . . . 0.0 111.482 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 -66.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.83 -176.72 3.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.648 HG23 ' N ' ' A' ' 94' ' ' ALA . 4.1 mp -143.68 145.58 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -113.72 133.14 55.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.403 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.671 HG13 ' HB3' ' A' ' 12' ' ' ALA . 4.2 m -95.67 118.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 111.207 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 7.6 tt0 -94.61 78.58 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.285 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 74' ' ' VAL . 8.0 p90 -171.21 136.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.75 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -63.92 -60.86 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.471 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.31 -30.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.281 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -41.73 134.75 3.4 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.26 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' CG ' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -67.95 142.49 55.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -34.08 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 89' ' ' LEU . 2.4 p -122.09 147.16 46.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.42 -9.9 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -27.77 6.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -178.13 -37.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 80' ' ' GLN . . . 109.06 -10.23 34.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.633 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.22 -5.6 6.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.508 0.194 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.54 -76.28 0.64 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.545 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.581 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.3 OUTLIER -74.01 110.08 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.829 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.92 139.82 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.39 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -109.37 156.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.639 ' C ' HG23 ' A' ' 72' ' ' ILE . 88.8 m-85 -141.99 83.56 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.981 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.648 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.9 106.81 12.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 64.77 42.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.801 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 21.75 74.43 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.669 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -158.0 156.66 31.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 166.75 22.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.895 HG22 ' HG2' ' A' ' 65' ' ' MET . 19.6 t -84.49 -35.5 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -58.59 -28.12 65.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.58 -18.84 61.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.3 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.48 -74.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.794 0.33 . . . . 0.0 111.769 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 57' ' ' GLU . 4.5 tt -95.23 -56.72 2.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.83 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 61' ' ' PHE . 15.0 t -48.03 -26.43 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.94 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -15.68 61.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 0.0 111.311 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -76.08 5.18 7.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.769 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.46 4.54 58.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.394 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.836 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mt 64.46 76.32 0.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.165 0.507 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 176.91 103.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.822 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.902 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.07 148.55 36.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.31 153.05 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.28 127.9 44.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.03 147.13 64.11 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.94 120.54 8.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.422 2.081 . . . . 0.0 112.024 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 74' ' ' VAL . . . -145.64 107.94 4.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.849 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -121.98 168.81 11.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.848 HD11 ' CG2' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -106.23 144.02 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 16' ' ' LYS . 1.4 tt -82.13 -42.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.409 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' N ' HG23 ' A' ' 15' ' ' ILE . 7.6 ttmm -143.55 105.81 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.128 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.827 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -114.14 123.68 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 22' ' ' THR . 1.9 mp -94.23 -35.03 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.174 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.08 -64.58 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.173 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.06 -26.34 8.74 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.789 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.75 -79.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.663 ' O ' HD12 ' A' ' 18' ' ' ILE . 43.2 m -131.83 158.96 39.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.727 HG23 ' CB ' ' A' ' 17' ' ' ALA . 7.9 p -138.68 145.12 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.31 142.26 51.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 1.6 mt -115.91 152.11 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 95.62 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.474 ' HE1' HG11 ' A' ' 74' ' ' VAL . 49.4 t80 -106.6 93.64 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 58.25 41.84 22.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.973 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.66 24.03 68.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.59 128.04 24.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.604 0.24 . . . . 0.0 110.803 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.82 90.41 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.367 2.045 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ttm -78.41 113.07 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 p -73.54 135.5 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.725 ' HB3' HG13 ' A' ' 23' ' ' VAL . 4.7 t80 -127.79 109.21 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.747 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 64.24 144.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 85' ' ' TYR . 9.3 mp -91.05 172.01 8.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.48 99.43 10.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 11.1 mt-10 . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.672 0.273 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.865 ' CB ' HD22 ' A' ' 108' ' ' LEU . 18.8 ptpt 139.96 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.346 1.058 . . . . 0.0 108.474 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.47 ' CG ' ' CB ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER 50.53 25.35 1.94 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 -178.03 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -109.47 1.85 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.252 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 2.36 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.678 2.252 . . . . 0.0 113.024 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -85.59 -62.97 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' LYS . . . -45.77 -48.92 15.39 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.723 0.296 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 13.0 t -48.53 -29.48 4.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -91.46 -38.19 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.605 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.2 -65.4 0.56 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.241 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -60.68 -20.4 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -65.62 -33.4 75.81 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.16 -21.34 20.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.148 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.628 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -75.0 -5.32 43.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.011 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.93 ' HA ' HD11 ' A' ' 72' ' ' ILE . 22.6 m -123.39 -41.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.705 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' N ' HG23 ' A' ' 66' ' ' VAL . 28.1 tt0 -74.73 -66.8 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.903 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -92.83 5.39 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.628 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -98.96 92.07 5.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.487 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm 60.17 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.214 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 13' ' ' THR . 8.0 mttt 166.95 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.93 HD11 ' HA ' ' A' ' 66' ' ' VAL . 2.7 mt 79.23 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 72' ' ' ILE . 17.0 pt-20 -141.28 140.11 33.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.692 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 12' ' ' ALA . 13.8 p -95.92 109.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HG3' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -124.84 -86.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.831 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.486 ' CE1' ' CD2' ' A' ' 91' ' ' TYR . 2.7 t80 59.75 117.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 111.163 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -86.03 57.17 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.454 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -166.73 -44.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.34 144.63 9.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.682 ' CB ' HD12 ' A' ' 89' ' ' LEU . 5.7 pm0 -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.0 110.722 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -114.34 -55.72 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.565 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -141.4 -175.3 4.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.729 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 82' ' ' THR . 24.2 t70 104.02 -72.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.532 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.687 ' H ' HD22 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -92.15 90.6 7.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.394 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' HB2' HD11 ' A' ' 36' ' ' LEU . 43.1 t80 64.86 11.35 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.921 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 58.75 30.79 66.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.465 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 165.35 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.464 0.306 . . . . 0.0 110.789 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.72 -12.87 36.57 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.062 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.687 HD22 ' H ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -83.7 109.77 17.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 34' ' ' PHE . . . -144.23 134.74 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.486 ' CD2' ' CE1' ' A' ' 76' ' ' PHE . 5.5 m-85 -112.11 119.92 40.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.24 136.07 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.604 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' HG3' ' A' ' 75' ' ' GLU . 74.5 m-85 -127.34 77.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.784 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.06 141.81 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.246 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 p30 48.88 31.23 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.651 0.739 . . . . 0.0 109.505 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.51 -47.01 2.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.059 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -161.7 111.69 1.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.764 0.282 . . . . 0.0 111.589 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.774 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 15.3 ttm -147.41 80.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.283 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -98.95 -59.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.111 0.482 . . . . 0.0 111.961 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 105' ' ' ARG . 5.8 p-10 -89.56 -57.21 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.215 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.404 ' HG3' ' HG3' ' A' ' 98' ' ' MET . 6.5 pt-20 -40.56 -28.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.774 ' HB2' ' HG2' ' A' ' 98' ' ' MET . . . -67.18 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.657 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.623 HD11 HD23 ' A' ' 108' ' ' LEU . 1.3 tm? -114.42 -57.58 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.456 0.646 . . . . 0.0 111.469 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 100' ' ' ASN . 18.5 t -48.82 -16.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.012 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -49.93 -28.66 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.975 0.417 . . . . 0.0 110.486 179.457 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -98.41 23.04 8.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.068 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.85 38.65 65.28 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.865 HD22 ' CB ' ' A' ' 53' ' ' LYS . 33.0 mt 55.87 87.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.62 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.61 -6.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HA ' ' CD2' ' A' ' 54' ' ' TYR . 8.1 ptpt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.927 0.394 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -127.07 104.05 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.56 106.53 18.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.03 106.91 17.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 74' ' ' VAL . 6.5 mt-10 -128.24 126.54 23.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.36 121.46 9.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.385 2.057 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.15 107.43 4.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 72' ' ' ILE . 2.5 p -125.44 150.58 47.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.58 141.74 41.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.695 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 16' ' ' LYS . 15.4 tt -88.64 -47.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.703 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' N ' HG23 ' A' ' 15' ' ' ILE . 19.1 mttt -155.07 130.3 9.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 111.46 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.03 133.51 55.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.698 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 19' ' ' ASP . 17.3 tt -54.66 -49.45 67.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.23 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 166.93 -152.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.84 -10.52 4.79 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.449 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 18' ' ' ILE . 29.2 t70 -67.15 -71.17 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.026 0.413 . . . . 0.0 111.129 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -147.0 159.05 44.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 23' ' ' VAL . 29.4 m -121.45 117.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.978 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -83.34 124.9 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 2.4 mp -89.67 160.85 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.1 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.63 98.32 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt 57.57 43.42 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.32 22.56 76.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.597 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -114.31 133.64 22.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.576 0.226 . . . . 0.0 110.815 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.06 99.49 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.458 2.105 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 mtt -95.9 149.75 21.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.88 144.55 36.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.976 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 90' ' ' ALA . 32.5 t80 -138.02 122.81 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 62.86 145.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.26 103.09 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.74 102.82 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.839 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 13.7 mt-10 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HB3' ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER 64.81 4.67 2.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD1' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER 172.11 -25.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.736 0.303 . . . . 0.0 110.813 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.15 -102.07 2.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.371 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.96 -25.69 63.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.689 ' OE1' ' HB3' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -73.61 -36.93 65.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . . . -47.89 -26.23 1.62 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -32.37 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.689 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -54.82 -47.14 74.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.512 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.657 ' HB2' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -47.85 -47.87 31.26 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.885 0.374 . . . . 0.0 110.488 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.7 t -81.94 -26.15 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -26.77 65.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.747 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 69' ' ' ALA . 11.9 mttp -92.02 -24.86 19.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.48 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 24.6 ttp -57.21 -15.25 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.414 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.497 HG12 ' HG ' ' A' ' 14' ' ' LEU . 33.4 m -105.23 -42.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.3 mt-10 -95.6 -69.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.714 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.24 -20.49 62.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.592 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -93.08 -179.84 5.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.356 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -69.45 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.068 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 172.61 149.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.922 0.391 . . . . 0.0 110.924 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.609 ' H ' HG22 ' A' ' 13' ' ' THR . 1.8 mp -102.78 161.61 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.051 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.3 mt-10 -133.78 149.55 51.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.6 p -100.48 109.82 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.967 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -88.48 -178.54 5.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 75' ' ' GLU . 15.5 p90 46.94 117.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.04 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.08 32.02 6.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -59.26 -27.55 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.069 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.45 -84.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.21 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.27 110.82 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.601 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -110.11 -40.29 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.511 HG21 ' O ' ' A' ' 89' ' ' LEU . 82.7 p -130.1 133.94 47.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.38 -8.31 58.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.087 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.59 70.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -177.19 -37.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.05 -10.27 34.03 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.536 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.552 ' HB3' HG23 ' A' ' 33' ' ' THR . 1.4 mpp_? -123.21 -24.11 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.54 -84.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.736 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' HG21 ' A' ' 82' ' ' THR . 3.1 tp -89.08 116.22 27.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.335 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.541 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . . . -144.04 141.88 30.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 1.5 m-85 -80.89 127.3 32.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.13 149.77 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -134.42 89.12 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.25 115.55 18.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.24 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 t70 67.57 26.64 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.13 -31.26 7.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.816 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -134.17 131.43 38.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 111.025 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.18 158.36 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' VAL . 12.2 t -95.12 -8.64 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -63.06 -16.57 60.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -18.83 30.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.564 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -61.53 -84.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.517 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.995 HD23 ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -111.64 -24.07 10.3 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.626 ' N ' HD22 ' A' ' 103' ' ' LEU . 63.6 t -58.93 -31.47 45.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -98.17 -16.01 19.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -83.87 -25.2 30.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.533 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.12 47.8 2.16 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.332 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 2.6 tt -147.98 6.16 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.995 ' HB3' HD23 ' A' ' 103' ' ' LEU . . . 176.32 86.78 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.587 ' C ' ' HB1' ' A' ' 58' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.596 HD22 ' H ' ' A' ' 7' ' ' LEU . 1.6 mm? -79.06 112.87 16.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.034 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -70.0 153.21 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -106.95 106.91 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -110.52 129.65 23.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.379 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.1 120.02 7.58 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.253 1.969 . . . . 0.0 112.486 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -146.0 107.81 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.472 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -117.49 163.41 16.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.021 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.656 HD21 ' CB ' ' A' ' 66' ' ' VAL . 1.6 pp -106.23 144.19 33.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.606 HD11 ' SD ' ' A' ' 26' ' ' MET . 38.3 mm -62.2 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HG2' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -168.99 135.42 1.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.808 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.146 ' HB2' HG23 ' A' ' 23' ' ' VAL . . . -114.12 137.73 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.132 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 19' ' ' ASP . 6.8 tt -57.71 -46.36 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' HG23 ' A' ' 18' ' ' ILE . 1.1 p30 166.45 -110.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.41 -10.62 59.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.54 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.493 ' HB2' HG21 ' A' ' 18' ' ' ILE . 3.7 m-20 -70.17 -80.75 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.714 0.292 . . . . 0.0 111.435 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -131.48 157.76 42.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.378 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.146 HG23 ' HB2' ' A' ' 17' ' ' ALA . 7.5 p -147.96 107.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -83.5 111.37 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.514 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HA ' ' CB ' ' A' ' 14' ' ' LEU . 3.6 mt -89.74 161.71 15.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.634 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.606 ' SD ' HD11 ' A' ' 15' ' ' ILE . 7.2 ttp -106.41 109.04 20.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -126.1 92.67 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.02 41.04 5.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.86 37.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.644 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -124.74 114.86 26.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.519 0.2 . . . . 0.0 110.876 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.75 83.0 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.487 2.124 . . . . 0.0 112.275 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 mtm -80.94 123.46 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.693 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -110.23 148.08 32.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.897 ' CD1' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -88.83 -171.02 3.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HG2' ' CD2' ' A' ' 34' ' ' PHE . 6.9 ptt180 -46.68 148.42 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -88.76 172.12 9.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 37' ' ' LEU . 1.4 pt? -94.41 156.15 16.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.93 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.682 0.754 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.87 2.12 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.521 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 76.7 t80 -83.47 0.97 43.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.224 0.535 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.55 -60.36 1.81 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -92.06 -48.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.674 2.916 . . . . 0.0 113.153 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.466 ' CG ' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -65.03 -56.92 10.28 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . . . -45.95 -49.33 15.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 111.428 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' LYS . 4.2 m -60.06 -19.97 55.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.73 -58.12 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.128 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -72.85 -62.63 1.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.911 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.78 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.9 m -49.63 -27.58 4.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.219 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 59' ' ' SER . 37.3 ttmt -76.61 -21.77 55.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -23.27 23.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.647 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 5.0 mmt -89.95 -1.03 57.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 62' ' ' THR . 15.9 m -123.3 -41.69 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -85.7 -72.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.58 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.49 -20.69 64.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -102.46 111.14 23.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.685 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.58 51.35 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 30.2 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.571 HG21 HG12 ' A' ' 92' ' ' ILE . 1.2 mp -80.87 149.73 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.67 168.43 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.2 109.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 5.3 mm-40 -91.45 82.24 5.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.537 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.4 m-85 -168.66 117.8 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 7' ' ' LEU . 2.9 t0 -65.65 -44.82 85.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.898 0.38 . . . . 0.0 110.804 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -169.49 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.378 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.18 149.45 0.88 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.873 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.8 160.99 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 mtt-85 -95.12 -55.29 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.608 HG21 ' HB2' ' A' ' 89' ' ' LEU . 10.9 p -140.19 157.55 45.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.184 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -98.79 -25.44 14.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.676 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.44 ' HE3' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -45.87 -29.33 1.34 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.452 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -176.28 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.38 25.72 6.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -160.73 -24.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.13 -80.27 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.608 ' HB2' HG21 ' A' ' 82' ' ' THR . 4.7 mp -74.09 117.22 15.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.0 159.87 41.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.121 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 36.0 m-85 -103.35 142.17 34.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -120.53 110.92 30.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 91' ' ' TYR . 17.3 m-85 -113.69 71.73 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.183 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB2' HD11 ' A' ' 92' ' ' ILE . . . -79.58 101.28 8.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.059 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 67.37 35.06 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 35.8 83.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.04 157.27 16.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.119 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.34 84.08 2.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.539 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 30.1 m -60.97 -47.24 94.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.273 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.483 ' N ' HG23 ' A' ' 99' ' ' VAL . 3.3 t30 -49.19 -24.1 1.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.506 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -91.31 -63.12 1.3 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.15 -15.73 30.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 109' ' ' ALA . 4.9 tt -99.91 -49.04 4.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 109' ' ' ALA . 22.9 t -90.12 -62.26 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -58.65 -24.53 61.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.692 0.282 . . . . 0.0 111.227 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -70.19 -17.67 63.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.342 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.707 ' C ' HD12 ' A' ' 108' ' ' LEU . . . 97.32 47.17 2.24 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.474 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.707 HD12 ' C ' ' A' ' 107' ' ' GLY . 5.8 mp -153.22 34.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.805 ' O ' HG13 ' A' ' 104' ' ' VAL . . . 167.7 42.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.767 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.789 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -136.21 132.85 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -104.01 152.2 22.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.17 130.44 43.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -119.65 101.03 7.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -127.66 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 76' ' ' PHE . 24.3 mt -123.43 119.71 30.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -108.93 121.34 44.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.756 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -79.42 110.93 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.241 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.86 130.59 23.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.566 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.91 120.31 7.93 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.227 1.951 . . . . 0.0 112.544 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.66 107.7 4.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -125.27 141.58 52.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.249 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.808 HD22 ' HB2' ' A' ' 17' ' ' ALA . 3.5 mp -67.04 144.05 56.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pt -87.21 -28.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -167.91 94.22 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -98.64 115.5 28.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.354 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mt -80.64 -31.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 59' ' ' SER . 20.4 m-20 68.22 -65.68 0.25 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.079 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.16 33.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.689 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.422 ' O ' HD12 ' A' ' 37' ' ' LEU . 85.9 m-20 -121.44 -77.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -146.13 159.07 43.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 HG12 ' HB1' ' A' ' 17' ' ' ALA . 18.4 m -134.89 148.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.199 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 132.51 41.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -99.14 160.55 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.4 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.797 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -122.63 109.12 13.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.07 29.06 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.75 -4.13 83.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -85.94 127.81 60.69 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.799 0.3 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.69 83.27 2.11 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.563 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.62 111.35 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.679 ' CG2' HD11 ' A' ' 36' ' ' LEU . 8.9 t -86.57 155.01 20.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -123.58 97.5 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.473 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER 67.51 122.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD11 ' CG2' ' A' ' 33' ' ' THR . 5.9 mp -115.77 172.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 21' ' ' ASP . 1.8 mp -54.66 101.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.82 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.971 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.99 153.59 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.3 120.52 21.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.9 110.58 58.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.78 -25.74 39.33 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.418 2.079 . . . . 0.0 112.401 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -116.66 46.5 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.96 -45.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.949 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -58.36 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.39 146.68 34.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.789 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.43 -32.13 10.44 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.443 2.095 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.51 -55.84 15.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -83.73 -34.74 24.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.02 -49.8 1.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.144 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.65 HG23 ' N ' ' A' ' 52' ' ' GLU . 8.9 m -128.28 -63.64 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 117.425 0.612 . . . . 0.0 112.125 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.68 ' HG3' HD12 ' A' ' 108' ' ' LEU . 1.4 mm-40 -118.64 -65.99 1.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.848 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.9 mmtt -120.26 -53.93 2.12 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.588 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -124.72 -25.35 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 51' ' ' VAL . . . 88.18 -107.24 3.31 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.588 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 90.1 Cg_exo -44.93 -28.26 2.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.595 2.197 . . . . 0.0 112.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.47 -70.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.653 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.843 ' HB2' ' N ' ' A' ' 109' ' ' ALA . . . -52.41 -27.86 17.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.734 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 63' ' ' LYS . 10.4 t -70.0 -44.9 68.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.71 97.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.487 ' CD2' HD12 ' A' ' 103' ' ' LEU . 17.0 t80 -60.97 -44.26 97.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.113 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.421 HG23 HG11 ' A' ' 99' ' ' VAL . 1.9 m -76.46 -26.72 55.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 59' ' ' SER . 4.2 mmtp -59.06 -27.87 65.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -31.95 15.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.714 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.836 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 4.7 mmt -62.01 -13.68 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.308 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 17' ' ' ALA . 30.1 m -117.16 -41.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.715 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.5 tt0 -70.33 -67.53 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -45.11 12.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -80.71 60.66 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.81 58.42 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.3 31.66 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.748 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.723 HG12 ' HB2' ' A' ' 94' ' ' ALA . 2.1 mt -89.31 151.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -146.27 161.79 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 10' ' ' GLU . 4.9 m -96.01 109.64 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.455 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -101.4 72.52 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.54 ' HA ' HD22 ' A' ' 7' ' ' LEU . 20.9 p90 -177.38 118.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -114.03 30.32 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -59.15 -29.96 67.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.39 -33.67 5.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.14 126.04 30.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.2 -23.73 12.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 83' ' ' ASP . 1.3 t -140.18 133.56 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 82' ' ' THR . 6.5 t0 174.8 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.454 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -80.2 -66.97 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.535 ' CE1' HD13 ' A' ' 36' ' ' LEU . 23.4 t80 -118.79 -10.69 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.377 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 102.35 40.6 2.55 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.132 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 4.0 ttp180 89.6 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 110.636 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' HA3' ' CD1' ' A' ' 85' ' ' TYR . . . -103.0 -13.17 29.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.666 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.78 116.83 31.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.19 130.73 22.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' HB2' ' CD1' ' A' ' 76' ' ' PHE . 47.8 m-85 -61.97 122.0 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.581 HD11 ' OD1' ' A' ' 100' ' ' ASN . 8.1 pt -118.06 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 81.1 m-85 -121.81 79.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.53 124.47 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.83 47.93 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.629 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.49 21.0 40.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.339 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -146.57 153.92 40.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.068 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 mtm -81.3 148.37 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.421 HG11 HG23 ' A' ' 62' ' ' THR . 21.4 t -93.19 -32.65 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.581 ' OD1' HD11 ' A' ' 92' ' ' ILE . 11.2 m120 -65.48 -24.89 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.16 -18.91 23.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.396 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.73 -84.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.743 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.705 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.6 -15.96 13.36 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' HD13 ' A' ' 103' ' ' LEU . 15.1 t -70.36 -28.53 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -15.78 62.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.062 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -86.49 10.13 16.21 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.539 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 108' ' ' LEU . . . 97.51 34.58 5.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.622 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' HG3' ' A' ' 52' ' ' GLU . 6.2 mt 50.91 108.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 111.45 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.843 ' N ' ' HB2' ' A' ' 58' ' ' ALA . . . 88.57 -70.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.31 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 106' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.894 0.378 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 p -107.36 102.66 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.69 113.46 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -111.99 147.96 34.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.963 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.99 143.5 27.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.973 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -106.44 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.47 103.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.31 140.58 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 106.86 13.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 74' ' ' VAL . 6.0 mt-10 -130.38 144.02 51.6 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.18 121.61 6.22 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.607 2.204 . . . . 0.0 112.552 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.05 107.62 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.777 HG23 HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -111.82 163.38 14.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.7 pp -106.06 136.64 45.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.0 mt -74.48 -58.83 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 145.27 14.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB2' HG13 ' A' ' 23' ' ' VAL . . . -110.08 150.18 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 ' H ' ' A' ' 22' ' ' THR . 2.6 pt -63.11 -14.77 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 59' ' ' SER . 5.3 m-20 82.82 -8.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.2 -38.52 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.06 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 166.66 -18.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.643 0.222 . . . . 0.0 111.475 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.745 ' CG2' HD23 ' A' ' 36' ' ' LEU . 46.8 m -96.51 144.27 26.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' HB2' ' A' ' 17' ' ' ALA . 3.1 t -138.51 158.05 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -128.67 105.07 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.635 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -86.94 161.52 18.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.371 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.14 98.09 6.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.838 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -107.82 105.27 15.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 55.18 53.88 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.15 24.23 54.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -128.73 119.0 19.99 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.55 102.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.35 2.033 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.5 ttm -84.28 135.72 34.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 36' ' ' LEU . 1.9 p -86.77 142.12 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.514 ' HB2' HD12 ' A' ' 25' ' ' LEU . 16.8 t80 -135.68 94.73 3.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.725 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 34.78 74.54 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.936 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.745 HD23 ' CG2' ' A' ' 22' ' ' THR . 2.7 mp -98.64 127.0 44.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.2 82.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.733 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.19 112.76 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -152.33 128.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.6 104.13 5.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.91 84.26 7.01 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.98 -25.45 22.11 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.668 2.245 . . . . 0.0 112.388 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.5 -31.07 42.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.4 m -150.33 116.41 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.94 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 -50.83 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' HB2' ' CA ' ' A' ' 50' ' ' GLY . 5.2 p80 -128.66 74.96 80.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.8 2.71 8.34 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.821 2.347 . . . . 0.0 113.099 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -91.76 0.46 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -38.3 5.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.867 0.365 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' A' ' 46' ' ' HIS . . . 80.26 -5.65 62.73 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' HA ' ' H ' ' A' ' 55' ' ' GLY . 34.0 m -127.35 27.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.926 0.394 . . . . 0.0 111.3 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.645 ' C ' ' HB3' ' A' ' 109' ' ' ALA . 5.9 mt-10 -83.19 -38.0 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HA ' ' C ' ' A' ' 108' ' ' LEU . 4.5 pttp -143.84 13.53 1.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.833 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 54' ' ' TYR . 12.7 t80 -126.15 -25.28 3.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.416 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -48.34 174.37 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.156 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.415 ' HD2' ' OXT' ' A' ' 110' ' ' LYS . 47.9 Cg_exo -56.47 2.51 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 113.509 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 109' ' ' ALA . 3.4 mt-10 -96.65 -49.02 5.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.871 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . -40.74 -52.39 2.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.948 0.34 . . . . 0.0 111.199 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 57.1 p -61.38 -47.76 84.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.392 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.12 -36.22 28.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.468 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.889 ' CE1' HG23 ' A' ' 99' ' ' VAL . 89.0 t80 -51.95 -60.7 2.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.509 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.8 OUTLIER -78.29 -30.98 48.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 1.6 tppp? -61.77 -21.87 64.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.011 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -89.97 -33.48 16.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.588 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 2.2 mtm -58.31 -15.67 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.209 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 67' ' ' GLU . 33.2 m -116.9 -41.38 2.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' HG23 ' A' ' 66' ' ' VAL . 10.8 tt0 -74.48 -64.88 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 111.49 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.11 -43.56 21.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.588 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -70.26 -175.06 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.024 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -129.92 -54.92 1.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.045 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 93' ' ' TYR . 3.7 mp -143.0 145.22 23.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.1 164.92 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.2 p -110.94 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.216 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' PHE . 22.3 mt-10 -91.16 128.65 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 75' ' ' GLU . 5.1 p90 48.74 168.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.274 0.559 . . . . 0.0 112.013 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -93.54 -14.15 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.341 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.55 -8.6 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.656 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.54 -77.55 0.25 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -106.34 111.32 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -30.61 8.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.476 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 80.9 p -90.51 -175.71 4.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.4 t0 76.59 -61.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.825 ' HD3' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.71 -16.75 63.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -179.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.141 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 109.24 -10.54 33.65 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.348 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 1.1 tpp180 171.96 26.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.191 0.196 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.82 -49.95 4.12 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.906 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.825 HD13 ' HD3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -73.91 109.76 7.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 111.129 -179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.3 122.51 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.977 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.1 111.97 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.779 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.698 HG13 HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -84.98 124.72 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.26 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.79 ' C ' HG23 ' A' ' 72' ' ' ILE . 12.1 m-85 -134.91 88.2 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.775 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.588 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.72 91.03 5.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.95 51.26 7.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.19 24.8 56.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.246 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 130.39 56.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ttt -104.52 83.87 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.889 HG23 ' CE1' ' A' ' 61' ' ' PHE . 6.5 m -68.22 -19.35 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.491 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 1.8 t-20 -56.3 -63.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 111.045 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -18.75 48.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.356 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.55 -46.55 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' A' ' 61' ' ' PHE . 8.7 tt -111.09 -50.79 2.91 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 59.7 t -58.76 -16.88 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -22.08 18.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.454 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.43 23.17 5.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.555 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 108' ' ' LEU . . . 94.55 -3.03 68.11 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.76 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 1.0 OUTLIER 99.24 22.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.698 0.799 . . . . 0.0 110.98 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.645 ' HB3' ' C ' ' A' ' 52' ' ' GLU . . . -177.73 -165.7 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.697 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.415 ' OXT' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.909 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.891 0.377 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 t -130.38 118.64 21.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 t -76.79 145.82 38.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 p -88.11 147.78 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -77.95 143.94 37.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' HD22 ' A' ' 7' ' ' LEU . 66.4 mttt -125.58 146.94 49.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 76' ' ' PHE . 1.4 mm? -127.32 104.02 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.25 121.86 45.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.912 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -78.0 112.11 14.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.29 137.4 22.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 121.96 9.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.519 2.146 . . . . 0.0 112.351 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.507 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -145.24 107.78 4.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.538 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.04 135.41 54.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.978 HD13 HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -68.18 113.42 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.852 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -31.76 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.39 91.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.545 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.98 ' HB3' HG21 ' A' ' 66' ' ' VAL . . . -95.64 106.18 18.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 20' ' ' GLY . 1.9 mp -80.38 -53.9 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER 82.34 -19.8 0.39 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.543 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 18' ' ' ILE . . . -61.38 -25.72 65.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.315 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -170.5 -40.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.718 HG23 ' HG3' ' A' ' 35' ' ' ARG . 1.1 m -128.27 159.07 36.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.903 0.382 . . . . 0.0 111.276 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 17' ' ' ALA . 2.9 t -150.71 145.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -126.1 147.13 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -130.61 156.87 44.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ttp -113.18 97.94 6.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.582 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -103.78 106.16 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.382 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 48.57 36.9 8.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.229 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.05 -21.18 43.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -87.94 125.0 65.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 110.542 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.0 Cg_endo -66.87 97.36 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.416 2.077 . . . . 0.0 112.462 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.94 129.65 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 87' ' ' ARG . 29.4 m -81.2 133.24 35.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 111.294 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.536 ' HB2' HD12 ' A' ' 25' ' ' LEU . 49.2 t80 -139.24 34.95 2.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.009 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.718 ' HG3' HG23 ' A' ' 22' ' ' THR . 67.7 ttp85 -61.19 127.46 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.57 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tp -134.93 81.69 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.3 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.721 ' O ' HD22 ' A' ' 38' ' ' LEU . 5.7 tt -85.12 100.1 11.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.721 HD22 ' O ' ' A' ' 37' ' ' LEU . 2.1 mm? -136.15 105.47 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.339 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 40' ' ' ASP . 20.2 t -153.21 159.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' N ' HG12 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -150.85 89.78 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.426 HG23 HG12 ' A' ' 39' ' ' VAL . 27.0 p -113.93 85.18 9.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.445 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.18 -37.34 87.6 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.317 2.011 . . . . 0.0 111.53 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -165.54 20.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.121 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 46' ' ' HIS . 1.9 m -167.91 141.01 3.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.53 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -77.86 -15.71 58.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.231 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.425 ' H ' HG22 ' A' ' 44' ' ' THR . 2.4 p80 -132.51 62.3 62.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.948 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -30.17 45.74 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.124 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -97.21 -101.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.75 ' HB3' HG22 ' A' ' 51' ' ' VAL . 2.4 mptp? -107.66 -38.78 5.79 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.786 0.326 . . . . 0.0 111.164 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.49 38.74 95.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 49' ' ' LYS . 21.0 m -127.03 -51.27 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.629 0.252 . . . . 0.0 111.669 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -116.8 -52.36 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.281 0.562 . . . . 0.0 109.739 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -24.69 -74.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.873 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.055 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -156.03 25.0 0.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.363 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.52 -132.56 2.84 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.148 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.59 -5.34 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.098 1.865 . . . . 0.0 111.133 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 3.5 mm-40 -93.12 -42.34 9.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.817 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.055 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . . . -39.42 -32.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -51.08 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 109.962 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -40.91 -44.1 2.23 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.381 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.756 ' HB2' HD21 ' A' ' 103' ' ' LEU . 3.1 t80 -43.79 -47.45 8.03 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.86 -47.02 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.212 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 67.7 mttt -50.71 -27.64 7.47 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 62.4 mttt -79.15 -32.73 44.43 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.769 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 mtp -93.16 -0.52 56.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.231 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.98 HG21 ' HB3' ' A' ' 17' ' ' ALA . 93.2 t -117.69 -41.73 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.669 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.69 -79.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.735 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -57.63 -21.92 42.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.48 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.769 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -63.88 178.72 0.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 0.0 111.402 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -69.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.3 133.99 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 65' ' ' MET . 3.8 mp -96.06 161.66 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 72' ' ' ILE . 1.4 pt-20 -146.1 139.84 26.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.641 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 12' ' ' ALA . 26.0 t -95.74 109.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 3.5 pt-20 -112.31 106.62 15.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.7 p90 175.63 117.89 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.585 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.31 74.39 0.87 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.844 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 -54.98 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.15 -100.71 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.88 121.75 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.471 ' CZ ' ' HB1' ' A' ' 90' ' ' ALA . 6.4 ptt180 -89.25 -30.89 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.5 HG22 ' HG3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -104.45 151.1 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.014 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.2 -18.87 13.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HG3' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -71.02 -78.65 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -108.44 -22.51 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.14 -10.05 70.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.402 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 20.8 mmt85 -129.93 -24.03 2.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.359 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.93 -78.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.748 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.85 115.09 12.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 0.0 111.069 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.471 ' HB1' ' CZ ' ' A' ' 81' ' ' ARG . . . -144.08 158.91 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.051 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.68 142.09 28.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.457 HG23 HG21 ' A' ' 72' ' ' ILE . 27.5 mt -117.05 116.46 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' C ' HG23 ' A' ' 72' ' ' ILE . 17.1 m-85 -114.61 78.22 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.065 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -78.99 93.25 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 63.99 44.61 4.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.203 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 25.69 58.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.863 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 155.36 44.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.91 0.386 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.0 mtt -120.67 99.16 6.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.637 HG12 ' HB3' ' A' ' 102' ' ' ALA . 5.1 t -72.79 -8.14 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.554 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 17.9 p30 -47.82 -30.8 4.32 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -91.2 -18.73 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.811 0.339 . . . . 0.0 111.537 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.637 ' HB3' HG12 ' A' ' 99' ' ' VAL . . . -48.98 -69.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.888 HD22 ' N ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -111.37 -32.18 6.81 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.888 ' N ' HD22 ' A' ' 103' ' ' LEU . 5.0 t -59.8 -20.67 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -77.56 -24.37 49.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.706 ' HB2' HD21 ' A' ' 108' ' ' LEU . 6.8 mt-30 -61.75 -17.41 55.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.033 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.681 ' C ' HD13 ' A' ' 108' ' ' LEU . . . 98.18 34.5 5.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.425 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.706 HD21 ' HB2' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -156.52 -115.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 58' ' ' ALA . . . -178.03 16.77 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.233 -0.292 . . . . 0.0 111.706 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.983 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.825 0.345 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m -108.27 138.97 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.76 138.78 31.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 t -64.93 133.8 52.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -92.82 144.17 25.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -87.93 153.99 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.92 154.22 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.0 153.43 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.28 106.81 2.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.67 151.12 46.79 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.235 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.53 120.11 7.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.31 2.006 . . . . 0.0 112.215 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 74' ' ' VAL . . . -146.15 107.83 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.615 HG21 ' CE ' ' A' ' 71' ' ' LYS . 12.2 t -122.05 168.0 12.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.181 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.791 HD13 ' OG1' ' A' ' 62' ' ' THR . 1.3 mt -78.56 143.96 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.741 HG22 ' HD3' ' A' ' 16' ' ' LYS . 16.2 mt -75.88 -47.81 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.741 ' HD3' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -177.15 86.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.706 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.625 ' CB ' HG13 ' A' ' 23' ' ' VAL . . . -71.14 117.92 13.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.182 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.794 HG22 ' OD1' ' A' ' 19' ' ' ASP . 29.2 mm -60.18 -61.26 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.794 ' OD1' HG22 ' A' ' 18' ' ' ILE . 7.2 p-10 172.43 -137.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.372 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.94 -10.2 58.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.439 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.59 -84.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.786 0.293 . . . . 0.0 111.435 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -125.4 159.12 32.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.366 . . . . 0.0 111.117 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.625 HG13 ' CB ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.84 112.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -106.24 145.95 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -110.56 161.19 15.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.098 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 ttt -106.81 104.15 13.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' CE1' HG11 ' A' ' 74' ' ' VAL . 18.3 t80 -112.95 91.58 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.97 51.23 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.493 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 23.4 62.17 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.579 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -127.99 114.83 20.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.522 0.201 . . . . 0.0 110.816 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 97.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.443 2.095 . . . . 0.0 112.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.39 144.08 28.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.61 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.51 136.98 32.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.046 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.664 ' CD2' ' HB3' ' A' ' 90' ' ' ALA . 32.8 t80 -135.55 107.07 6.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 62.47 157.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.99 8.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 86.03 7.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.05 127.35 30.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.1 118.96 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -131.36 94.13 3.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.825 HG21 ' O ' ' A' ' 45' ' ' LYS . 9.5 t -93.79 124.71 55.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.54 -24.47 8.96 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.405 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.53 -63.41 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.584 HG23 ' HG2' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -179.98 -54.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.825 ' O ' HG21 ' A' ' 41' ' ' THR . 1.1 ptpp? -132.25 -175.63 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.53 ' HB3' ' CD ' ' A' ' 47' ' ' PRO . 4.1 t60 -159.88 -61.68 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.53 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 9.9 Cg_endo -50.72 -21.1 7.55 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -44.51 -51.03 9.2 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.0 -38.56 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.83 -48.31 1.62 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.395 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 13.3 p -52.07 -18.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.62 -22.65 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.613 0.244 . . . . 0.0 111.231 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 173.11 -8.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -135.79 25.23 3.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.673 0.273 . . . . 0.0 111.016 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.31 -133.15 6.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.97 -1.11 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.3 2.59 4.87 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.107 1.871 . . . . 0.0 111.584 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.676 ' CD ' HD23 ' A' ' 108' ' ' LEU . 8.6 mm-40 -94.92 -64.75 1.03 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.106 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.614 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . . . -40.25 -33.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.227 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 19' ' ' ASP . 40.0 p -79.3 -48.14 14.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.108 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.71 96.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 104' ' ' VAL . 30.1 t80 -44.95 -39.42 5.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.456 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.791 ' OG1' HD13 ' A' ' 14' ' ' LEU . 3.9 t -94.15 -29.07 15.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.331 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -26.33 68.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 68' ' ' ASN . 2.2 tttt -91.99 -38.3 12.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.987 0.423 . . . . 0.0 110.289 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.435 ' HA ' ' CB ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -57.43 -17.04 11.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 14' ' ' LEU . 4.6 m -104.89 -40.5 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -76.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 6.3 t30 -55.1 -36.28 65.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.381 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -76.17 -170.22 1.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.154 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -71.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.615 ' CE ' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER 176.47 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.232 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.949 HG21 HG13 ' A' ' 92' ' ' ILE . 2.2 mt 83.92 146.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 110.948 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -129.71 147.01 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.0 p -97.12 109.64 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.79 -76.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.255 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 55.0 p90 -85.89 117.67 24.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.17 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.22 24.04 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.969 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -140.44 -55.12 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.44 99.66 0.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.51 157.23 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.445 ' HB3' HD23 ' A' ' 89' ' ' LEU . 2.8 tpt85 -96.92 -44.8 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.413 ' CG2' ' HG3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -104.37 164.09 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -116.88 30.7 7.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.034 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 1.3 mttm -78.55 -66.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.742 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 93.7 t80 -137.93 11.2 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.35 40.11 97.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.093 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -174.43 -24.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.497 0.189 . . . . 0.0 111.356 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.7 -64.35 3.25 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 81' ' ' ARG . 2.6 tp -93.26 114.16 26.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.664 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . . . -131.85 146.68 52.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -83.45 122.58 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.949 HG13 HG21 ' A' ' 72' ' ' ILE . 11.2 tt -121.07 110.02 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.542 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -129.7 107.6 9.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.954 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB2' HG13 ' A' ' 72' ' ' ILE . . . -84.74 92.48 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.9 40.06 5.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.16 33.32 69.19 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -103.53 129.93 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.91 84.95 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 99' ' ' VAL . 21.6 t -75.75 -7.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 3.8 t-20 -56.52 -22.99 36.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -91.03 -18.87 23.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.91 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.871 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.701 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.43 -21.18 11.94 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.602 ' N ' HD22 ' A' ' 103' ' ' LEU . 20.1 t -61.93 -23.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 0.0 111.499 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -15.58 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.39 23.14 1.66 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.08 47.18 87.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.685 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.676 HD23 ' CD ' ' A' ' 57' ' ' GLU . 5.3 mp -122.83 -44.88 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.816 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 58' ' ' ALA . . . -134.33 37.31 3.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 15.2 mtmm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.849 0.357 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 m -90.86 114.49 26.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -101.43 135.38 43.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.4 p -97.09 118.91 34.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.0 113.34 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.685 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.6 150.58 47.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 76' ' ' PHE . 10.9 tp -88.21 155.14 19.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 113.3 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -67.67 106.93 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -96.1 152.08 38.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 119.1 6.07 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.668 1.579 . . . . 0.0 112.286 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 74' ' ' VAL . . . -146.55 107.63 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.362 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 m -123.67 145.86 48.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -91.34 144.13 25.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.706 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 16' ' ' LYS . 3.9 tp -86.1 -46.27 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.362 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' N ' HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.84 135.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.719 ' HB2' HG13 ' A' ' 23' ' ' VAL . . . -114.21 150.14 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -55.61 -47.64 78.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.678 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 19.9 t70 169.25 -110.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.809 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.73 -10.47 58.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.748 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -80.27 -90.04 0.06 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 m -97.14 159.09 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.064 0.459 . . . . 0.0 111.671 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -147.13 108.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.438 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 146.98 27.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.091 0.472 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 6.1 mt -124.22 130.92 53.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.681 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.403 ' CE ' HD13 ' A' ' 15' ' ' ILE . 1.6 tpp -85.45 100.71 12.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 29.8 t80 -126.06 112.47 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 27' ' ' TYR . 10.1 ptpt 47.44 29.05 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.31 -19.79 50.26 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.873 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -86.06 114.97 60.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.34 102.59 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.569 2.179 . . . . 0.0 112.408 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.5 mtt -99.28 127.7 45.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.485 HG22 ' HD2' ' A' ' 87' ' ' ARG . 1.5 t -105.55 140.42 38.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.17 151.44 48.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 60.49 102.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -135.46 99.65 4.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.561 . . . . 0.0 111.327 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.25 126.88 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.842 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.69 118.94 26.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.69 123.86 62.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -116.31 116.07 27.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.413 HG21 ' OG1' ' A' ' 44' ' ' THR . 0.1 OUTLIER -144.89 129.28 8.97 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.729 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -52.45 8.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.365 2.043 . . . . 0.0 112.592 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -39.19 18.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 41' ' ' THR . 0.1 OUTLIER -97.3 95.33 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.042 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -118.79 27.2 9.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.059 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.449 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 18.0 m80 -141.03 62.89 17.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 46' ' ' HIS . 3.4 Cg_exo -80.17 -61.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.979 2.453 . . . . 0.0 111.951 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -157.18 29.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.782 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.56 -10.86 60.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.307 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.594 ' C ' ' HA2' ' A' ' 55' ' ' GLY . . . 116.17 -48.11 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.548 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.57 ' HA ' ' N ' ' A' ' 55' ' ' GLY . 13.2 p -57.99 -11.78 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.32 -45.4 8.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.493 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HB3' ' N ' ' A' ' 110' ' ' LYS . 4.4 tptt -112.25 -28.51 7.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.67 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -169.61 -26.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.594 ' HA2' ' C ' ' A' ' 50' ' ' GLY . . . 85.58 -101.04 2.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.29 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 64.5 Cg_exo -40.77 -28.65 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.46 2.107 . . . . 0.0 112.724 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -73.11 -45.38 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.202 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . . . -51.49 -49.07 62.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -64.06 -37.63 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' GLU . . . -47.91 -34.1 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.16 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.816 ' CZ ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -53.54 -44.35 69.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.314 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.816 HG23 ' CZ ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -94.03 -28.39 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.417 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -69.42 -22.11 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ALA . 6.3 mtpt -84.96 -33.15 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.032 0.444 . . . . 0.0 109.941 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.575 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.39 -14.37 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.431 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 14' ' ' LEU . 30.2 m -107.76 -41.68 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.8 mt-10 -95.47 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.39 -28.9 69.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.685 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -86.91 171.65 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.433 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.84 -60.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.71 169.72 24.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.668 HG21 ' HB ' ' A' ' 92' ' ' ILE . 3.6 mp -141.51 157.11 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.8 mt-10 -134.65 171.2 14.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.968 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 12' ' ' ALA . 21.5 t -107.84 115.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.356 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.7 85.69 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.75 ' O ' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.89 130.35 55.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.908 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -63.64 -53.61 48.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.0 -35.83 16.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.64 78.47 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -117.7 110.72 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -28.15 7.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 7.6 p -89.95 -175.79 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 82' ' ' THR . 4.0 m-20 81.09 -57.5 0.28 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -69.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.674 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -153.5 11.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.566 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.45 24.03 71.73 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.221 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HD2' HG22 ' A' ' 33' ' ' THR . 2.6 ptt180 167.99 -24.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.633 0.254 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.39 -39.16 5.5 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.11 109.58 21.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.59 28.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.082 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.424 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -105.28 126.22 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 72' ' ' ILE . 16.1 pt -125.72 143.49 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 111.453 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.61 ' C ' HG23 ' A' ' 72' ' ' ILE . 73.3 m-85 -140.24 107.98 5.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 65' ' ' MET . . . -79.23 107.31 11.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.403 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.78 47.13 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.58 77.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -107.34 119.05 38.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -98.53 83.91 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.754 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.44 -27.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.555 ' OD1' HG21 ' A' ' 104' ' ' VAL . 32.3 t30 -56.46 -41.75 77.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 105' ' ' ARG . 8.8 mt-10 -86.38 -18.71 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.331 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -24.86 20.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 103' ' ' LEU . 2.8 tm? -111.22 -66.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.555 HG21 ' OD1' ' A' ' 100' ' ' ASN . 15.0 t -52.98 -37.31 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.692 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -69.77 -15.9 63.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.379 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.58 5.87 26.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.53 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.14 29.08 8.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.529 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 5.6 mt 64.27 107.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.651 0.263 . . . . 0.0 111.112 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 58' ' ' ALA . . . 82.41 -117.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.439 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.473 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.6 p -103.34 100.14 10.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -62.85 160.01 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 p -91.85 115.88 28.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.19 137.83 47.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -91.84 109.62 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -127.01 131.42 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.919 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -120.0 110.18 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -101.13 107.36 18.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -138.44 152.42 71.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.795 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.68 120.85 8.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.517 2.144 . . . . 0.0 112.148 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' CB ' HG13 ' A' ' 74' ' ' VAL . . . -145.35 107.91 4.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -120.49 159.4 25.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.997 HD13 HG23 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -102.71 141.39 35.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.9 mt -77.49 -58.96 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.239 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.72 124.03 36.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.81 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . -113.99 111.29 21.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -94.84 -49.08 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.514 ' OD2' HG21 ' A' ' 62' ' ' THR . 3.2 m-20 76.05 -54.89 0.61 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.18 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.39 -25.52 4.42 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.035 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -132.79 -79.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 m -140.82 158.82 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 17' ' ' ALA . 3.3 t -132.58 155.27 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.52 134.28 44.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.12 155.99 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.1 ttp -102.77 101.24 11.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.712 ' HE2' HG21 ' A' ' 74' ' ' VAL . 43.2 t80 -114.5 94.79 4.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.011 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 tttm 56.18 29.86 15.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.56 56.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.714 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.81 126.69 65.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.54 0.209 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 95.92 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.428 2.086 . . . . 0.0 112.429 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.5 mtt -77.42 99.97 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.59 HG23 ' HG2' ' A' ' 87' ' ' ARG . 1.8 t -70.93 132.58 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.728 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 9.5 t80 -116.79 134.85 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 59.58 164.11 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -127.32 155.43 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.33 102.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.996 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -60.82 177.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' HD12 ' A' ' 38' ' ' LEU . 21.4 t -76.23 154.76 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.081 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 39' ' ' VAL . 66.4 m-20 -120.96 104.28 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -84.77 121.23 74.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.25 -27.82 23.68 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.44 2.093 . . . . 0.0 112.39 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -47.06 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 47' ' ' PRO . 12.9 p -96.46 -77.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.12 30.39 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.486 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.59 ' ND1' HG11 ' A' ' 51' ' ' VAL . 6.1 t60 -176.56 -61.29 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.234 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 66.4 Cg_endo -72.4 -3.75 13.97 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.497 2.131 . . . . 0.0 113.092 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.7 -43.0 2.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.694 0.283 . . . . 0.0 111.473 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 46' ' ' HIS . 4.2 ptpt -56.85 -38.05 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.348 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.95 7.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.752 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG11 ' ND1' ' A' ' 46' ' ' HIS . 7.4 p -49.73 -26.17 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HG2' ' HD3' ' A' ' 53' ' ' LYS . 2.2 pt-20 -57.04 -30.43 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.325 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -107.69 -41.22 5.07 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.549 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -108.11 21.38 17.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 111.704 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 51' ' ' VAL . . . -82.91 -107.78 0.48 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.161 -1.019 . . . . 0.0 110.954 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.9 2.54 7.01 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.55 2.167 . . . . 0.0 111.913 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -97.23 -68.06 0.82 Allowed 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.836 ' CB ' HD22 ' A' ' 108' ' ' LEU . . . -40.8 -56.43 2.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 0.0 111.953 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -57.37 -18.68 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.908 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -91.1 -40.51 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.443 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.555 ' CD2' HD11 ' A' ' 103' ' ' LEU . 11.0 t80 -62.35 -62.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.514 HG21 ' OD2' ' A' ' 19' ' ' ASP . 39.1 p -53.29 -35.75 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.961 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 59' ' ' SER . 3.8 tppp? -48.88 -31.9 8.0 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.616 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -83.31 -36.93 24.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.996 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.08 -0.8 37.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.741 178.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.997 HG23 HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -109.9 -41.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.386 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 13.3 tt0 -95.26 -72.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.922 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.43 -45.05 85.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.996 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -98.46 141.44 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.972 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.65 29.06 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.59 61.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.0 mp -110.16 146.59 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.68 162.28 29.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.712 HG21 ' HE2' ' A' ' 27' ' ' TYR . 7.2 m -95.97 117.26 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.86 166.13 15.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.715 ' H ' HD23 ' A' ' 7' ' ' LEU . 16.0 m-85 60.68 163.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -66.68 -17.9 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -177.37 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 110.933 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.97 88.7 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.22 111.01 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.17 -36.0 5.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.028 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.759 ' H ' HD12 ' A' ' 89' ' ' LEU . 1.9 m -105.95 -176.39 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 82' ' ' THR . 2.4 m-20 -109.21 -18.3 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.672 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -58.38 -161.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.483 ' CE1' ' HB2' ' A' ' 87' ' ' ARG . 1.2 p90 -84.34 11.68 8.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.791 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 89' ' ' LEU . . . 108.13 35.93 2.43 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.486 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.59 ' HG2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -101.89 -24.11 14.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.163 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.88 60.38 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.207 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -107.89 113.08 26.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.251 0.526 . . . . 0.0 111.381 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB3' ' CD1' ' A' ' 34' ' ' PHE . . . -144.36 109.87 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.39 126.61 35.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.688 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.599 HG22 ' CE ' ' A' ' 65' ' ' MET . 3.2 mp -116.14 107.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.602 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.453 ' C ' HG23 ' A' ' 72' ' ' ILE . 48.1 m-85 -130.07 84.47 2.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.52 110.39 14.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.183 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t70 48.69 30.58 2.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.039 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.45 26.27 63.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.323 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -79.75 164.05 23.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.89 83.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.666 HG11 ' HE3' ' A' ' 65' ' ' MET . 9.7 m -91.4 -34.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 2.1 p-10 -66.71 -33.21 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.29 -20.7 21.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.5 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -58.43 -84.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.55 0.215 . . . . 0.0 111.483 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -112.16 -24.23 9.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.69 ' N ' HD22 ' A' ' 103' ' ' LEU . 53.4 t -57.99 -19.38 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.272 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -56.99 -34.86 68.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 110.423 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -98.61 21.97 10.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.684 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 108' ' ' LEU . . . 97.15 -4.59 62.69 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.178 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.836 HD22 ' CB ' ' A' ' 58' ' ' ALA . 6.0 mt 140.9 -25.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.595 0.758 . . . . 0.0 111.156 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . . . -168.57 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' H ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.692 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.75 126.37 54.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -67.7 125.3 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.959 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m -104.94 107.09 17.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.88 122.92 42.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' C ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -94.94 125.47 39.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.958 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 7' ' ' LEU . 1.2 mm? -119.99 106.55 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.46 152.34 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -105.98 106.95 17.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.528 ' O ' HG22 ' A' ' 74' ' ' VAL . 3.4 mt-10 -114.17 148.26 39.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.92 120.74 8.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.379 2.053 . . . . 0.0 112.463 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.671 ' CB ' HG13 ' A' ' 74' ' ' VAL . . . -145.35 107.84 4.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.649 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -115.94 158.73 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.06 HD13 HG12 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.04 142.06 36.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.612 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 16' ' ' LYS . 3.4 tt -95.9 -47.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.822 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' N ' HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -155.22 132.87 11.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 111.344 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.916 ' HB2' HG23 ' A' ' 23' ' ' VAL . . . -114.25 149.75 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.905 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.699 ' CG2' HG22 ' A' ' 22' ' ' THR . 2.8 tt -53.65 -44.24 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.126 0.488 . . . . 0.0 110.143 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.6 OUTLIER 169.1 -108.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.708 ' HA3' HD21 ' A' ' 108' ' ' LEU . . . -93.6 -10.05 59.49 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.123 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -95.52 -82.19 0.39 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.699 HG22 ' CG2' ' A' ' 18' ' ' ILE . 14.6 t -96.45 159.37 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.916 HG23 ' HB2' ' A' ' 17' ' ' ALA . 3.8 p -148.1 133.17 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.721 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -82.79 143.83 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 3.0 mt -133.32 149.06 51.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.36 97.63 7.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 74' ' ' VAL . 31.8 t80 -105.44 106.27 16.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.981 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 58.33 30.29 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.95 -12.86 66.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.789 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.94 125.38 68.77 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.613 0.244 . . . . 0.0 110.723 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 93.78 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.404 2.069 . . . . 0.0 112.321 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.574 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 5.6 tpt -80.73 120.64 24.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -91.85 121.51 33.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 17.8 t80 -105.14 61.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 85' ' ' TYR . 1.7 mtt-85 -66.65 93.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -110.04 81.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.809 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.92 127.77 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.33 -176.52 6.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.839 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.431 HG12 HG23 ' A' ' 41' ' ' THR . 21.5 t -65.41 122.89 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.093 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.19 110.06 18.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.431 HG23 HG12 ' A' ' 39' ' ' VAL . 32.9 p -144.13 157.03 57.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.9 59.39 3.52 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.127 . . . . 0.0 112.321 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -164.03 -44.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.746 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 t -99.67 26.03 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -65.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.746 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.436 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 5.3 m-70 60.48 71.78 0.81 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.63 14.24 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.84 2.36 . . . . 0.0 112.876 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -84.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.629 0.252 . . . . 0.0 111.041 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -107.07 -38.23 6.08 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 55' ' ' GLY . . . 66.05 32.76 83.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.709 ' HA ' ' N ' ' A' ' 55' ' ' GLY . 12.7 p -86.1 27.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.692 0.282 . . . . 0.0 111.486 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -50.02 -32.55 15.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.898 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -125.93 -27.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.54 178.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.601 ' H ' ' HB1' ' A' ' 109' ' ' ALA . 1.3 t80 -176.72 -25.56 0.01 OUTLIER 'General case' 0 C--N 1.345 0.4 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.666 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.709 ' N ' ' HA ' ' A' ' 51' ' ' VAL . . . 79.99 -104.81 2.26 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.601 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 2.2 Cg_endo -41.13 -28.07 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.912 2.408 . . . . 0.0 112.608 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 15.7 tp10 -78.56 -30.7 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.191 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . . . -39.27 -60.16 0.95 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -84.09 -47.39 10.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -48.5 -31.35 6.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.381 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' HG ' ' A' ' 103' ' ' LEU . 54.8 t80 -56.85 -58.49 7.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.225 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.25 -23.39 43.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.557 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -25.26 63.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -87.13 -26.92 23.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.296 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.959 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -70.16 -6.44 34.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.572 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 1.06 HG12 HD13 ' A' ' 14' ' ' LEU . 20.7 m -112.3 -41.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.6 mt-10 -87.92 -68.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.593 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -73.53 -32.54 64.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 0.0 111.251 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.959 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -113.97 149.39 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.086 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -165.35 70.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.86 84.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 94' ' ' ALA . 3.2 mp -135.65 150.73 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.22 149.96 47.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.645 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.671 HG13 ' CB ' ' A' ' 12' ' ' ALA . 6.2 m -95.91 109.87 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.804 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.1 82.91 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.432 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 7' ' ' LEU . 45.5 p90 -178.85 133.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.18 16.76 19.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -64.92 -34.67 78.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.51 27.53 68.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.95 110.8 20.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -4.66 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.405 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -89.78 -175.69 4.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.994 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 82' ' ' THR . 3.6 t0 84.94 -49.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.474 ' CD ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -85.03 -67.86 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.868 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 35' ' ' ARG . 70.5 t80 -149.32 11.4 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.72 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 70.44 18.08 75.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.532 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 169.19 -24.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.622 0.249 . . . . 0.0 111.186 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.87 -38.77 86.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.919 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD23 ' CD ' ' A' ' 84' ' ' LYS . 1.5 tm? -80.42 109.88 15.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.574 ' HB2' ' HE2' ' A' ' 32' ' ' MET . . . -144.19 117.95 9.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 93.68 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.464 HG22 HG12 ' A' ' 74' ' ' VAL . 3.0 pt -112.71 158.18 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.43 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.66 89.56 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.759 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.87 141.25 36.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.571 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 49.18 31.25 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.434 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.1 -37.62 3.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.744 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -139.33 139.59 37.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.004 0.43 . . . . 0.0 111.235 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.31 94.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.112 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.33 -28.66 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -66.01 -37.4 85.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -29.73 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.3 -33.95 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -59.29 -58.15 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.66 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.82 HG13 HD12 ' A' ' 108' ' ' LEU . 33.9 t -66.09 -14.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.537 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -24.88 60.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -94.35 23.29 5.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.17 -3.32 61.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.596 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.82 HD12 HG13 ' A' ' 104' ' ' VAL . 2.6 tt 69.55 86.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.945 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . . . -166.63 -41.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.088 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' C ' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.903 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.51 113.77 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.7 t -106.56 153.32 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 m -80.63 139.33 36.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.851 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 100.86 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -123.87 139.25 54.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.9 112.91 14.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -82.04 109.64 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.644 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.7 111.09 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -129.25 143.05 47.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.07 120.86 7.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.491 2.127 . . . . 0.0 112.52 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 107.94 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.649 HG21 ' HG2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -124.04 149.87 45.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.924 HD12 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -98.56 139.6 34.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.58 -34.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -137.87 93.27 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.563 ' HB1' ' CB ' ' A' ' 62' ' ' THR . . . -99.58 111.06 23.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.527 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 22' ' ' THR . 7.3 mt -101.07 -46.9 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.677 ' H ' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER 69.7 -61.62 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.235 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.33 -27.7 2.92 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.834 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -127.42 -76.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.929 0.395 . . . . 0.0 110.781 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -140.24 146.82 39.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.677 HG22 ' H ' ' A' ' 19' ' ' ASP . 10.7 t -120.77 143.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -128.65 109.47 11.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.774 HD21 ' CD2' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -101.88 154.26 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.689 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 tpp -85.62 94.92 9.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.547 ' CE1' HG11 ' A' ' 74' ' ' VAL . 53.1 t80 -120.71 93.66 4.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 tttm 54.54 41.17 32.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.9 16.03 78.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -118.0 142.29 30.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.643 0.259 . . . . 0.0 110.761 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.15 97.98 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 107.75 7.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 p -72.05 125.94 28.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -115.23 95.94 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.76 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 62.07 89.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 171.95 12.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.32 103.12 10.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.57 158.96 36.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.78 112.1 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -154.9 87.74 1.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.03 75.78 10.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.21 82.67 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.715 2.277 . . . . 0.0 112.418 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.33 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.992 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.5 -28.05 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.323 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 pttm 44.22 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.549 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 44.1 t-80 -122.22 50.89 2.78 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.297 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 46' ' ' HIS . 95.5 Cg_endo -77.47 -1.8 11.97 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.548 2.165 . . . . 0.0 112.668 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -73.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -90.83 -38.2 13.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.22 42.03 94.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.418 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 51' ' ' VAL . 14.7 t -96.26 23.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 0.0 111.278 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.3 mt-10 -111.11 13.17 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.989 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.827 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER 161.34 -2.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.465 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 8.2 m-85 -131.11 -1.53 4.06 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.12 -140.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.443 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 2.41 7.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.551 2.167 . . . . 0.0 112.864 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HB2' ' CA ' ' A' ' 109' ' ' ALA . 9.9 mt-10 -95.98 -63.8 1.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.105 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 53' ' ' LYS . . . -40.43 -33.35 0.25 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.789 0.328 . . . . 0.0 111.517 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -81.65 -57.95 3.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.481 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.05 -28.39 7.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.503 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.66 ' HD2' HG23 ' A' ' 62' ' ' THR . 61.4 t80 -57.64 -65.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.64 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.66 HG23 ' HD2' ' A' ' 61' ' ' PHE . 67.6 p -79.58 -26.49 41.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 22.7 ttmt -60.16 -24.73 64.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG2' ' CB ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -92.07 -25.09 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.919 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.584 ' HB2' HD11 ' A' ' 14' ' ' LEU . 0.7 OUTLIER -63.7 -9.23 13.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.527 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.924 HG13 HD12 ' A' ' 14' ' ' LEU . 28.3 m -114.72 -41.31 3.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.6 mt-10 -88.12 -68.87 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.345 . . . . 0.0 111.912 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' CB ' ' HG2' ' A' ' 64' ' ' LYS . 1.0 OUTLIER -68.58 -29.96 68.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -72.29 170.47 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.185 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -108.61 -55.92 2.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.649 ' HG2' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER -166.51 163.74 17.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.705 HG21 ' CG2' ' A' ' 92' ' ' ILE . 1.6 mp -142.4 162.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -135.04 137.44 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.43 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.2 p -95.83 109.81 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 4.5 pt-20 -129.62 139.79 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -166.99 132.01 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.0 -30.28 71.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.983 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -107.81 -47.35 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.838 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.86 -40.66 2.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.75 116.52 32.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.18 -55.04 4.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.549 ' HB ' ' CD ' ' A' ' 84' ' ' LYS . 96.4 m -121.96 158.02 30.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.027 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.89 47.06 0.98 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.761 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.549 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -92.21 -38.79 11.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.723 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.483 ' N ' ' HG2' ' A' ' 84' ' ' LYS . 4.9 t80 -158.3 11.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.415 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.94 32.05 78.5 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.365 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.88 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.559 0.219 . . . . 0.0 111.234 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -45.43 -79.66 0.06 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.945 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.431 ' H ' ' HD2' ' A' ' 84' ' ' LYS . 0.3 OUTLIER -80.86 122.13 26.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.865 0.365 . . . . 0.0 110.78 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.13 148.35 34.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.483 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -72.35 142.07 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.784 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.705 ' CG2' HG21 ' A' ' 72' ' ' ILE . 17.6 mm -128.53 120.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.187 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 75' ' ' GLU . 1.1 m-85 -116.64 78.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.691 ' CA ' HG23 ' A' ' 72' ' ' ILE . . . -79.6 111.19 15.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 68.4 45.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.326 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.24 24.64 52.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.062 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -134.19 150.44 51.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.283 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.22 107.19 15.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.7 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' VAL . 11.9 t -72.5 -7.9 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.774 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 4.9 m-80 -58.66 -20.32 47.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.19 -18.72 24.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.394 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -61.71 -84.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.14 -22.23 11.08 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.716 HG22 ' CD2' ' A' ' 108' ' ' LEU . 14.6 t -54.83 -23.29 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -57.72 -24.12 55.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.963 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -103.76 19.12 20.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.69 ' O ' HD12 ' A' ' 108' ' ' LEU . . . 82.29 -3.2 82.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.854 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.716 ' CD2' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER 78.38 74.0 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.584 0.231 . . . . 0.0 110.874 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.62 ' CB ' ' O ' ' A' ' 108' ' ' LEU . . . 131.15 -71.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.638 0.775 . . . . 0.0 110.226 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.985 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.838 0.352 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 t -115.82 139.96 49.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -103.59 126.91 51.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -67.82 126.07 28.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -81.81 125.85 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.929 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.49 110.75 18.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 mt -127.06 103.96 7.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -94.55 128.8 41.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.732 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -81.21 115.73 20.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -135.87 129.29 18.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.443 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.67 120.52 8.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.368 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB3' HG13 ' A' ' 74' ' ' VAL . . . -145.42 107.39 4.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -116.99 164.08 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.907 ' HB2' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -96.92 144.04 27.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.896 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -90.21 -40.61 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.5 OUTLIER 178.57 126.02 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.985 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.789 ' CB ' HG12 ' A' ' 23' ' ' VAL . . . -103.84 148.59 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 21' ' ' ASP . 4.2 pt -51.12 -40.36 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 4.5 p30 165.11 -113.66 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.37 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.31 -10.12 59.77 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.618 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.534 ' HB3' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -72.64 -82.46 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.489 ' H ' HD11 ' A' ' 18' ' ' ILE . 91.4 m -130.14 159.43 36.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.418 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.024 HG11 HG21 ' A' ' 62' ' ' THR . 22.9 m -124.8 154.4 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.229 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.99 135.33 54.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 mp -110.95 159.89 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.9 94.91 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.33 95.35 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.11 30.16 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.01 43.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.685 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -85.81 114.99 59.9 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.518 0.199 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.88 102.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.504 2.136 . . . . 0.0 112.337 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.414 ' HE1' HD22 ' A' ' 25' ' ' LEU . 4.2 ttp -87.6 150.04 23.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.911 HG21 HD23 ' A' ' 36' ' ' LEU . 3.5 m -104.84 140.01 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' HB2' HD13 ' A' ' 25' ' ' LEU . 13.6 t80 -124.56 112.85 17.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.73 87.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.211 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.911 HD23 HG21 ' A' ' 33' ' ' THR . 0.3 OUTLIER -105.75 81.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD23 HG22 ' A' ' 39' ' ' VAL . 3.2 tp -125.53 145.7 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.01 105.22 12.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.674 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG22 HD23 ' A' ' 37' ' ' LEU . 5.4 m -153.75 142.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.947 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -145.8 87.38 1.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 110.875 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.51 75.44 10.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 75.6 Cg_endo -88.1 -14.22 3.47 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.806 2.338 . . . . 0.0 112.438 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.1 tm-20 165.89 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.528 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -154.09 -64.45 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.498 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.84 -55.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.7 p80 178.32 83.34 0.15 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.53 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.52 -26.35 12.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 111.876 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 pttt 175.83 -53.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.396 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' O ' ' CA ' ' A' ' 55' ' ' GLY . 4.5 mtmp? -107.81 -38.81 5.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' GLY . . . 106.89 35.32 2.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.312 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.568 HG12 ' HB1' ' A' ' 109' ' ' ALA . 18.4 t -66.56 1.41 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 42' ' ' PRO . 5.8 mm-40 -89.54 15.01 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.836 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 8.3 tttt -167.06 -45.8 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 169.81 -22.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.14 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . 46.78 -111.75 0.77 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.214 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.42 -19.79 45.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.002 1.801 . . . . 0.0 111.011 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.882 ' HB3' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -88.56 -20.82 24.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.657 ' HB2' ' CD1' ' A' ' 54' ' ' TYR . . . -39.98 -35.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.452 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -79.21 -43.32 24.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 0.0 109.719 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' GLU . . . -50.71 -40.37 53.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.527 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CE1' HG12 ' A' ' 99' ' ' VAL . 10.6 t80 -40.23 -61.58 0.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.948 0.404 . . . . 0.0 110.427 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.024 HG21 HG11 ' A' ' 23' ' ' VAL . 2.4 m -88.19 -49.74 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.114 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CG1' ' A' ' 66' ' ' VAL . 34.1 ttmt -40.34 -29.32 0.08 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 2.9 tttm -85.8 -33.25 21.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.0 110.421 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.895 ' HG2' HG22 ' A' ' 99' ' ' VAL . 6.7 tpp -94.15 -0.67 55.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.011 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 62' ' ' THR . 7.4 p -123.48 -41.72 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -95.59 -55.2 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 111.828 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -87.06 5.26 38.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.791 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -99.54 173.53 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.403 . . . . 0.0 111.482 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 -66.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.83 -176.72 3.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.648 HG23 ' N ' ' A' ' 94' ' ' ALA . 4.1 mp -143.68 145.58 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -113.72 133.14 55.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.403 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.671 HG13 ' HB3' ' A' ' 12' ' ' ALA . 4.2 m -95.67 118.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 111.207 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 7.6 tt0 -94.61 78.58 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.285 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 74' ' ' VAL . 8.0 p90 -171.21 136.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.75 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -63.92 -60.86 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.471 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.31 -30.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.281 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -41.73 134.75 3.4 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.26 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' CG ' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -67.95 142.49 55.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -34.08 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 89' ' ' LEU . 2.4 p -122.09 147.16 46.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.42 -9.9 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -27.77 6.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -178.13 -37.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 80' ' ' GLN . . . 109.06 -10.23 34.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.633 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.22 -5.6 6.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.508 0.194 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.54 -76.28 0.64 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.545 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.581 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.3 OUTLIER -74.01 110.08 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.829 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.92 139.82 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.39 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -109.37 156.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.639 ' C ' HG23 ' A' ' 72' ' ' ILE . 88.8 m-85 -141.99 83.56 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.981 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.648 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.9 106.81 12.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 64.77 42.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.801 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 21.75 74.43 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.669 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -158.0 156.66 31.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 166.75 22.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.895 HG22 ' HG2' ' A' ' 65' ' ' MET . 19.6 t -84.49 -35.5 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -58.59 -28.12 65.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.58 -18.84 61.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.3 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.48 -74.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.794 0.33 . . . . 0.0 111.769 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 57' ' ' GLU . 4.5 tt -95.23 -56.72 2.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.83 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 61' ' ' PHE . 15.0 t -48.03 -26.43 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.94 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -15.68 61.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 0.0 111.311 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -76.08 5.18 7.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.769 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.46 4.54 58.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.394 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.836 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mt 64.46 76.32 0.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.165 0.507 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.568 ' HB1' HG12 ' A' ' 51' ' ' VAL . . . 176.91 103.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.822 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.902 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.923 0.392 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.1 p -136.23 127.94 29.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 t -98.13 150.1 21.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -63.11 145.22 55.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 106.49 18.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 131.56 46.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.07 148.55 36.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.31 153.05 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.28 127.9 44.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.03 147.13 64.11 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.94 120.54 8.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.422 2.081 . . . . 0.0 112.024 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 74' ' ' VAL . . . -145.64 107.94 4.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.849 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -121.98 168.81 11.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.848 HD11 ' CG2' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -106.23 144.02 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 16' ' ' LYS . 1.4 tt -82.13 -42.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.409 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' N ' HG23 ' A' ' 15' ' ' ILE . 7.6 ttmm -143.55 105.81 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.128 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.827 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -114.14 123.68 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 22' ' ' THR . 1.9 mp -94.23 -35.03 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.174 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.08 -64.58 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.173 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.06 -26.34 8.74 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.789 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.75 -79.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.663 ' O ' HD12 ' A' ' 18' ' ' ILE . 43.2 m -131.83 158.96 39.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.727 HG23 ' CB ' ' A' ' 17' ' ' ALA . 7.9 p -138.68 145.12 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.31 142.26 51.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 1.6 mt -115.91 152.11 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 95.62 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.474 ' HE1' HG11 ' A' ' 74' ' ' VAL . 49.4 t80 -106.6 93.64 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 58.25 41.84 22.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.973 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.66 24.03 68.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.59 128.04 24.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.604 0.24 . . . . 0.0 110.803 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.82 90.41 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.367 2.045 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ttm -78.41 113.07 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 p -73.54 135.5 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.725 ' HB3' HG13 ' A' ' 23' ' ' VAL . 4.7 t80 -127.79 109.21 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.747 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 64.24 144.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 85' ' ' TYR . 9.3 mp -91.05 172.01 8.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.48 99.43 10.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.7 tp -132.38 106.44 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 40' ' ' ASP . 17.3 t -136.38 159.23 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 39' ' ' VAL . 2.2 t0 -92.87 127.2 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 t -124.05 85.78 54.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.82 -55.14 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.502 2.135 . . . . 0.0 112.38 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -24.63 9.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.3 -54.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -48.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.711 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.68 143.8 49.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.717 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -86.6 26.23 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.851 2.368 . . . . 0.0 112.687 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 mttm 59.3 27.89 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -107.12 -38.16 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.2 95.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.252 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 51' ' ' VAL . 14.4 p -117.3 16.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.709 0.29 . . . . 0.0 111.454 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 11.1 mt-10 -116.0 13.31 15.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.412 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.865 ' CB ' HD22 ' A' ' 108' ' ' LEU . 18.8 ptpt 139.96 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.346 1.058 . . . . 0.0 108.474 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.47 ' CG ' ' CB ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER 50.53 25.35 1.94 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 -178.03 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -109.47 1.85 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.252 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 2.36 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.678 2.252 . . . . 0.0 113.024 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -85.59 -62.97 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' LYS . . . -45.77 -48.92 15.39 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.723 0.296 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 13.0 t -48.53 -29.48 4.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -91.46 -38.19 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.605 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.2 -65.4 0.56 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.241 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -60.68 -20.4 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -65.62 -33.4 75.81 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.16 -21.34 20.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.148 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.628 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -75.0 -5.32 43.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.011 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.93 ' HA ' HD11 ' A' ' 72' ' ' ILE . 22.6 m -123.39 -41.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.705 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' N ' HG23 ' A' ' 66' ' ' VAL . 28.1 tt0 -74.73 -66.8 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.903 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -92.83 5.39 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.628 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -98.96 92.07 5.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.487 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm 60.17 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.214 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 13' ' ' THR . 8.0 mttt 166.95 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.93 HD11 ' HA ' ' A' ' 66' ' ' VAL . 2.7 mt 79.23 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 72' ' ' ILE . 17.0 pt-20 -141.28 140.11 33.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.692 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 12' ' ' ALA . 13.8 p -95.92 109.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HG3' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -124.84 -86.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.831 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.486 ' CE1' ' CD2' ' A' ' 91' ' ' TYR . 2.7 t80 59.75 117.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 111.163 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -86.03 57.17 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.454 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -166.73 -44.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.34 144.63 9.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.682 ' CB ' HD12 ' A' ' 89' ' ' LEU . 5.7 pm0 -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.0 110.722 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -114.34 -55.72 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.565 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -141.4 -175.3 4.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.729 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 82' ' ' THR . 24.2 t70 104.02 -72.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.532 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.687 ' H ' HD22 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -92.15 90.6 7.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.394 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' HB2' HD11 ' A' ' 36' ' ' LEU . 43.1 t80 64.86 11.35 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.921 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 58.75 30.79 66.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.465 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 165.35 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.464 0.306 . . . . 0.0 110.789 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.72 -12.87 36.57 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.062 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.687 HD22 ' H ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -83.7 109.77 17.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 34' ' ' PHE . . . -144.23 134.74 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.486 ' CD2' ' CE1' ' A' ' 76' ' ' PHE . 5.5 m-85 -112.11 119.92 40.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.24 136.07 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.604 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' HG3' ' A' ' 75' ' ' GLU . 74.5 m-85 -127.34 77.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.784 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.06 141.81 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.246 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 p30 48.88 31.23 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.651 0.739 . . . . 0.0 109.505 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.51 -47.01 2.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.059 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -161.7 111.69 1.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.764 0.282 . . . . 0.0 111.589 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.774 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 15.3 ttm -147.41 80.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.283 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -98.95 -59.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.111 0.482 . . . . 0.0 111.961 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 105' ' ' ARG . 5.8 p-10 -89.56 -57.21 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.215 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.404 ' HG3' ' HG3' ' A' ' 98' ' ' MET . 6.5 pt-20 -40.56 -28.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.774 ' HB2' ' HG2' ' A' ' 98' ' ' MET . . . -67.18 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.657 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.623 HD11 HD23 ' A' ' 108' ' ' LEU . 1.3 tm? -114.42 -57.58 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.456 0.646 . . . . 0.0 111.469 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 100' ' ' ASN . 18.5 t -48.82 -16.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.012 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -49.93 -28.66 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.975 0.417 . . . . 0.0 110.486 179.457 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -98.41 23.04 8.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.068 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.85 38.65 65.28 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.865 HD22 ' CB ' ' A' ' 53' ' ' LYS . 33.0 mt 55.87 87.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.62 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.61 -6.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HA ' ' CD2' ' A' ' 54' ' ' TYR . 8.1 ptpt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 p -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.932 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 p -71.93 116.95 12.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.3 m -101.6 147.58 26.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -84.14 134.22 34.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 105.41 17.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -127.07 104.05 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.56 106.53 18.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.03 106.91 17.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 74' ' ' VAL . 6.5 mt-10 -128.24 126.54 23.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.36 121.46 9.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.385 2.057 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.15 107.43 4.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 72' ' ' ILE . 2.5 p -125.44 150.58 47.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.58 141.74 41.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.695 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 16' ' ' LYS . 15.4 tt -88.64 -47.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.703 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' N ' HG23 ' A' ' 15' ' ' ILE . 19.1 mttt -155.07 130.3 9.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 111.46 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.03 133.51 55.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.698 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 19' ' ' ASP . 17.3 tt -54.66 -49.45 67.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.23 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 166.93 -152.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.84 -10.52 4.79 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.449 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 18' ' ' ILE . 29.2 t70 -67.15 -71.17 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.026 0.413 . . . . 0.0 111.129 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -147.0 159.05 44.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 23' ' ' VAL . 29.4 m -121.45 117.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.978 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -83.34 124.9 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 2.4 mp -89.67 160.85 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.1 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.63 98.32 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt 57.57 43.42 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.32 22.56 76.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.597 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -114.31 133.64 22.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.576 0.226 . . . . 0.0 110.815 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.06 99.49 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.458 2.105 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 mtt -95.9 149.75 21.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.88 144.55 36.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.976 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 90' ' ' ALA . 32.5 t80 -138.02 122.81 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 62.86 145.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.26 103.09 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.74 102.82 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.839 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.97 107.76 17.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.61 140.26 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -141.72 89.73 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -62.65 145.84 94.92 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.99 -50.65 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.418 2.079 . . . . 0.0 112.371 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -159.3 28.51 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.802 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 t -150.77 -168.28 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.568 ' ND1' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -70.2 -62.35 2.29 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.683 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 51' ' ' VAL . 3.3 Cg_endo -46.38 -44.7 20.1 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.817 2.345 . . . . 0.0 112.548 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -28.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -73.39 -30.08 63.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.1 42.08 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.625 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.568 HG11 ' ND1' ' A' ' 46' ' ' HIS . 31.4 m -95.8 -30.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.054 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 13.7 mt-10 -92.71 13.56 19.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HB3' ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER 64.81 4.67 2.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD1' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER 172.11 -25.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.736 0.303 . . . . 0.0 110.813 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.15 -102.07 2.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.371 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.96 -25.69 63.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.689 ' OE1' ' HB3' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -73.61 -36.93 65.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . . . -47.89 -26.23 1.62 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -32.37 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.689 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -54.82 -47.14 74.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.512 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.657 ' HB2' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -47.85 -47.87 31.26 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.885 0.374 . . . . 0.0 110.488 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.7 t -81.94 -26.15 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -26.77 65.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.747 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 69' ' ' ALA . 11.9 mttp -92.02 -24.86 19.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.48 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 24.6 ttp -57.21 -15.25 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.414 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.497 HG12 ' HG ' ' A' ' 14' ' ' LEU . 33.4 m -105.23 -42.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.3 mt-10 -95.6 -69.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.714 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.24 -20.49 62.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.592 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -93.08 -179.84 5.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.356 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -69.45 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.068 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 172.61 149.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.922 0.391 . . . . 0.0 110.924 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.609 ' H ' HG22 ' A' ' 13' ' ' THR . 1.8 mp -102.78 161.61 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.051 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.3 mt-10 -133.78 149.55 51.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.6 p -100.48 109.82 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.967 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -88.48 -178.54 5.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 75' ' ' GLU . 15.5 p90 46.94 117.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.04 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.08 32.02 6.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -59.26 -27.55 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.069 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.45 -84.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.21 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.27 110.82 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.601 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -110.11 -40.29 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.511 HG21 ' O ' ' A' ' 89' ' ' LEU . 82.7 p -130.1 133.94 47.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.38 -8.31 58.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.087 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.59 70.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -177.19 -37.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.05 -10.27 34.03 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.536 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.552 ' HB3' HG23 ' A' ' 33' ' ' THR . 1.4 mpp_? -123.21 -24.11 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.54 -84.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.736 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' HG21 ' A' ' 82' ' ' THR . 3.1 tp -89.08 116.22 27.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.335 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.541 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . . . -144.04 141.88 30.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 1.5 m-85 -80.89 127.3 32.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.13 149.77 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -134.42 89.12 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.25 115.55 18.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.24 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 t70 67.57 26.64 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.13 -31.26 7.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.816 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -134.17 131.43 38.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 111.025 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.18 158.36 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' VAL . 12.2 t -95.12 -8.64 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -63.06 -16.57 60.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -18.83 30.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -61.53 -84.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.517 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.995 HD23 ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -111.64 -24.07 10.3 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.626 ' N ' HD22 ' A' ' 103' ' ' LEU . 63.6 t -58.93 -31.47 45.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -98.17 -16.01 19.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -83.87 -25.2 30.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.533 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.12 47.8 2.16 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.332 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 2.6 tt -147.98 6.16 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.995 ' HB3' HD23 ' A' ' 103' ' ' LEU . . . 176.32 86.78 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.587 ' C ' ' HB1' ' A' ' 58' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.829 0.347 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -111.33 95.15 5.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 p -90.41 119.05 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.6 p -74.44 128.31 35.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.03 138.44 52.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.826 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -103.14 138.57 39.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 111.119 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.596 HD22 ' H ' ' A' ' 7' ' ' LEU . 1.6 mm? -79.06 112.87 16.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.034 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -70.0 153.21 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -106.95 106.91 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -110.52 129.65 23.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.379 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.1 120.02 7.58 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.253 1.969 . . . . 0.0 112.486 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -146.0 107.81 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.472 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -117.49 163.41 16.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.021 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.656 HD21 ' CB ' ' A' ' 66' ' ' VAL . 1.6 pp -106.23 144.19 33.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.606 HD11 ' SD ' ' A' ' 26' ' ' MET . 38.3 mm -62.2 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HG2' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -168.99 135.42 1.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.808 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.146 ' HB2' HG23 ' A' ' 23' ' ' VAL . . . -114.12 137.73 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.132 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 19' ' ' ASP . 6.8 tt -57.71 -46.36 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' HG23 ' A' ' 18' ' ' ILE . 1.1 p30 166.45 -110.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.41 -10.62 59.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.54 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.493 ' HB2' HG21 ' A' ' 18' ' ' ILE . 3.7 m-20 -70.17 -80.75 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.714 0.292 . . . . 0.0 111.435 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -131.48 157.76 42.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.378 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.146 HG23 ' HB2' ' A' ' 17' ' ' ALA . 7.5 p -147.96 107.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -83.5 111.37 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.514 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HA ' ' CB ' ' A' ' 14' ' ' LEU . 3.6 mt -89.74 161.71 15.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.634 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.606 ' SD ' HD11 ' A' ' 15' ' ' ILE . 7.2 ttp -106.41 109.04 20.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -126.1 92.67 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.02 41.04 5.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.86 37.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.644 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -124.74 114.86 26.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.519 0.2 . . . . 0.0 110.876 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.75 83.0 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.487 2.124 . . . . 0.0 112.275 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 mtm -80.94 123.46 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.693 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -110.23 148.08 32.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.897 ' CD1' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -88.83 -171.02 3.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HG2' ' CD2' ' A' ' 34' ' ' PHE . 6.9 ptt180 -46.68 148.42 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -88.76 172.12 9.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 37' ' ' LEU . 1.4 pt? -94.41 156.15 16.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.93 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.44 -178.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 41' ' ' THR . 21.7 t -80.3 138.44 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.66 96.17 7.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 39' ' ' VAL . 24.0 p -123.71 156.18 65.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 41' ' ' THR . 33.7 Cg_endo -64.32 -14.71 45.6 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.605 2.203 . . . . 0.0 112.425 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.38 -28.41 65.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.11 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 m -161.0 78.94 0.6 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -74.54 154.14 38.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' CG ' ' HA3' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -96.86 101.82 10.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.1 -43.84 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.415 2.077 . . . . 0.0 112.201 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -145.01 -55.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.712 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 67.9 mttt -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.352 0.596 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' HA3' ' CG ' ' A' ' 46' ' ' HIS . . . 70.23 -51.9 0.79 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.574 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' H ' ' A' ' 52' ' ' GLU . 2.1 p -130.43 -67.37 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.214 1.007 . . . . 0.0 112.216 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.701 ' H ' HG13 ' A' ' 51' ' ' VAL . 29.1 tp10 -121.29 -78.11 0.59 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.682 0.754 . . . . 0.0 111.317 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.87 2.12 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.521 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 76.7 t80 -83.47 0.97 43.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.224 0.535 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.55 -60.36 1.81 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.712 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 85.7 Cg_endo -92.06 -48.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.674 2.916 . . . . 0.0 113.153 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.466 ' CG ' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -65.03 -56.92 10.28 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . . . -45.95 -49.33 15.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 111.428 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' LYS . 4.2 m -60.06 -19.97 55.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.73 -58.12 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.128 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -72.85 -62.63 1.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.911 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.78 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.9 m -49.63 -27.58 4.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.219 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 59' ' ' SER . 37.3 ttmt -76.61 -21.77 55.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -23.27 23.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.647 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 5.0 mmt -89.95 -1.03 57.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 62' ' ' THR . 15.9 m -123.3 -41.69 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -85.7 -72.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.58 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.49 -20.69 64.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -102.46 111.14 23.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.685 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.58 51.35 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 30.2 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.571 HG21 HG12 ' A' ' 92' ' ' ILE . 1.2 mp -80.87 149.73 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.67 168.43 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.2 109.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 5.3 mm-40 -91.45 82.24 5.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.537 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.4 m-85 -168.66 117.8 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 7' ' ' LEU . 2.9 t0 -65.65 -44.82 85.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.898 0.38 . . . . 0.0 110.804 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -169.49 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.378 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.18 149.45 0.88 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.873 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.8 160.99 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 mtt-85 -95.12 -55.29 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.608 HG21 ' HB2' ' A' ' 89' ' ' LEU . 10.9 p -140.19 157.55 45.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.184 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -98.79 -25.44 14.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.676 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.44 ' HE3' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -45.87 -29.33 1.34 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.452 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -176.28 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.38 25.72 6.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -160.73 -24.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.13 -80.27 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.608 ' HB2' HG21 ' A' ' 82' ' ' THR . 4.7 mp -74.09 117.22 15.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.0 159.87 41.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.121 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 36.0 m-85 -103.35 142.17 34.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -120.53 110.92 30.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 91' ' ' TYR . 17.3 m-85 -113.69 71.73 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.183 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB2' HD11 ' A' ' 92' ' ' ILE . . . -79.58 101.28 8.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.059 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 67.37 35.06 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 35.8 83.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.04 157.27 16.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.119 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.34 84.08 2.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.539 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 30.1 m -60.97 -47.24 94.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.273 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.483 ' N ' HG23 ' A' ' 99' ' ' VAL . 3.3 t30 -49.19 -24.1 1.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.506 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -91.31 -63.12 1.3 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.15 -15.73 30.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 109' ' ' ALA . 4.9 tt -99.91 -49.04 4.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 109' ' ' ALA . 22.9 t -90.12 -62.26 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -58.65 -24.53 61.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.692 0.282 . . . . 0.0 111.227 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -70.19 -17.67 63.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.342 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.707 ' C ' HD12 ' A' ' 108' ' ' LEU . . . 97.32 47.17 2.24 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.474 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.707 HD12 ' C ' ' A' ' 107' ' ' GLY . 5.8 mp -153.22 34.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.805 ' O ' HG13 ' A' ' 104' ' ' VAL . . . 167.7 42.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.767 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.789 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 pttt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.83 0.348 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 76' ' ' PHE . 24.3 mt -123.43 119.71 30.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -108.93 121.34 44.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.756 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -79.42 110.93 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.241 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.86 130.59 23.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.566 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.91 120.31 7.93 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.227 1.951 . . . . 0.0 112.544 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.66 107.7 4.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -125.27 141.58 52.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.249 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.808 HD22 ' HB2' ' A' ' 17' ' ' ALA . 3.5 mp -67.04 144.05 56.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pt -87.21 -28.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -167.91 94.22 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -98.64 115.5 28.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.354 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mt -80.64 -31.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 59' ' ' SER . 20.4 m-20 68.22 -65.68 0.25 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.079 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.16 33.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.689 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.422 ' O ' HD12 ' A' ' 37' ' ' LEU . 85.9 m-20 -121.44 -77.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -146.13 159.07 43.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 HG12 ' HB1' ' A' ' 17' ' ' ALA . 18.4 m -134.89 148.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.199 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 132.51 41.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -99.14 160.55 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.4 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.797 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -122.63 109.12 13.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.07 29.06 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.75 -4.13 83.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -85.94 127.81 60.69 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.799 0.3 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.69 83.27 2.11 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.563 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.62 111.35 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.679 ' CG2' HD11 ' A' ' 36' ' ' LEU . 8.9 t -86.57 155.01 20.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -123.58 97.5 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.473 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER 67.51 122.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD11 ' CG2' ' A' ' 33' ' ' THR . 5.9 mp -115.77 172.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 21' ' ' ASP . 1.8 mp -54.66 101.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.971 179.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.68 ' HG3' HD12 ' A' ' 108' ' ' LEU . 1.4 mm-40 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.9 mmtt -120.26 -53.93 2.12 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.588 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -124.72 -25.35 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.18 -107.24 3.31 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.588 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 90.1 Cg_exo -44.93 -28.26 2.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.595 2.197 . . . . 0.0 112.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.47 -70.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.653 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.843 ' HB2' ' N ' ' A' ' 109' ' ' ALA . . . -52.41 -27.86 17.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.734 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 63' ' ' LYS . 10.4 t -70.0 -44.9 68.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.71 97.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.487 ' CD2' HD12 ' A' ' 103' ' ' LEU . 17.0 t80 -60.97 -44.26 97.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.113 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.421 HG23 HG11 ' A' ' 99' ' ' VAL . 1.9 m -76.46 -26.72 55.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 59' ' ' SER . 4.2 mmtp -59.06 -27.87 65.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -31.95 15.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.714 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.836 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 4.7 mmt -62.01 -13.68 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.308 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 17' ' ' ALA . 30.1 m -117.16 -41.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.715 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.5 tt0 -70.33 -67.53 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -45.11 12.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -80.71 60.66 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.81 58.42 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.3 31.66 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.748 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.723 HG12 ' HB2' ' A' ' 94' ' ' ALA . 2.1 mt -89.31 151.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -146.27 161.79 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 10' ' ' GLU . 4.9 m -96.01 109.64 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.455 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -101.4 72.52 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.54 ' HA ' HD22 ' A' ' 7' ' ' LEU . 20.9 p90 -177.38 118.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -114.03 30.32 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -59.15 -29.96 67.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.39 -33.67 5.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.14 126.04 30.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.2 -23.73 12.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 83' ' ' ASP . 1.3 t -140.18 133.56 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 82' ' ' THR . 6.5 t0 174.8 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.454 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -80.2 -66.97 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.535 ' CE1' HD13 ' A' ' 36' ' ' LEU . 23.4 t80 -118.79 -10.69 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.377 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 102.35 40.6 2.55 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.132 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 4.0 ttp180 89.6 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 110.636 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.44 ' HA3' ' CD1' ' A' ' 85' ' ' TYR . . . -103.0 -13.17 29.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.666 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.78 116.83 31.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.19 130.73 22.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' HB2' ' CD1' ' A' ' 76' ' ' PHE . 47.8 m-85 -61.97 122.0 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.736 HD11 ' ND2' ' A' ' 100' ' ' ASN . 8.1 pt -118.06 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 81.1 m-85 -121.81 79.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.53 124.47 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.83 47.93 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.629 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.49 21.0 40.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.339 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -146.57 153.92 40.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.068 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 mtm -81.3 148.37 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.421 HG11 HG23 ' A' ' 62' ' ' THR . 21.4 t -93.19 -32.65 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.736 ' ND2' HD11 ' A' ' 92' ' ' ILE . 38.7 m-80 -65.48 -24.89 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.16 -18.91 23.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.396 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.73 -84.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.743 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.705 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.6 -15.96 13.36 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' HD13 ' A' ' 103' ' ' LEU . 15.1 t -70.36 -28.53 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -15.78 62.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.062 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -86.49 10.13 16.21 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.539 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 108' ' ' LEU . . . 97.51 34.58 5.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.622 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' HG3' ' A' ' 52' ' ' GLU . 6.2 mt 50.91 108.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 111.45 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.843 ' N ' ' HB2' ' A' ' 58' ' ' ALA . . . 88.57 -70.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.31 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 106' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mttm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.47 103.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.31 140.58 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 106.86 13.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 74' ' ' VAL . 6.0 mt-10 -130.38 144.02 51.6 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.18 121.61 6.22 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.607 2.204 . . . . 0.0 112.552 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.05 107.62 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.777 HG23 HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -111.82 163.38 14.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.7 pp -106.06 136.64 45.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.0 mt -74.48 -58.83 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 145.27 14.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB2' HG13 ' A' ' 23' ' ' VAL . . . -110.08 150.18 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 ' H ' ' A' ' 22' ' ' THR . 2.6 pt -63.11 -14.77 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 59' ' ' SER . 5.3 m-20 82.82 -8.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.2 -38.52 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.06 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 166.66 -18.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.643 0.222 . . . . 0.0 111.475 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.745 ' CG2' HD23 ' A' ' 36' ' ' LEU . 46.8 m -96.51 144.27 26.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' HB2' ' A' ' 17' ' ' ALA . 3.1 t -138.51 158.05 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -128.67 105.07 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.635 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -86.94 161.52 18.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.371 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.14 98.09 6.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.838 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -107.82 105.27 15.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 55.18 53.88 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.15 24.23 54.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -128.73 119.0 19.99 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.55 102.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.35 2.033 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.5 ttm -84.28 135.72 34.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 36' ' ' LEU . 1.9 p -86.77 142.12 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.514 ' HB2' HD12 ' A' ' 25' ' ' LEU . 16.8 t80 -135.68 94.73 3.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.725 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 34.78 74.54 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.936 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.745 HD23 ' CG2' ' A' ' 22' ' ' THR . 2.7 mp -98.64 127.0 44.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.2 82.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.733 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.645 ' C ' ' HB3' ' A' ' 109' ' ' ALA . 5.9 mt-10 . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 121.233 0.54 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HA ' ' C ' ' A' ' 108' ' ' LEU . 4.5 pttp -143.84 13.53 1.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.833 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 54' ' ' TYR . 12.7 t80 -126.15 -25.28 3.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.416 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -48.34 174.37 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.156 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.415 ' HD2' ' OXT' ' A' ' 110' ' ' LYS . 47.9 Cg_exo -56.47 2.51 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 113.509 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 109' ' ' ALA . 3.4 mt-10 -96.65 -49.02 5.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.871 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . -40.74 -52.39 2.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.948 0.34 . . . . 0.0 111.199 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 57.1 p -61.38 -47.76 84.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.392 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.12 -36.22 28.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.468 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.889 ' CE1' HG23 ' A' ' 99' ' ' VAL . 89.0 t80 -51.95 -60.7 2.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.509 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.8 OUTLIER -78.29 -30.98 48.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 1.6 tppp? -61.77 -21.87 64.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.011 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -89.97 -33.48 16.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.588 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 2.2 mtm -58.31 -15.67 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.209 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 67' ' ' GLU . 33.2 m -116.9 -41.38 2.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' HG23 ' A' ' 66' ' ' VAL . 10.8 tt0 -74.48 -64.88 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 111.49 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.11 -43.56 21.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.588 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -70.26 -175.06 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.024 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -129.92 -54.92 1.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.045 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 93' ' ' TYR . 3.7 mp -143.0 145.22 23.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.1 164.92 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.2 p -110.94 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.216 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' PHE . 22.3 mt-10 -91.16 128.65 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 75' ' ' GLU . 5.1 p90 48.74 168.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.274 0.559 . . . . 0.0 112.013 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -93.54 -14.15 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.341 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.55 -8.6 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.656 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.54 -77.55 0.25 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -106.34 111.32 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -30.61 8.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.476 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 80.9 p -90.51 -175.71 4.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.4 t0 76.59 -61.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.825 ' HD3' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.71 -16.75 63.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -179.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.141 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 109.24 -10.54 33.65 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.348 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 1.1 tpp180 171.96 26.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.191 0.196 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.82 -49.95 4.12 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.906 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.825 HD13 ' HD3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -73.91 109.76 7.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 111.129 -179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.3 122.51 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.977 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.1 111.97 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.779 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.698 HG13 HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -84.98 124.72 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.26 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.79 ' C ' HG23 ' A' ' 72' ' ' ILE . 12.1 m-85 -134.91 88.2 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.775 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.588 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.72 91.03 5.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.95 51.26 7.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.19 24.8 56.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.246 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 130.39 56.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ttt -104.52 83.87 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.889 HG23 ' CE1' ' A' ' 61' ' ' PHE . 6.5 m -68.22 -19.35 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.491 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 1.8 t-20 -56.3 -63.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 111.045 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -18.75 48.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.356 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.55 -46.55 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' A' ' 61' ' ' PHE . 8.7 tt -111.09 -50.79 2.91 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 59.7 t -58.76 -16.88 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -22.08 18.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.454 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.43 23.17 5.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.555 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 108' ' ' LEU . . . 94.55 -3.03 68.11 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.76 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 1.0 OUTLIER 99.24 22.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.698 0.799 . . . . 0.0 110.98 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.645 ' HB3' ' C ' ' A' ' 52' ' ' GLU . . . -177.73 -165.7 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.697 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.415 ' OXT' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.909 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' HD22 ' A' ' 7' ' ' LEU . 66.4 mttt . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.878 0.371 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 76' ' ' PHE . 1.4 mm? -127.32 104.02 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.25 121.86 45.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.912 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -78.0 112.11 14.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.29 137.4 22.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 121.96 9.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.519 2.146 . . . . 0.0 112.351 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.507 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -145.24 107.78 4.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.538 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.04 135.41 54.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.978 HD13 HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -68.18 113.42 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.852 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -31.76 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.39 91.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.545 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.98 ' HB3' HG21 ' A' ' 66' ' ' VAL . . . -95.64 106.18 18.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 20' ' ' GLY . 1.9 mp -80.38 -53.9 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER 82.34 -19.8 0.39 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.543 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 18' ' ' ILE . . . -61.38 -25.72 65.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.315 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -170.5 -40.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.718 HG23 ' HG3' ' A' ' 35' ' ' ARG . 1.1 m -128.27 159.07 36.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.903 0.382 . . . . 0.0 111.276 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 17' ' ' ALA . 2.9 t -150.71 145.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -126.1 147.13 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -130.61 156.87 44.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ttp -113.18 97.94 6.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.582 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -103.78 106.16 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.382 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 48.57 36.9 8.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.229 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.05 -21.18 43.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -87.94 125.0 65.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 110.542 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.0 Cg_endo -66.87 97.36 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.416 2.077 . . . . 0.0 112.462 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.94 129.65 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 87' ' ' ARG . 29.4 m -81.2 133.24 35.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 111.294 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.536 ' HB2' HD12 ' A' ' 25' ' ' LEU . 49.2 t80 -139.24 34.95 2.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.009 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.718 ' HG3' HG23 ' A' ' 22' ' ' THR . 67.7 ttp85 -61.19 127.46 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.57 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tp -134.93 81.69 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.3 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.721 ' O ' HD22 ' A' ' 38' ' ' LEU . 5.7 tt -85.12 100.1 11.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.721 HD22 ' O ' ' A' ' 37' ' ' LEU . 2.1 mm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.339 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER . . . . . 0 CA--C 1.52 -0.198 0 CA-C-O 121.281 0.562 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -24.69 -74.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.873 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.055 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -156.03 25.0 0.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.363 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.52 -132.56 2.84 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.148 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.59 -5.34 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.098 1.865 . . . . 0.0 111.133 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 3.5 mm-40 -93.12 -42.34 9.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.817 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.055 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . . . -39.42 -32.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -51.08 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 109.962 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -40.91 -44.1 2.23 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.381 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.756 ' HB2' HD21 ' A' ' 103' ' ' LEU . 3.1 t80 -43.79 -47.45 8.03 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.86 -47.02 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.212 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 67.7 mttt -50.71 -27.64 7.47 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 62.4 mttt -79.15 -32.73 44.43 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.769 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 mtp -93.16 -0.52 56.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.231 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.98 HG21 ' HB3' ' A' ' 17' ' ' ALA . 93.2 t -117.69 -41.73 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.669 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.69 -79.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.735 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -57.63 -21.92 42.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.48 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.769 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -63.88 178.72 0.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 0.0 111.402 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -69.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.3 133.99 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 65' ' ' MET . 3.8 mp -96.06 161.66 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 72' ' ' ILE . 1.4 pt-20 -146.1 139.84 26.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.641 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 12' ' ' ALA . 26.0 t -95.74 109.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 3.5 pt-20 -112.31 106.62 15.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.7 p90 175.63 117.89 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.585 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.31 74.39 0.87 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.844 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 -54.98 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.15 -100.71 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.88 121.75 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.471 ' CZ ' ' HB1' ' A' ' 90' ' ' ALA . 6.4 ptt180 -89.25 -30.89 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.5 HG22 ' HG3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -104.45 151.1 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.014 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.2 -18.87 13.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HG3' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -71.02 -78.65 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -108.44 -22.51 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.14 -10.05 70.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.402 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 20.8 mmt85 -129.93 -24.03 2.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.359 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.93 -78.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.748 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.85 115.09 12.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 0.0 111.069 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.471 ' HB1' ' CZ ' ' A' ' 81' ' ' ARG . . . -144.08 158.91 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.051 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.68 142.09 28.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.457 HG23 HG21 ' A' ' 72' ' ' ILE . 27.5 mt -117.05 116.46 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' C ' HG23 ' A' ' 72' ' ' ILE . 17.1 m-85 -114.61 78.22 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.065 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -78.99 93.25 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 63.99 44.61 4.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.203 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 25.69 58.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.863 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 155.36 44.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.91 0.386 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.0 mtt -120.67 99.16 6.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.637 HG12 ' HB3' ' A' ' 102' ' ' ALA . 5.1 t -72.79 -8.14 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.554 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 17.9 p30 -47.82 -30.8 4.32 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -91.2 -18.73 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.811 0.339 . . . . 0.0 111.537 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.637 ' HB3' HG12 ' A' ' 99' ' ' VAL . . . -48.98 -69.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.888 HD22 ' N ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -111.37 -32.18 6.81 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.888 ' N ' HD22 ' A' ' 103' ' ' LEU . 5.0 t -59.8 -20.67 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -77.56 -24.37 49.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.706 ' HB2' HD21 ' A' ' 108' ' ' LEU . 6.8 mt-30 -61.75 -17.41 55.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.033 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.681 ' C ' HD13 ' A' ' 108' ' ' LEU . . . 98.18 34.5 5.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.425 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.706 HD21 ' HB2' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -156.52 -115.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 58' ' ' ALA . . . -178.03 16.77 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.233 -0.292 . . . . 0.0 111.706 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.983 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.824 0.345 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.92 154.22 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.0 153.43 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.28 106.81 2.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.67 151.12 46.79 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.235 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.53 120.11 7.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.31 2.006 . . . . 0.0 112.215 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 74' ' ' VAL . . . -146.15 107.83 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.615 HG21 ' CE ' ' A' ' 71' ' ' LYS . 12.2 t -122.05 168.0 12.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.181 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.791 HD13 ' OG1' ' A' ' 62' ' ' THR . 1.3 mt -78.56 143.96 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.741 HG22 ' HD3' ' A' ' 16' ' ' LYS . 16.2 mt -75.88 -47.81 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.741 ' HD3' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -177.15 86.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.706 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.625 ' CB ' HG13 ' A' ' 23' ' ' VAL . . . -71.14 117.92 13.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.182 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.794 HG22 ' OD1' ' A' ' 19' ' ' ASP . 29.2 mm -60.18 -61.26 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.794 ' OD1' HG22 ' A' ' 18' ' ' ILE . 7.2 p-10 172.43 -137.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.372 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.94 -10.2 58.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.439 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.59 -84.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.786 0.293 . . . . 0.0 111.435 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -125.4 159.12 32.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.366 . . . . 0.0 111.117 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.625 HG13 ' CB ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.84 112.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -106.24 145.95 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -110.56 161.19 15.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.098 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 ttt -106.81 104.15 13.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' CE1' HG11 ' A' ' 74' ' ' VAL . 18.3 t80 -112.95 91.58 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.97 51.23 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.493 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 23.4 62.17 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.579 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -127.99 114.83 20.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.522 0.201 . . . . 0.0 110.816 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 97.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.443 2.095 . . . . 0.0 112.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.39 144.08 28.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.61 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.51 136.98 32.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.046 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.664 ' CD2' ' HB3' ' A' ' 90' ' ' ALA . 32.8 t80 -135.55 107.07 6.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 62.47 157.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.99 8.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 86.03 7.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.776 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.613 0.244 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 173.11 -8.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -135.79 25.23 3.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.673 0.273 . . . . 0.0 111.016 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.31 -133.15 6.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.97 -1.11 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.3 2.59 4.87 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.107 1.871 . . . . 0.0 111.584 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.676 ' CD ' HD23 ' A' ' 108' ' ' LEU . 8.6 mm-40 -94.92 -64.75 1.03 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.106 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.614 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . . . -40.25 -33.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.227 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 19' ' ' ASP . 40.0 p -79.3 -48.14 14.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.108 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.71 96.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 104' ' ' VAL . 30.1 t80 -44.95 -39.42 5.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.456 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.791 ' OG1' HD13 ' A' ' 14' ' ' LEU . 3.9 t -94.15 -29.07 15.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.331 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -26.33 68.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 68' ' ' ASN . 2.2 tttt -91.99 -38.3 12.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.987 0.423 . . . . 0.0 110.289 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.435 ' HA ' ' CB ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -57.43 -17.04 11.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 14' ' ' LEU . 4.6 m -104.89 -40.5 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -76.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 6.3 t30 -55.1 -36.28 65.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.381 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -76.17 -170.22 1.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.154 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -71.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.615 ' CE ' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER 176.47 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.232 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.949 HG21 HG13 ' A' ' 92' ' ' ILE . 2.2 mt 83.92 146.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 110.948 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -129.71 147.01 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.0 p -97.12 109.64 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.79 -76.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.255 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 55.0 p90 -85.89 117.67 24.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.17 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.22 24.04 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.969 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -140.44 -55.12 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.44 99.66 0.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.51 157.23 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.445 ' HB3' HD23 ' A' ' 89' ' ' LEU . 2.8 tpt85 -96.92 -44.8 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.413 ' CG2' ' HG3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -104.37 164.09 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -116.88 30.7 7.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.034 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 1.3 mttm -78.55 -66.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.742 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 93.7 t80 -137.93 11.2 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.35 40.11 97.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.093 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -174.43 -24.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.497 0.189 . . . . 0.0 111.356 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.7 -64.35 3.25 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 81' ' ' ARG . 2.6 tp -93.26 114.16 26.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.664 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . . . -131.85 146.68 52.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -83.45 122.58 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.949 HG13 HG21 ' A' ' 72' ' ' ILE . 11.2 tt -121.07 110.02 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.542 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -129.7 107.6 9.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.954 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB2' HG13 ' A' ' 72' ' ' ILE . . . -84.74 92.48 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.9 40.06 5.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.16 33.32 69.19 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -103.53 129.93 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.91 84.95 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 99' ' ' VAL . 21.6 t -75.75 -7.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 3.8 t-20 -56.52 -22.99 36.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -91.03 -18.87 23.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.91 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.871 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.701 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.43 -21.18 11.94 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.602 ' N ' HD22 ' A' ' 103' ' ' LEU . 20.1 t -61.93 -23.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 0.0 111.499 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -15.58 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.39 23.14 1.66 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.08 47.18 87.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.685 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.676 HD23 ' CD ' ' A' ' 57' ' ' GLU . 5.3 mp -122.83 -44.88 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.816 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 58' ' ' ALA . . . -134.33 37.31 3.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 15.2 mtmm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 121.026 0.441 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 76' ' ' PHE . 10.9 tp -88.21 155.14 19.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 113.3 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -67.67 106.93 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -96.1 152.08 38.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 119.1 6.07 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.668 1.579 . . . . 0.0 112.286 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 74' ' ' VAL . . . -146.55 107.63 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.362 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 m -123.67 145.86 48.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -91.34 144.13 25.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.706 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 16' ' ' LYS . 3.9 tp -86.1 -46.27 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.362 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' N ' HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.84 135.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.719 ' HB2' HG13 ' A' ' 23' ' ' VAL . . . -114.21 150.14 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -55.61 -47.64 78.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.678 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 19.9 t70 169.25 -110.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.809 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.73 -10.47 58.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.748 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -80.27 -90.04 0.06 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 m -97.14 159.09 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.064 0.459 . . . . 0.0 111.671 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -147.13 108.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.438 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 146.98 27.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.091 0.472 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 6.1 mt -124.22 130.92 53.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.681 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.403 ' CE ' HD13 ' A' ' 15' ' ' ILE . 1.6 tpp -85.45 100.71 12.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 29.8 t80 -126.06 112.47 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 27' ' ' TYR . 10.1 ptpt 47.44 29.05 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.31 -19.79 50.26 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.873 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -86.06 114.97 60.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.34 102.59 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.569 2.179 . . . . 0.0 112.408 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.5 mtt -99.28 127.7 45.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.485 HG22 ' HD2' ' A' ' 87' ' ' ARG . 1.5 t -105.55 140.42 38.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.17 151.44 48.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 60.49 102.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -135.46 99.65 4.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.561 . . . . 0.0 111.327 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.25 126.88 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.842 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.928 0.394 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HB3' ' N ' ' A' ' 110' ' ' LYS . 4.4 tptt -112.25 -28.51 7.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.67 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -169.61 -26.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -101.04 2.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.29 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 64.5 Cg_exo -40.77 -28.65 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.46 2.107 . . . . 0.0 112.724 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -73.11 -45.38 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.202 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . . . -51.49 -49.07 62.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -64.06 -37.63 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' GLU . . . -47.91 -34.1 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.16 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.816 ' CZ ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -53.54 -44.35 69.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.314 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.816 HG23 ' CZ ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -94.03 -28.39 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.417 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -69.42 -22.11 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ALA . 6.3 mtpt -84.96 -33.15 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.032 0.444 . . . . 0.0 109.941 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.575 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.39 -14.37 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.431 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 14' ' ' LEU . 30.2 m -107.76 -41.68 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.8 mt-10 -95.47 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.39 -28.9 69.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.685 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -86.91 171.65 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.433 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.84 -60.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.71 169.72 24.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.668 HG21 ' HB ' ' A' ' 92' ' ' ILE . 3.6 mp -141.51 157.11 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.8 mt-10 -134.65 171.2 14.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.968 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 12' ' ' ALA . 21.5 t -107.84 115.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.356 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.7 85.69 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.75 ' O ' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.89 130.35 55.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.908 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -63.64 -53.61 48.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.0 -35.83 16.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.64 78.47 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -117.7 110.72 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -28.15 7.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 7.6 p -89.95 -175.79 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 82' ' ' THR . 4.0 m-20 81.09 -57.5 0.28 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -69.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.674 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -153.5 11.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.566 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.45 24.03 71.73 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.221 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HD2' HG22 ' A' ' 33' ' ' THR . 2.6 ptt180 167.99 -24.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.633 0.254 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.39 -39.16 5.5 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.11 109.58 21.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.59 28.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.082 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.424 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -105.28 126.22 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 72' ' ' ILE . 16.1 pt -125.72 143.49 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 111.453 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.61 ' C ' HG23 ' A' ' 72' ' ' ILE . 73.3 m-85 -140.24 107.98 5.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 65' ' ' MET . . . -79.23 107.31 11.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.403 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.78 47.13 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.58 77.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -107.34 119.05 38.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -98.53 83.91 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.754 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.44 -27.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.555 ' OD1' HG21 ' A' ' 104' ' ' VAL . 32.3 t30 -56.46 -41.75 77.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 105' ' ' ARG . 8.8 mt-10 -86.38 -18.71 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.331 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -24.86 20.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 103' ' ' LEU . 2.8 tm? -111.22 -66.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.555 HG21 ' OD1' ' A' ' 100' ' ' ASN . 15.0 t -52.98 -37.31 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.692 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -69.77 -15.9 63.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.379 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.58 5.87 26.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.53 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.14 29.08 8.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.529 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 5.6 mt 64.27 107.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.651 0.263 . . . . 0.0 111.112 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 58' ' ' ALA . . . 82.41 -117.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.439 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.473 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 mttm . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -127.01 131.42 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.919 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -120.0 110.18 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -101.13 107.36 18.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -138.44 152.42 71.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.795 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.68 120.85 8.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.517 2.144 . . . . 0.0 112.148 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' CB ' HG13 ' A' ' 74' ' ' VAL . . . -145.35 107.91 4.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -120.49 159.4 25.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.997 HD13 HG23 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -102.71 141.39 35.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.9 mt -77.49 -58.96 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.239 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.72 124.03 36.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.81 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . -113.99 111.29 21.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -94.84 -49.08 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.514 ' OD2' HG21 ' A' ' 62' ' ' THR . 3.2 m-20 76.05 -54.89 0.61 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.18 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.39 -25.52 4.42 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.035 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -132.79 -79.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 m -140.82 158.82 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 17' ' ' ALA . 3.3 t -132.58 155.27 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.52 134.28 44.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.12 155.99 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.1 ttp -102.77 101.24 11.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.712 ' HE2' HG21 ' A' ' 74' ' ' VAL . 43.2 t80 -114.5 94.79 4.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.011 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 tttm 56.18 29.86 15.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.56 56.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.714 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.81 126.69 65.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.54 0.209 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 95.92 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.428 2.086 . . . . 0.0 112.429 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.5 mtt -77.42 99.97 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.59 HG23 ' HG2' ' A' ' 87' ' ' ARG . 1.8 t -70.93 132.58 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.728 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 9.5 t80 -116.79 134.85 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 59.58 164.11 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -127.32 155.43 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.33 102.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.996 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 54' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HG2' ' HD3' ' A' ' 53' ' ' LYS . 2.2 pt-20 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.448 0.166 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -107.69 -41.22 5.07 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.549 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -108.11 21.38 17.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 111.704 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.91 -107.78 0.48 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.161 -1.019 . . . . 0.0 110.954 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.9 2.54 7.01 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.55 2.167 . . . . 0.0 111.913 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -97.23 -68.06 0.82 Allowed 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.836 ' CB ' HD22 ' A' ' 108' ' ' LEU . . . -40.8 -56.43 2.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 0.0 111.953 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -57.37 -18.68 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.908 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -91.1 -40.51 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.443 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.555 ' CD2' HD11 ' A' ' 103' ' ' LEU . 11.0 t80 -62.35 -62.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.514 HG21 ' OD2' ' A' ' 19' ' ' ASP . 39.1 p -53.29 -35.75 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.961 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 59' ' ' SER . 3.8 tppp? -48.88 -31.9 8.0 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.616 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -83.31 -36.93 24.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.996 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.08 -0.8 37.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.741 178.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.997 HG23 HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -109.9 -41.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.386 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 13.3 tt0 -95.26 -72.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.922 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.43 -45.05 85.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.996 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -98.46 141.44 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.972 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.65 29.06 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.59 61.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.0 mp -110.16 146.59 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.68 162.28 29.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.712 HG21 ' HE2' ' A' ' 27' ' ' TYR . 7.2 m -95.97 117.26 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.86 166.13 15.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.715 ' H ' HD23 ' A' ' 7' ' ' LEU . 16.0 m-85 60.68 163.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -66.68 -17.9 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -177.37 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 110.933 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.97 88.7 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.22 111.01 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.17 -36.0 5.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.028 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.759 ' H ' HD12 ' A' ' 89' ' ' LEU . 1.9 m -105.95 -176.39 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 82' ' ' THR . 2.4 m-20 -109.21 -18.3 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.672 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -58.38 -161.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.483 ' CE1' ' HB2' ' A' ' 87' ' ' ARG . 1.2 p90 -84.34 11.68 8.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.791 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 89' ' ' LEU . . . 108.13 35.93 2.43 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.486 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.59 ' HG2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -101.89 -24.11 14.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.163 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.88 60.38 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.207 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -107.89 113.08 26.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.251 0.526 . . . . 0.0 111.381 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB3' ' CD1' ' A' ' 34' ' ' PHE . . . -144.36 109.87 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.39 126.61 35.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.688 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.599 HG22 ' CE ' ' A' ' 65' ' ' MET . 3.2 mp -116.14 107.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.602 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.453 ' C ' HG23 ' A' ' 72' ' ' ILE . 48.1 m-85 -130.07 84.47 2.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.52 110.39 14.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.183 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t70 48.69 30.58 2.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.039 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.45 26.27 63.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.323 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -79.75 164.05 23.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.89 83.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.666 HG11 ' HE3' ' A' ' 65' ' ' MET . 9.7 m -91.4 -34.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 2.1 p-10 -66.71 -33.21 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.29 -20.7 21.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.5 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -58.43 -84.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.55 0.215 . . . . 0.0 111.483 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -112.16 -24.23 9.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.69 ' N ' HD22 ' A' ' 103' ' ' LEU . 53.4 t -57.99 -19.38 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.272 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -56.99 -34.86 68.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 110.423 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -98.61 21.97 10.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.684 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 108' ' ' LEU . . . 97.15 -4.59 62.69 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.178 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.836 HD22 ' CB ' ' A' ' 58' ' ' ALA . 6.0 mt 140.9 -25.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.595 0.758 . . . . 0.0 111.156 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . . . -168.57 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' H ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.692 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.433 ' C ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.861 0.362 . . . . 0.0 110.958 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 7' ' ' LEU . 1.2 mm? -119.99 106.55 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.46 152.34 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -105.98 106.95 17.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.528 ' O ' HG22 ' A' ' 74' ' ' VAL . 3.4 mt-10 -114.17 148.26 39.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.92 120.74 8.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.379 2.053 . . . . 0.0 112.463 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.671 ' CB ' HG13 ' A' ' 74' ' ' VAL . . . -145.35 107.84 4.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.649 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -115.94 158.73 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.06 HD13 HG12 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.04 142.06 36.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.612 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 16' ' ' LYS . 3.4 tt -95.9 -47.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.822 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' N ' HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -155.22 132.87 11.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 111.344 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.916 ' HB2' HG23 ' A' ' 23' ' ' VAL . . . -114.25 149.75 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.905 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.699 ' CG2' HG22 ' A' ' 22' ' ' THR . 2.8 tt -53.65 -44.24 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.126 0.488 . . . . 0.0 110.143 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.6 OUTLIER 169.1 -108.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.708 ' HA3' HD21 ' A' ' 108' ' ' LEU . . . -93.6 -10.05 59.49 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.123 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -95.52 -82.19 0.39 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.699 HG22 ' CG2' ' A' ' 18' ' ' ILE . 14.6 t -96.45 159.37 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.916 HG23 ' HB2' ' A' ' 17' ' ' ALA . 3.8 p -148.1 133.17 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.721 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -82.79 143.83 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 3.0 mt -133.32 149.06 51.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.36 97.63 7.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 74' ' ' VAL . 31.8 t80 -105.44 106.27 16.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.981 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 58.33 30.29 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.95 -12.86 66.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.789 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.94 125.38 68.77 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.613 0.244 . . . . 0.0 110.723 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 93.78 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.404 2.069 . . . . 0.0 112.321 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.574 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 5.6 tpt -80.73 120.64 24.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -91.85 121.51 33.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 17.8 t80 -105.14 61.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 85' ' ' TYR . 1.7 mtt-85 -66.65 93.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -110.04 81.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.809 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.92 127.77 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.839 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.898 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -125.93 -27.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.54 178.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.601 ' H ' ' HB1' ' A' ' 109' ' ' ALA . 1.3 t80 -176.72 -25.56 0.01 OUTLIER 'General case' 0 C--N 1.345 0.4 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.666 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.593 ' H ' ' HB1' ' A' ' 109' ' ' ALA . . . 79.99 -104.81 2.26 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.601 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 2.2 Cg_endo -41.13 -28.07 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.912 2.408 . . . . 0.0 112.608 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 15.7 tp10 -78.56 -30.7 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.191 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . . . -39.27 -60.16 0.95 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -84.09 -47.39 10.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -48.5 -31.35 6.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.381 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' HG ' ' A' ' 103' ' ' LEU . 54.8 t80 -56.85 -58.49 7.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.225 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.405 HG23 ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -79.25 -23.39 43.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.557 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -25.26 63.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -87.13 -26.92 23.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.296 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.959 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -70.16 -6.44 34.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.572 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 1.06 HG12 HD13 ' A' ' 14' ' ' LEU . 20.7 m -112.3 -41.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.6 mt-10 -87.92 -68.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.593 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -73.53 -32.54 64.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 0.0 111.251 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.959 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -113.97 149.39 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.086 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -165.35 70.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.86 84.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 94' ' ' ALA . 3.2 mp -135.65 150.73 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.22 149.96 47.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.645 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.671 HG13 ' CB ' ' A' ' 12' ' ' ALA . 6.2 m -95.91 109.87 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.804 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.1 82.91 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.432 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 7' ' ' LEU . 45.5 p90 -178.85 133.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.18 16.76 19.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -64.92 -34.67 78.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.51 27.53 68.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.95 110.8 20.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -4.66 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.405 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -89.78 -175.69 4.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.994 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 82' ' ' THR . 3.6 t0 84.94 -49.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.474 ' CD ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -85.03 -67.86 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.868 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 35' ' ' ARG . 70.5 t80 -149.32 11.4 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.72 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 70.44 18.08 75.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.532 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 169.19 -24.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.622 0.249 . . . . 0.0 111.186 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.87 -38.77 86.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.919 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD23 ' CD ' ' A' ' 84' ' ' LYS . 1.5 tm? -80.42 109.88 15.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.574 ' HB2' ' HE2' ' A' ' 32' ' ' MET . . . -144.19 117.95 9.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 93.68 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.464 HG22 HG12 ' A' ' 74' ' ' VAL . 3.0 pt -112.71 158.18 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.43 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.66 89.56 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.759 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.87 141.25 36.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.571 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 49.18 31.25 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.434 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.1 -37.62 3.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.744 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -139.33 139.59 37.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.004 0.43 . . . . 0.0 111.235 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.31 94.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.112 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.33 -28.66 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.405 ' ND2' HG23 ' A' ' 62' ' ' THR . 14.4 m120 -66.01 -37.4 85.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -29.73 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.3 -33.95 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -59.29 -58.15 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.66 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.82 HG13 HD12 ' A' ' 108' ' ' LEU . 33.9 t -66.09 -14.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.537 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -24.88 60.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -94.35 23.29 5.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.17 -3.32 61.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.596 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.82 HD12 HG13 ' A' ' 104' ' ' VAL . 2.6 tt 69.55 86.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.945 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . . . -166.63 -41.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.088 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' C ' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.903 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.886 0.374 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.9 112.91 14.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -82.04 109.64 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.644 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.7 111.09 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -129.25 143.05 47.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.07 120.86 7.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.491 2.127 . . . . 0.0 112.52 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 107.94 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.649 HG21 ' HG2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -124.04 149.87 45.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.924 HD12 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -98.56 139.6 34.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.58 -34.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -137.87 93.27 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.563 ' HB1' ' CB ' ' A' ' 62' ' ' THR . . . -99.58 111.06 23.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.527 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 22' ' ' THR . 7.3 mt -101.07 -46.9 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.677 ' H ' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER 69.7 -61.62 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.235 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.33 -27.7 2.92 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.834 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -127.42 -76.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.929 0.395 . . . . 0.0 110.781 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -140.24 146.82 39.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.677 HG22 ' H ' ' A' ' 19' ' ' ASP . 10.7 t -120.77 143.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -128.65 109.47 11.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.774 HD21 ' CD2' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -101.88 154.26 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.689 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 tpp -85.62 94.92 9.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.547 ' CE1' HG11 ' A' ' 74' ' ' VAL . 53.1 t80 -120.71 93.66 4.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 tttm 54.54 41.17 32.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.9 16.03 78.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -118.0 142.29 30.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.643 0.259 . . . . 0.0 110.761 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.15 97.98 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 107.75 7.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 p -72.05 125.94 28.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -115.23 95.94 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.76 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 62.07 89.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 171.95 12.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.32 103.12 10.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.3 mt-10 . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.741 0.305 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.827 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER 161.34 -2.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.465 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 8.2 m-85 -131.11 -1.53 4.06 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.12 -140.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.443 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 2.41 7.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.551 2.167 . . . . 0.0 112.864 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HB2' ' CA ' ' A' ' 109' ' ' ALA . 9.9 mt-10 -95.98 -63.8 1.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.105 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 53' ' ' LYS . . . -40.43 -33.35 0.25 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.789 0.328 . . . . 0.0 111.517 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -81.65 -57.95 3.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.481 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.05 -28.39 7.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.503 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.66 ' HD2' HG23 ' A' ' 62' ' ' THR . 61.4 t80 -57.64 -65.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.64 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.66 HG23 ' HD2' ' A' ' 61' ' ' PHE . 67.6 p -79.58 -26.49 41.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 22.7 ttmt -60.16 -24.73 64.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG2' ' CB ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -92.07 -25.09 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.919 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.584 ' HB2' HD11 ' A' ' 14' ' ' LEU . 0.7 OUTLIER -63.7 -9.23 13.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.527 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.924 HG13 HD12 ' A' ' 14' ' ' LEU . 28.3 m -114.72 -41.31 3.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.6 mt-10 -88.12 -68.87 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.345 . . . . 0.0 111.912 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' CB ' ' HG2' ' A' ' 64' ' ' LYS . 1.0 OUTLIER -68.58 -29.96 68.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -72.29 170.47 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.185 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -108.61 -55.92 2.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.649 ' HG2' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER -166.51 163.74 17.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.705 HG21 ' CG2' ' A' ' 92' ' ' ILE . 1.6 mp -142.4 162.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -135.04 137.44 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.43 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.2 p -95.83 109.81 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 4.5 pt-20 -129.62 139.79 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -166.99 132.01 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.0 -30.28 71.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.983 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -107.81 -47.35 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.838 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.86 -40.66 2.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.75 116.52 32.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.18 -55.04 4.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.549 ' HB ' ' CD ' ' A' ' 84' ' ' LYS . 96.4 m -121.96 158.02 30.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.027 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.89 47.06 0.98 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.761 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.549 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -92.21 -38.79 11.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.723 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.483 ' N ' ' HG2' ' A' ' 84' ' ' LYS . 4.9 t80 -158.3 11.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.415 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.94 32.05 78.5 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.365 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.88 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.559 0.219 . . . . 0.0 111.234 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -45.43 -79.66 0.06 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.945 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.431 ' H ' ' HD2' ' A' ' 84' ' ' LYS . 0.3 OUTLIER -80.86 122.13 26.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.865 0.365 . . . . 0.0 110.78 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.13 148.35 34.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.483 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -72.35 142.07 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.784 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.705 ' CG2' HG21 ' A' ' 72' ' ' ILE . 17.6 mm -128.53 120.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.187 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 75' ' ' GLU . 1.1 m-85 -116.64 78.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.691 ' CA ' HG23 ' A' ' 72' ' ' ILE . . . -79.6 111.19 15.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 68.4 45.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.326 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.24 24.64 52.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.062 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -134.19 150.44 51.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.283 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.22 107.19 15.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.7 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' VAL . 11.9 t -72.5 -7.9 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.774 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 4.9 m-80 -58.66 -20.32 47.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.19 -18.72 24.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.394 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -61.71 -84.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.14 -22.23 11.08 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.716 HG22 ' CD2' ' A' ' 108' ' ' LEU . 14.6 t -54.83 -23.29 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -57.72 -24.12 55.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.963 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -103.76 19.12 20.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.69 ' O ' HD12 ' A' ' 108' ' ' LEU . . . 82.29 -3.2 82.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.854 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.716 ' CD2' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER 78.38 74.0 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.584 0.231 . . . . 0.0 110.874 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.62 ' CB ' ' O ' ' A' ' 108' ' ' LEU . . . 131.15 -71.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.638 0.775 . . . . 0.0 110.226 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.985 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 mt -127.06 103.96 7.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -94.55 128.8 41.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.732 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -81.21 115.73 20.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -135.87 129.29 18.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.443 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.67 120.52 8.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.368 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB3' HG13 ' A' ' 74' ' ' VAL . . . -145.42 107.39 4.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -116.99 164.08 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.907 ' HB2' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -96.92 144.04 27.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.896 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -90.21 -40.61 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.5 OUTLIER 178.57 126.02 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.985 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.789 ' CB ' HG12 ' A' ' 23' ' ' VAL . . . -103.84 148.59 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 21' ' ' ASP . 4.2 pt -51.12 -40.36 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 4.5 p30 165.11 -113.66 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.37 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.31 -10.12 59.77 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.618 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.534 ' HB3' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -72.64 -82.46 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.489 ' H ' HD11 ' A' ' 18' ' ' ILE . 91.4 m -130.14 159.43 36.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.418 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.024 HG11 HG21 ' A' ' 62' ' ' THR . 22.9 m -124.8 154.4 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.229 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.99 135.33 54.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 mp -110.95 159.89 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.9 94.91 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.33 95.35 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.11 30.16 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.01 43.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.685 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -85.81 114.99 59.9 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.518 0.199 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.88 102.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.504 2.136 . . . . 0.0 112.337 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.414 ' HE1' HD22 ' A' ' 25' ' ' LEU . 4.2 ttp -87.6 150.04 23.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.911 HG21 HD23 ' A' ' 36' ' ' LEU . 3.5 m -104.84 140.01 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.475 ' HB2' HD13 ' A' ' 25' ' ' LEU . 13.6 t80 -124.56 112.85 17.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.73 87.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.211 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.911 HD23 HG21 ' A' ' 33' ' ' THR . 0.3 OUTLIER -105.75 81.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tp -125.53 145.7 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.674 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.836 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 8.3 tttt -167.06 -45.8 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 169.81 -22.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.14 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 46.78 -111.75 0.77 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.214 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.42 -19.79 45.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.002 1.801 . . . . 0.0 111.011 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.882 ' HB3' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -88.56 -20.82 24.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.657 ' HB2' ' CD1' ' A' ' 54' ' ' TYR . . . -39.98 -35.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.452 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -79.21 -43.32 24.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 0.0 109.719 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' GLU . . . -50.71 -40.37 53.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.527 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CE1' HG12 ' A' ' 99' ' ' VAL . 10.6 t80 -40.23 -61.58 0.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.948 0.404 . . . . 0.0 110.427 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 1.024 HG21 HG11 ' A' ' 23' ' ' VAL . 2.4 m -88.19 -49.74 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.114 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CG1' ' A' ' 66' ' ' VAL . 34.1 ttmt -40.34 -29.32 0.08 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 2.9 tttm -85.8 -33.25 21.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.0 110.421 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.895 ' HG2' HG22 ' A' ' 99' ' ' VAL . 6.7 tpp -94.15 -0.67 55.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.011 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 62' ' ' THR . 7.4 p -123.48 -41.72 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -95.59 -55.2 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 111.828 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -87.06 5.26 38.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.791 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -99.54 173.53 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.403 . . . . 0.0 111.482 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 -66.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.83 -176.72 3.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.648 HG23 ' N ' ' A' ' 94' ' ' ALA . 4.1 mp -143.68 145.58 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -113.72 133.14 55.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.403 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.671 HG13 ' HB3' ' A' ' 12' ' ' ALA . 4.2 m -95.67 118.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 111.207 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 7.6 tt0 -94.61 78.58 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.285 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 74' ' ' VAL . 8.0 p90 -171.21 136.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.75 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -63.92 -60.86 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.471 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.31 -30.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.281 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -41.73 134.75 3.4 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.26 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' CG ' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -67.95 142.49 55.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -34.08 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 89' ' ' LEU . 2.4 p -122.09 147.16 46.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.42 -9.9 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -27.77 6.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -178.13 -37.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 80' ' ' GLN . . . 109.06 -10.23 34.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.633 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.22 -5.6 6.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.508 0.194 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.54 -76.28 0.64 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.545 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.581 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.3 OUTLIER -74.01 110.08 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.829 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.92 139.82 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.39 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -109.37 156.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.639 ' C ' HG23 ' A' ' 72' ' ' ILE . 88.8 m-85 -141.99 83.56 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.981 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.648 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.9 106.81 12.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 64.77 42.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.801 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 21.75 74.43 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.669 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -158.0 156.66 31.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 166.75 22.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.895 HG22 ' HG2' ' A' ' 65' ' ' MET . 19.6 t -84.49 -35.5 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.458 HD22 HG11 ' A' ' 104' ' ' VAL . 21.3 m120 -58.59 -28.12 65.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.58 -18.84 61.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.3 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.48 -74.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.794 0.33 . . . . 0.0 111.769 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 57' ' ' GLU . 4.5 tt -95.23 -56.72 2.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.83 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 61' ' ' PHE . 15.0 t -48.03 -26.43 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.94 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -15.68 61.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 0.0 111.311 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -76.08 5.18 7.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.769 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.46 4.54 58.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.394 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.836 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mt 64.46 76.32 0.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.165 0.507 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 176.91 103.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.822 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.902 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.07 148.55 36.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.31 153.05 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.28 127.9 44.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.03 147.13 64.11 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.94 120.54 8.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.422 2.081 . . . . 0.0 112.024 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 74' ' ' VAL . . . -145.64 107.94 4.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.849 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -121.98 168.81 11.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.848 HD11 ' CG2' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -106.23 144.02 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 16' ' ' LYS . 1.4 tt -82.13 -42.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.409 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' N ' HG23 ' A' ' 15' ' ' ILE . 7.6 ttmm -143.55 105.81 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.128 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.827 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -114.14 123.68 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 22' ' ' THR . 1.9 mp -94.23 -35.03 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.174 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.08 -64.58 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.173 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.06 -26.34 8.74 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.789 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.75 -79.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.663 ' O ' HD12 ' A' ' 18' ' ' ILE . 43.2 m -131.83 158.96 39.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.727 HG23 ' CB ' ' A' ' 17' ' ' ALA . 7.9 p -138.68 145.12 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.31 142.26 51.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 1.6 mt -115.91 152.11 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 95.62 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.474 ' HE1' HG11 ' A' ' 74' ' ' VAL . 49.4 t80 -106.6 93.64 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 58.25 41.84 22.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.973 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.66 24.03 68.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.59 128.04 24.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.604 0.24 . . . . 0.0 110.803 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.82 90.41 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.367 2.045 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ttm -78.41 113.07 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 p -73.54 135.5 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.725 ' HB3' HG13 ' A' ' 23' ' ' VAL . 4.7 t80 -127.79 109.21 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.747 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 64.24 144.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 85' ' ' TYR . 9.3 mp -91.05 172.01 8.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.48 99.43 10.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 11.1 mt-10 . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.672 0.273 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.865 ' CB ' HD22 ' A' ' 108' ' ' LEU . 18.8 ptpt 139.96 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.346 1.058 . . . . 0.0 108.474 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.47 ' CG ' ' CB ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER 50.53 25.35 1.94 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 -178.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -109.47 1.85 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.252 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 2.36 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.678 2.252 . . . . 0.0 113.024 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -85.59 -62.97 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' LYS . . . -45.77 -48.92 15.39 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.723 0.296 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 13.0 t -48.53 -29.48 4.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -91.46 -38.19 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.605 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.2 -65.4 0.56 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.241 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -60.68 -20.4 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -65.62 -33.4 75.81 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.16 -21.34 20.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.148 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.628 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -75.0 -5.32 43.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.011 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.93 ' HA ' HD11 ' A' ' 72' ' ' ILE . 22.6 m -123.39 -41.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.705 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' N ' HG23 ' A' ' 66' ' ' VAL . 28.1 tt0 -74.73 -66.8 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.903 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -92.83 5.39 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.628 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -98.96 92.07 5.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.487 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm 60.17 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.214 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 13' ' ' THR . 8.0 mttt 166.95 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.93 HD11 ' HA ' ' A' ' 66' ' ' VAL . 2.7 mt 79.23 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 72' ' ' ILE . 17.0 pt-20 -141.28 140.11 33.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.692 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 12' ' ' ALA . 13.8 p -95.92 109.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HG3' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -124.84 -86.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.831 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.486 ' CE1' ' CD2' ' A' ' 91' ' ' TYR . 2.7 t80 59.75 117.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 111.163 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -86.03 57.17 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.454 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -166.73 -44.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.34 144.63 9.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.682 ' CB ' HD12 ' A' ' 89' ' ' LEU . 5.7 pm0 -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.0 110.722 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -114.34 -55.72 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.565 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -141.4 -175.3 4.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.729 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 82' ' ' THR . 24.2 t70 104.02 -72.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.532 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.687 ' H ' HD22 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -92.15 90.6 7.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.394 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' HB2' HD11 ' A' ' 36' ' ' LEU . 43.1 t80 64.86 11.35 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.921 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 58.75 30.79 66.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.465 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 165.35 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.464 0.306 . . . . 0.0 110.789 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.72 -12.87 36.57 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.062 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.687 HD22 ' H ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -83.7 109.77 17.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 34' ' ' PHE . . . -144.23 134.74 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.486 ' CD2' ' CE1' ' A' ' 76' ' ' PHE . 5.5 m-85 -112.11 119.92 40.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.24 136.07 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.604 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' HG3' ' A' ' 75' ' ' GLU . 74.5 m-85 -127.34 77.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.784 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.06 141.81 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.246 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 p30 48.88 31.23 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.651 0.739 . . . . 0.0 109.505 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.51 -47.01 2.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.059 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -161.7 111.69 1.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.764 0.282 . . . . 0.0 111.589 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.774 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 15.3 ttm -147.41 80.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.283 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -98.95 -59.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.111 0.482 . . . . 0.0 111.961 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 105' ' ' ARG . 5.8 p-10 -89.56 -57.21 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.215 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.404 ' HG3' ' HG3' ' A' ' 98' ' ' MET . 6.5 pt-20 -40.56 -28.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.774 ' HB2' ' HG2' ' A' ' 98' ' ' MET . . . -67.18 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.657 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.623 HD11 HD23 ' A' ' 108' ' ' LEU . 1.3 tm? -114.42 -57.58 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.456 0.646 . . . . 0.0 111.469 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 100' ' ' ASN . 18.5 t -48.82 -16.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.012 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -49.93 -28.66 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.975 0.417 . . . . 0.0 110.486 179.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -98.41 23.04 8.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.068 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.85 38.65 65.28 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.865 HD22 ' CB ' ' A' ' 53' ' ' LYS . 33.0 mt 55.87 87.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.62 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.61 -6.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HA ' ' CD2' ' A' ' 54' ' ' TYR . 8.1 ptpt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.927 0.394 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -127.07 104.05 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.56 106.53 18.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.03 106.91 17.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 74' ' ' VAL . 6.5 mt-10 -128.24 126.54 23.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.36 121.46 9.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.385 2.057 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.15 107.43 4.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 72' ' ' ILE . 2.5 p -125.44 150.58 47.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.58 141.74 41.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.695 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 16' ' ' LYS . 15.4 tt -88.64 -47.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.703 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' N ' HG23 ' A' ' 15' ' ' ILE . 19.1 mttt -155.07 130.3 9.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 111.46 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.03 133.51 55.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.698 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 19' ' ' ASP . 17.3 tt -54.66 -49.45 67.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.23 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 166.93 -152.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.84 -10.52 4.79 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.449 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 18' ' ' ILE . 29.2 t70 -67.15 -71.17 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.026 0.413 . . . . 0.0 111.129 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -147.0 159.05 44.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 23' ' ' VAL . 29.4 m -121.45 117.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.978 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -83.34 124.9 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 2.4 mp -89.67 160.85 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.1 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.63 98.32 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt 57.57 43.42 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.32 22.56 76.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.597 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -114.31 133.64 22.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.576 0.226 . . . . 0.0 110.815 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.06 99.49 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.458 2.105 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 mtt -95.9 149.75 21.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.88 144.55 36.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.976 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 90' ' ' ALA . 32.5 t80 -138.02 122.81 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 62.86 145.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.26 103.09 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.74 102.82 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.839 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 13.7 mt-10 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HB3' ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER 64.81 4.67 2.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD1' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER 172.11 -25.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.736 0.303 . . . . 0.0 110.813 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.15 -102.07 2.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.371 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.96 -25.69 63.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.689 ' OE1' ' HB3' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -73.61 -36.93 65.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . . . -47.89 -26.23 1.62 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -32.37 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.689 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -54.82 -47.14 74.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.512 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.657 ' HB2' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -47.85 -47.87 31.26 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.885 0.374 . . . . 0.0 110.488 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.7 t -81.94 -26.15 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -26.77 65.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.747 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 69' ' ' ALA . 11.9 mttp -92.02 -24.86 19.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.48 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 24.6 ttp -57.21 -15.25 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.414 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.497 HG12 ' HG ' ' A' ' 14' ' ' LEU . 33.4 m -105.23 -42.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.3 mt-10 -95.6 -69.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.714 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.24 -20.49 62.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.592 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -93.08 -179.84 5.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.356 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -69.45 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.068 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 172.61 149.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.922 0.391 . . . . 0.0 110.924 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.609 ' H ' HG22 ' A' ' 13' ' ' THR . 1.8 mp -102.78 161.61 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.051 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.3 mt-10 -133.78 149.55 51.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.6 p -100.48 109.82 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.967 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -88.48 -178.54 5.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 75' ' ' GLU . 15.5 p90 46.94 117.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.04 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.08 32.02 6.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -59.26 -27.55 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.069 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.45 -84.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.21 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.27 110.82 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.601 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -110.11 -40.29 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.511 HG21 ' O ' ' A' ' 89' ' ' LEU . 82.7 p -130.1 133.94 47.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.38 -8.31 58.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.087 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.59 70.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -177.19 -37.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.05 -10.27 34.03 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.536 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.552 ' HB3' HG23 ' A' ' 33' ' ' THR . 1.4 mpp_? -123.21 -24.11 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.54 -84.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.736 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' HG21 ' A' ' 82' ' ' THR . 3.1 tp -89.08 116.22 27.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.335 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.541 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . . . -144.04 141.88 30.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 1.5 m-85 -80.89 127.3 32.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.13 149.77 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -134.42 89.12 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.25 115.55 18.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.24 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 t70 67.57 26.64 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.13 -31.26 7.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.816 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -134.17 131.43 38.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 111.025 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.18 158.36 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' VAL . 12.2 t -95.12 -8.64 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -63.06 -16.57 60.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -18.83 30.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.564 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -61.53 -84.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.517 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.995 HD23 ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -111.64 -24.07 10.3 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.626 ' N ' HD22 ' A' ' 103' ' ' LEU . 63.6 t -58.93 -31.47 45.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -98.17 -16.01 19.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -83.87 -25.2 30.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.533 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.12 47.8 2.16 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.332 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 2.6 tt -147.98 6.16 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.995 ' HB3' HD23 ' A' ' 103' ' ' LEU . . . 176.32 86.78 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.587 ' C ' ' HB1' ' A' ' 58' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.596 HD22 ' H ' ' A' ' 7' ' ' LEU . 1.6 mm? -79.06 112.87 16.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.034 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -70.0 153.21 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -106.95 106.91 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -110.52 129.65 23.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.379 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.1 120.02 7.58 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.253 1.969 . . . . 0.0 112.486 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -146.0 107.81 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.472 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -117.49 163.41 16.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.021 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.656 HD21 ' CB ' ' A' ' 66' ' ' VAL . 1.6 pp -106.23 144.19 33.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.606 HD11 ' SD ' ' A' ' 26' ' ' MET . 38.3 mm -62.2 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HG2' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -168.99 135.42 1.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.808 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.146 ' HB2' HG23 ' A' ' 23' ' ' VAL . . . -114.12 137.73 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.132 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 19' ' ' ASP . 6.8 tt -57.71 -46.36 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' HG23 ' A' ' 18' ' ' ILE . 1.1 p30 166.45 -110.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.41 -10.62 59.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.54 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.493 ' HB2' HG21 ' A' ' 18' ' ' ILE . 3.7 m-20 -70.17 -80.75 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.714 0.292 . . . . 0.0 111.435 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -131.48 157.76 42.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.378 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.146 HG23 ' HB2' ' A' ' 17' ' ' ALA . 7.5 p -147.96 107.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -83.5 111.37 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.514 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HA ' ' CB ' ' A' ' 14' ' ' LEU . 3.6 mt -89.74 161.71 15.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.634 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.606 ' SD ' HD11 ' A' ' 15' ' ' ILE . 7.2 ttp -106.41 109.04 20.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -126.1 92.67 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.02 41.04 5.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.86 37.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.644 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -124.74 114.86 26.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.519 0.2 . . . . 0.0 110.876 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.75 83.0 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.487 2.124 . . . . 0.0 112.275 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 mtm -80.94 123.46 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.693 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -110.23 148.08 32.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.897 ' CD1' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -88.83 -171.02 3.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HG2' ' CD2' ' A' ' 34' ' ' PHE . 6.9 ptt180 -46.68 148.42 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -88.76 172.12 9.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 37' ' ' LEU . 1.4 pt? -94.41 156.15 16.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.93 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.682 0.754 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.87 2.12 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.521 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 76.7 t80 -83.47 0.97 43.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.224 0.535 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.55 -60.36 1.81 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -92.06 -48.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.674 2.916 . . . . 0.0 113.153 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.466 ' CG ' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -65.03 -56.92 10.28 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . . . -45.95 -49.33 15.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 111.428 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' LYS . 4.2 m -60.06 -19.97 55.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.73 -58.12 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.128 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -72.85 -62.63 1.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.911 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.78 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.9 m -49.63 -27.58 4.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.219 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 59' ' ' SER . 37.3 ttmt -76.61 -21.77 55.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -23.27 23.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.647 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 5.0 mmt -89.95 -1.03 57.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 62' ' ' THR . 15.9 m -123.3 -41.69 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -85.7 -72.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.58 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.49 -20.69 64.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -102.46 111.14 23.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.685 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.58 51.35 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 30.2 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.571 HG21 HG12 ' A' ' 92' ' ' ILE . 1.2 mp -80.87 149.73 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.67 168.43 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.2 109.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 5.3 mm-40 -91.45 82.24 5.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.537 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.4 m-85 -168.66 117.8 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 7' ' ' LEU . 2.9 t0 -65.65 -44.82 85.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.898 0.38 . . . . 0.0 110.804 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -169.49 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.378 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.18 149.45 0.88 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.873 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.8 160.99 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 mtt-85 -95.12 -55.29 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.608 HG21 ' HB2' ' A' ' 89' ' ' LEU . 10.9 p -140.19 157.55 45.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.184 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -98.79 -25.44 14.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.676 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.44 ' HE3' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -45.87 -29.33 1.34 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.452 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -176.28 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.38 25.72 6.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -160.73 -24.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.13 -80.27 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.608 ' HB2' HG21 ' A' ' 82' ' ' THR . 4.7 mp -74.09 117.22 15.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.0 159.87 41.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.121 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 36.0 m-85 -103.35 142.17 34.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -120.53 110.92 30.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 91' ' ' TYR . 17.3 m-85 -113.69 71.73 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.183 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB2' HD11 ' A' ' 92' ' ' ILE . . . -79.58 101.28 8.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.059 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 67.37 35.06 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 35.8 83.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.04 157.27 16.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.119 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.34 84.08 2.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.539 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 30.1 m -60.97 -47.24 94.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.273 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.483 ' N ' HG23 ' A' ' 99' ' ' VAL . 3.3 t30 -49.19 -24.1 1.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.506 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -91.31 -63.12 1.3 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.15 -15.73 30.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 109' ' ' ALA . 4.9 tt -99.91 -49.04 4.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 109' ' ' ALA . 22.9 t -90.12 -62.26 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -58.65 -24.53 61.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.692 0.282 . . . . 0.0 111.227 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -70.19 -17.67 63.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.342 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.707 ' C ' HD12 ' A' ' 108' ' ' LEU . . . 97.32 47.17 2.24 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.474 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.707 HD12 ' C ' ' A' ' 107' ' ' GLY . 5.8 mp -153.22 34.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.805 ' O ' HG13 ' A' ' 104' ' ' VAL . . . 167.7 42.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.767 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.789 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -136.21 132.85 36.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -104.01 152.2 22.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.17 130.44 43.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -119.65 101.03 7.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -127.66 141.32 51.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 76' ' ' PHE . 24.3 mt -123.43 119.71 30.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -108.93 121.34 44.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.756 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -79.42 110.93 15.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.241 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.86 130.59 23.62 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.566 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.91 120.31 7.93 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.227 1.951 . . . . 0.0 112.544 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.66 107.7 4.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -125.27 141.58 52.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.249 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.808 HD22 ' HB2' ' A' ' 17' ' ' ALA . 3.5 mp -67.04 144.05 56.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pt -87.21 -28.9 5.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -167.91 94.22 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -98.64 115.5 28.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.354 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mt -80.64 -31.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 59' ' ' SER . 20.4 m-20 68.22 -65.68 0.25 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.079 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.16 33.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.689 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.422 ' O ' HD12 ' A' ' 37' ' ' LEU . 85.9 m-20 -121.44 -77.73 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.783 0.325 . . . . 0.0 111.09 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -146.13 159.07 43.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 HG12 ' HB1' ' A' ' 17' ' ' ALA . 18.4 m -134.89 148.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.199 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 132.51 41.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.0 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -99.14 160.55 14.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.4 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.797 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -122.63 109.12 13.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.07 29.06 9.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.144 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.75 -4.13 83.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -85.94 127.81 60.69 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.799 0.3 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.69 83.27 2.11 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.563 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -89.62 111.35 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.679 ' CG2' HD11 ' A' ' 36' ' ' LEU . 8.9 t -86.57 155.01 20.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -123.58 97.5 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.473 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER 67.51 122.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD11 ' CG2' ' A' ' 33' ' ' THR . 5.9 mp -115.77 172.11 7.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 21' ' ' ASP . 1.8 mp -54.66 101.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.82 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.971 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.99 153.59 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -76.3 120.52 21.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.9 110.58 58.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.78 -25.74 39.33 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.418 2.079 . . . . 0.0 112.401 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -116.66 46.5 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.96 -45.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.949 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -58.36 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.39 146.68 34.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.789 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.43 -32.13 10.44 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.443 2.095 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -65.51 -55.84 15.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -83.73 -34.74 24.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.791 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.02 -49.8 1.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.144 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.65 HG23 ' N ' ' A' ' 52' ' ' GLU . 8.9 m -128.28 -63.64 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 117.425 0.612 . . . . 0.0 112.125 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.68 ' HG3' HD12 ' A' ' 108' ' ' LEU . 1.4 mm-40 -118.64 -65.99 1.12 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.848 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.9 mmtt -120.26 -53.93 2.12 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.588 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -124.72 -25.35 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 51' ' ' VAL . . . 88.18 -107.24 3.31 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.588 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 90.1 Cg_exo -44.93 -28.26 2.97 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.595 2.197 . . . . 0.0 112.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.47 -70.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.653 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.843 ' HB2' ' N ' ' A' ' 109' ' ' ALA . . . -52.41 -27.86 17.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.734 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 63' ' ' LYS . 10.4 t -70.0 -44.9 68.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.669 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.71 97.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.487 ' CD2' HD12 ' A' ' 103' ' ' LEU . 17.0 t80 -60.97 -44.26 97.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.113 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.421 HG23 HG11 ' A' ' 99' ' ' VAL . 1.9 m -76.46 -26.72 55.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 59' ' ' SER . 4.2 mmtp -59.06 -27.87 65.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -31.95 15.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.714 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.836 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 4.7 mmt -62.01 -13.68 28.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.308 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 17' ' ' ALA . 30.1 m -117.16 -41.04 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.715 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.5 tt0 -70.33 -67.53 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -45.11 12.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -80.71 60.66 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.81 58.42 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.3 31.66 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.748 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.723 HG12 ' HB2' ' A' ' 94' ' ' ALA . 2.1 mt -89.31 151.13 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.337 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -146.27 161.79 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 10' ' ' GLU . 4.9 m -96.01 109.64 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.455 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 0.3 OUTLIER -101.4 72.52 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.97 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.54 ' HA ' HD22 ' A' ' 7' ' ' LEU . 20.9 p90 -177.38 118.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.884 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -114.03 30.32 7.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -59.15 -29.96 67.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.39 -33.67 5.85 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.14 126.04 30.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.2 -23.73 12.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 83' ' ' ASP . 1.3 t -140.18 133.56 29.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 82' ' ' THR . 6.5 t0 174.8 -36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.454 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -80.2 -66.97 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.915 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.535 ' CE1' HD13 ' A' ' 36' ' ' LEU . 23.4 t80 -118.79 -10.69 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.377 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 87' ' ' ARG . . . 102.35 40.6 2.55 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.132 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 4.0 ttp180 89.6 26.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 110.636 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' HA3' ' CD1' ' A' ' 85' ' ' TYR . . . -103.0 -13.17 29.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.666 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.78 116.83 31.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.19 130.73 22.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' HB2' ' CD1' ' A' ' 76' ' ' PHE . 47.8 m-85 -61.97 122.0 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.736 HD11 ' ND2' ' A' ' 100' ' ' ASN . 8.1 pt -118.06 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 81.1 m-85 -121.81 79.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.819 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.53 124.47 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.83 47.93 5.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.629 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.49 21.0 40.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.339 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -146.57 153.92 40.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.068 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 mtm -81.3 148.37 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.421 HG11 HG23 ' A' ' 62' ' ' THR . 21.4 t -93.19 -32.65 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.736 ' ND2' HD11 ' A' ' 92' ' ' ILE . 38.7 m-80 -65.48 -24.89 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.022 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.16 -18.91 23.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.396 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.73 -84.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.743 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.705 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.6 -15.96 13.36 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' HD13 ' A' ' 103' ' ' LEU . 15.1 t -70.36 -28.53 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.144 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -15.78 62.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.062 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -86.49 10.13 16.21 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.539 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 108' ' ' LEU . . . 97.51 34.58 5.49 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.622 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.68 HD12 ' HG3' ' A' ' 52' ' ' GLU . 6.2 mt 50.91 108.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 111.45 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.843 ' N ' ' HB2' ' A' ' 58' ' ' ALA . . . 88.57 -70.04 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.31 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 106' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.169 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.894 0.378 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 p -107.36 102.66 11.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.69 113.46 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -111.99 147.96 34.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.963 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.99 143.5 27.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.973 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -106.44 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.47 103.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.31 140.58 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 106.86 13.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 74' ' ' VAL . 6.0 mt-10 -130.38 144.02 51.6 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.18 121.61 6.22 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.607 2.204 . . . . 0.0 112.552 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.05 107.62 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.777 HG23 HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -111.82 163.38 14.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.7 pp -106.06 136.64 45.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.0 mt -74.48 -58.83 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 145.27 14.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB2' HG13 ' A' ' 23' ' ' VAL . . . -110.08 150.18 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 ' H ' ' A' ' 22' ' ' THR . 2.6 pt -63.11 -14.77 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.495 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 59' ' ' SER . 5.3 m-20 82.82 -8.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.2 -38.52 5.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.06 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 166.66 -18.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.643 0.222 . . . . 0.0 111.475 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.745 ' CG2' HD23 ' A' ' 36' ' ' LEU . 46.8 m -96.51 144.27 26.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' HB2' ' A' ' 17' ' ' ALA . 3.1 t -138.51 158.05 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -128.67 105.07 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.635 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -86.94 161.52 18.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.371 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.14 98.09 6.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.838 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -107.82 105.27 15.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 55.18 53.88 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.15 24.23 54.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -128.73 119.0 19.99 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.511 0.196 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.55 102.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.35 2.033 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.5 ttm -84.28 135.72 34.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.653 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 36' ' ' LEU . 1.9 p -86.77 142.12 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.245 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.514 ' HB2' HD12 ' A' ' 25' ' ' LEU . 16.8 t80 -135.68 94.73 3.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.725 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 34.78 74.54 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.936 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.745 HD23 ' CG2' ' A' ' 22' ' ' THR . 2.7 mp -98.64 127.0 44.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.2 82.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.733 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.19 112.76 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -152.33 128.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.6 104.13 5.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.91 84.26 7.01 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.98 -25.45 22.11 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.668 2.245 . . . . 0.0 112.388 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.5 -31.07 42.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.4 m -150.33 116.41 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.94 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 -50.83 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' HB2' ' CA ' ' A' ' 50' ' ' GLY . 5.2 p80 -128.66 74.96 80.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.8 2.71 8.34 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.821 2.347 . . . . 0.0 113.099 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -91.76 0.46 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -38.3 5.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.867 0.365 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' A' ' 46' ' ' HIS . . . 80.26 -5.65 62.73 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.019 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' HA ' ' H ' ' A' ' 55' ' ' GLY . 34.0 m -127.35 27.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.926 0.394 . . . . 0.0 111.3 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.645 ' C ' ' HB3' ' A' ' 109' ' ' ALA . 5.9 mt-10 -83.19 -38.0 22.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HA ' ' C ' ' A' ' 108' ' ' LEU . 4.5 pttp -143.84 13.53 1.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.833 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 54' ' ' TYR . 12.7 t80 -126.15 -25.28 3.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.416 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -48.34 174.37 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.156 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.415 ' HD2' ' OXT' ' A' ' 110' ' ' LYS . 47.9 Cg_exo -56.47 2.51 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 113.509 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 109' ' ' ALA . 3.4 mt-10 -96.65 -49.02 5.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.871 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 108' ' ' LEU . . . -40.74 -52.39 2.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.948 0.34 . . . . 0.0 111.199 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 19' ' ' ASP . 57.1 p -61.38 -47.76 84.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.392 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.12 -36.22 28.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.468 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.889 ' CE1' HG23 ' A' ' 99' ' ' VAL . 89.0 t80 -51.95 -60.7 2.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.509 HG21 ' CG2' ' A' ' 23' ' ' VAL . 0.8 OUTLIER -78.29 -30.98 48.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 1.6 tppp? -61.77 -21.87 64.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.011 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -89.97 -33.48 16.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.588 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 2.2 mtm -58.31 -15.67 11.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.209 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 67' ' ' GLU . 33.2 m -116.9 -41.38 2.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' HG23 ' A' ' 66' ' ' VAL . 10.8 tt0 -74.48 -64.88 0.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 111.49 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.11 -43.56 21.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.064 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.588 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -70.26 -175.06 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.024 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -129.92 -54.92 1.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.045 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 93' ' ' TYR . 3.7 mp -143.0 145.22 23.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -117.1 164.92 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.2 p -110.94 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.216 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 76' ' ' PHE . 22.3 mt-10 -91.16 128.65 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 75' ' ' GLU . 5.1 p90 48.74 168.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.274 0.559 . . . . 0.0 112.013 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -93.54 -14.15 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.341 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.55 -8.6 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.656 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.54 -77.55 0.25 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -106.34 111.32 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -30.61 8.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.476 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 80.9 p -90.51 -175.71 4.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.4 t0 76.59 -61.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.825 ' HD3' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.71 -16.75 63.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -179.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.141 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 109.24 -10.54 33.65 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.348 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 1.1 tpp180 171.96 26.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.191 0.196 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.82 -49.95 4.12 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.906 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.825 HD13 ' HD3' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -73.91 109.76 7.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 111.129 -179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.3 122.51 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.977 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.1 111.97 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.779 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.698 HG13 HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -84.98 124.72 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.26 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.79 ' C ' HG23 ' A' ' 72' ' ' ILE . 12.1 m-85 -134.91 88.2 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.775 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.588 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.72 91.03 5.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.95 51.26 7.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.19 24.8 56.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.246 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 130.39 56.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ttt -104.52 83.87 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.798 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.889 HG23 ' CE1' ' A' ' 61' ' ' PHE . 6.5 m -68.22 -19.35 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.491 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 1.8 t-20 -56.3 -63.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.361 . . . . 0.0 111.045 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -18.75 48.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.356 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.55 -46.55 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' A' ' 61' ' ' PHE . 8.7 tt -111.09 -50.79 2.91 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 59.7 t -58.76 -16.88 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -22.08 18.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.454 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.43 23.17 5.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.555 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 108' ' ' LEU . . . 94.55 -3.03 68.11 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.76 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 107' ' ' GLY . 1.0 OUTLIER 99.24 22.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.698 0.799 . . . . 0.0 110.98 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.645 ' HB3' ' C ' ' A' ' 52' ' ' GLU . . . -177.73 -165.7 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.697 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.415 ' OXT' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.909 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.891 0.377 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 t -130.38 118.64 21.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 t -76.79 145.82 38.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 p -88.11 147.78 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -77.95 143.94 37.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' HD22 ' A' ' 7' ' ' LEU . 66.4 mttt -125.58 146.94 49.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 76' ' ' PHE . 1.4 mm? -127.32 104.02 7.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.25 121.86 45.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.912 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -78.0 112.11 14.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.29 137.4 22.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 121.96 9.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.519 2.146 . . . . 0.0 112.351 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.507 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -145.24 107.78 4.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.538 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.04 135.41 54.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.978 HD13 HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -68.18 113.42 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.852 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -31.76 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.39 91.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.545 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.98 ' HB3' HG21 ' A' ' 66' ' ' VAL . . . -95.64 106.18 18.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.177 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 20' ' ' GLY . 1.9 mp -80.38 -53.9 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER 82.34 -19.8 0.39 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.543 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 18' ' ' ILE . . . -61.38 -25.72 65.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.315 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -170.5 -40.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.76 0.314 . . . . 0.0 111.289 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.718 HG23 ' HG3' ' A' ' 35' ' ' ARG . 1.1 m -128.27 159.07 36.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.903 0.382 . . . . 0.0 111.276 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 17' ' ' ALA . 2.9 t -150.71 145.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -126.1 147.13 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -130.61 156.87 44.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ttp -113.18 97.94 6.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.582 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -103.78 106.16 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.382 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 48.57 36.9 8.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.229 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.05 -21.18 43.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -87.94 125.0 65.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.572 0.225 . . . . 0.0 110.542 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.0 Cg_endo -66.87 97.36 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.416 2.077 . . . . 0.0 112.462 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.94 129.65 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 87' ' ' ARG . 29.4 m -81.2 133.24 35.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 111.294 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.536 ' HB2' HD12 ' A' ' 25' ' ' LEU . 49.2 t80 -139.24 34.95 2.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.009 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.718 ' HG3' HG23 ' A' ' 22' ' ' THR . 67.7 ttp85 -61.19 127.46 31.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.57 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tp -134.93 81.69 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.3 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.721 ' O ' HD22 ' A' ' 38' ' ' LEU . 5.7 tt -85.12 100.1 11.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.286 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.721 HD22 ' O ' ' A' ' 37' ' ' LEU . 2.1 mm? -136.15 105.47 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.339 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 40' ' ' ASP . 20.2 t -153.21 159.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' N ' HG12 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -150.85 89.78 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.426 HG23 HG12 ' A' ' 39' ' ' VAL . 27.0 p -113.93 85.18 9.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.445 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.18 -37.34 87.6 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.317 2.011 . . . . 0.0 111.53 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -165.54 20.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.121 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 46' ' ' HIS . 1.9 m -167.91 141.01 3.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.53 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -77.86 -15.71 58.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.231 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.425 ' H ' HG22 ' A' ' 44' ' ' THR . 1.4 p-80 -132.51 62.3 62.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.948 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -30.17 45.74 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.124 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -97.21 -101.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.75 ' HB3' HG22 ' A' ' 51' ' ' VAL . 2.4 mptp? -107.66 -38.78 5.79 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.786 0.326 . . . . 0.0 111.164 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.49 38.74 95.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.296 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 49' ' ' LYS . 21.0 m -127.03 -51.27 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.629 0.252 . . . . 0.0 111.669 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -116.8 -52.36 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.281 0.562 . . . . 0.0 109.739 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -24.69 -74.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.873 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.055 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -156.03 25.0 0.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.363 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.52 -132.56 2.84 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.148 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.59 -5.34 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.098 1.865 . . . . 0.0 111.133 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 110' ' ' LYS . 3.5 mm-40 -93.12 -42.34 9.45 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.817 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.055 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . . . -39.42 -32.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -51.08 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 109.962 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -40.91 -44.1 2.23 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.381 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.756 ' HB2' HD21 ' A' ' 103' ' ' LEU . 3.1 t80 -43.79 -47.45 8.03 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.86 -47.02 10.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.212 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 67.7 mttt -50.71 -27.64 7.47 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 62.4 mttt -79.15 -32.73 44.43 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.769 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . 11.3 mtp -93.16 -0.52 56.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.231 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.98 HG21 ' HB3' ' A' ' 17' ' ' ALA . 93.2 t -117.69 -41.73 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.669 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.69 -79.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.735 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -57.63 -21.92 42.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.48 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.769 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -63.88 178.72 0.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.913 0.387 . . . . 0.0 111.402 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -69.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.3 133.99 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 65' ' ' MET . 3.8 mp -96.06 161.66 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 72' ' ' ILE . 1.4 pt-20 -146.1 139.84 26.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.641 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 12' ' ' ALA . 26.0 t -95.74 109.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 3.5 pt-20 -112.31 106.62 15.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.7 p90 175.63 117.89 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.585 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.31 74.39 0.87 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.844 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 -54.98 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.15 -100.71 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.88 121.75 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.471 ' CZ ' ' HB1' ' A' ' 90' ' ' ALA . 6.4 ptt180 -89.25 -30.89 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.955 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.5 HG22 ' HG3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -104.45 151.1 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.014 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.2 -18.87 13.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.264 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HG3' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER -71.02 -78.65 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -108.44 -22.51 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.14 -10.05 70.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.687 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.402 ' HB3' ' HB ' ' A' ' 33' ' ' THR . 20.8 mmt85 -129.93 -24.03 2.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 111.359 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.93 -78.94 0.15 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.748 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.85 115.09 12.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 0.0 111.069 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.471 ' HB1' ' CZ ' ' A' ' 81' ' ' ARG . . . -144.08 158.91 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.051 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.68 142.09 28.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.457 HG23 HG21 ' A' ' 72' ' ' ILE . 27.5 mt -117.05 116.46 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' C ' HG23 ' A' ' 72' ' ' ILE . 17.1 m-85 -114.61 78.22 1.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.065 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -78.99 93.25 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 63.99 44.61 4.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.203 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 25.69 58.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.863 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 155.36 44.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.91 0.386 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.0 mtt -120.67 99.16 6.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.703 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.637 HG12 ' HB3' ' A' ' 102' ' ' ALA . 5.1 t -72.79 -8.14 10.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.554 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 17.9 p30 -47.82 -30.8 4.32 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -91.2 -18.73 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.811 0.339 . . . . 0.0 111.537 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.637 ' HB3' HG12 ' A' ' 99' ' ' VAL . . . -48.98 -69.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.888 HD22 ' N ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -111.37 -32.18 6.81 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.888 ' N ' HD22 ' A' ' 103' ' ' LEU . 5.0 t -59.8 -20.67 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -77.56 -24.37 49.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.706 ' HB2' HD21 ' A' ' 108' ' ' LEU . 6.8 mt-30 -61.75 -17.41 55.8 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.033 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.681 ' C ' HD13 ' A' ' 108' ' ' LEU . . . 98.18 34.5 5.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.425 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.706 HD21 ' HB2' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -156.52 -115.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 58' ' ' ALA . . . -178.03 16.77 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.233 -0.292 . . . . 0.0 111.706 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.983 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.825 0.345 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m -108.27 138.97 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.76 138.78 31.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 t -64.93 133.8 52.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -92.82 144.17 25.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -87.93 153.99 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.92 154.22 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.0 153.43 41.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.28 106.81 2.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.67 151.12 46.79 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.235 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.53 120.11 7.81 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.31 2.006 . . . . 0.0 112.215 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 74' ' ' VAL . . . -146.15 107.83 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.089 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.615 HG21 ' CE ' ' A' ' 71' ' ' LYS . 12.2 t -122.05 168.0 12.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.181 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.791 HD13 ' OG1' ' A' ' 62' ' ' THR . 1.3 mt -78.56 143.96 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.741 HG22 ' HD3' ' A' ' 16' ' ' LYS . 16.2 mt -75.88 -47.81 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.741 ' HD3' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -177.15 86.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.706 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.625 ' CB ' HG13 ' A' ' 23' ' ' VAL . . . -71.14 117.92 13.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.182 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.794 HG22 ' OD1' ' A' ' 19' ' ' ASP . 29.2 mm -60.18 -61.26 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.801 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.794 ' OD1' HG22 ' A' ' 18' ' ' ILE . 7.2 p-10 172.43 -137.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.372 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.94 -10.2 58.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.439 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.59 -84.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.786 0.293 . . . . 0.0 111.435 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -125.4 159.12 32.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.366 . . . . 0.0 111.117 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.625 HG13 ' CB ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -144.84 112.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -106.24 145.95 30.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -110.56 161.19 15.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.098 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 ttt -106.81 104.15 13.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.699 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' CE1' HG11 ' A' ' 74' ' ' VAL . 18.3 t80 -112.95 91.58 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.97 51.23 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.493 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 23.4 62.17 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.579 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -127.99 114.83 20.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.522 0.201 . . . . 0.0 110.816 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 97.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.443 2.095 . . . . 0.0 112.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.39 144.08 28.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.61 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.51 136.98 32.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.046 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.664 ' CD2' ' HB3' ' A' ' 90' ' ' ALA . 32.8 t80 -135.55 107.07 6.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 62.47 157.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.99 8.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.77 86.03 7.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.05 127.35 30.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.776 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.1 118.96 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -131.36 94.13 3.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.78 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.825 HG21 ' O ' ' A' ' 45' ' ' LYS . 9.5 t -93.79 124.71 55.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.54 -24.47 8.96 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.405 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.53 -63.41 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.584 HG23 ' HG2' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -179.98 -54.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.988 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.825 ' O ' HG21 ' A' ' 41' ' ' THR . 1.1 ptpp? -132.25 -175.63 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.53 ' HB3' ' CD ' ' A' ' 47' ' ' PRO . 4.1 t60 -159.88 -61.68 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.53 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 9.9 Cg_endo -50.72 -21.1 7.55 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -44.51 -51.03 9.2 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.428 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.0 -38.56 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.83 -48.31 1.62 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.395 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 13.3 p -52.07 -18.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.62 -22.65 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.613 0.244 . . . . 0.0 111.231 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 173.11 -8.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -135.79 25.23 3.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.673 0.273 . . . . 0.0 111.016 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.31 -133.15 6.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.97 -1.11 . . . . 0.0 111.435 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.3 2.59 4.87 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.107 1.871 . . . . 0.0 111.584 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.676 ' CD ' HD23 ' A' ' 108' ' ' LEU . 8.6 mm-40 -94.92 -64.75 1.03 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.106 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.614 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . . . -40.25 -33.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.9 0.381 . . . . 0.0 111.227 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 19' ' ' ASP . 40.0 p -79.3 -48.14 14.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.108 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.71 96.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 104' ' ' VAL . 30.1 t80 -44.95 -39.42 5.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.456 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.791 ' OG1' HD13 ' A' ' 14' ' ' LEU . 3.9 t -94.15 -29.07 15.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.331 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -26.33 68.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 68' ' ' ASN . 2.2 tttt -91.99 -38.3 12.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.987 0.423 . . . . 0.0 110.289 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.435 ' HA ' ' CB ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -57.43 -17.04 11.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 14' ' ' LEU . 4.6 m -104.89 -40.5 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -76.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 6.3 t30 -55.1 -36.28 65.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.381 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -76.17 -170.22 1.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.154 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -71.0 0.34 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.615 ' CE ' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER 176.47 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.232 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.949 HG21 HG13 ' A' ' 92' ' ' ILE . 2.2 mt 83.92 146.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 110.948 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -129.71 147.01 51.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.0 p -97.12 109.64 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.79 -76.22 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.255 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 91' ' ' TYR . 55.0 p90 -85.89 117.67 24.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.17 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.22 24.04 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.969 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -140.44 -55.12 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.44 99.66 0.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.51 157.23 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.445 ' HB3' HD23 ' A' ' 89' ' ' LEU . 2.8 tpt85 -96.92 -44.8 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.413 ' CG2' ' HG3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -104.37 164.09 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -116.88 30.7 7.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.034 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HG3' ' CG2' ' A' ' 82' ' ' THR . 1.3 mttm -78.55 -66.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.742 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 93.7 t80 -137.93 11.2 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.35 40.11 97.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.093 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -174.43 -24.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.497 0.189 . . . . 0.0 111.356 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.7 -64.35 3.25 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 81' ' ' ARG . 2.6 tp -93.26 114.16 26.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.664 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . . . -131.85 146.68 52.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -83.45 122.58 28.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.949 HG13 HG21 ' A' ' 72' ' ' ILE . 11.2 tt -121.07 110.02 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.542 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -129.7 107.6 9.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.954 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB2' HG13 ' A' ' 72' ' ' ILE . . . -84.74 92.48 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.9 40.06 5.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.903 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.16 33.32 69.19 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -103.53 129.93 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.91 84.95 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 99' ' ' VAL . 21.6 t -75.75 -7.9 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.537 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 3.8 t-20 -56.52 -22.99 36.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.842 0.353 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -91.03 -18.87 23.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.91 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.871 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.701 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -111.43 -21.18 11.94 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.602 ' N ' HD22 ' A' ' 103' ' ' LEU . 20.1 t -61.93 -23.87 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 0.0 111.499 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -15.58 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.39 23.14 1.66 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.08 47.18 87.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.685 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.676 HD23 ' CD ' ' A' ' 57' ' ' GLU . 5.3 mp -122.83 -44.88 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.816 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 58' ' ' ALA . . . -134.33 37.31 3.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.083 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 53' ' ' LYS . 15.2 mtmm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.849 0.357 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 m -90.86 114.49 26.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.99 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -101.43 135.38 43.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.4 p -97.09 118.91 34.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.0 113.34 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.685 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.6 150.58 47.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 76' ' ' PHE . 10.9 tp -88.21 155.14 19.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 113.3 6.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.353 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -67.67 106.93 2.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.567 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -96.1 152.08 38.65 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 119.1 6.07 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.668 1.579 . . . . 0.0 112.286 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 74' ' ' VAL . . . -146.55 107.63 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.362 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 m -123.67 145.86 48.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 111.201 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -91.34 144.13 25.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.706 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 16' ' ' LYS . 3.9 tp -86.1 -46.27 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.362 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' N ' HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.84 135.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.991 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.719 ' HB2' HG13 ' A' ' 23' ' ' VAL . . . -114.21 150.14 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -55.61 -47.64 78.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.678 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 19.9 t70 169.25 -110.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.809 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.73 -10.47 58.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.748 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -80.27 -90.04 0.06 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 m -97.14 159.09 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.064 0.459 . . . . 0.0 111.671 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.719 HG13 ' HB2' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -147.13 108.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.438 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.93 146.98 27.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.091 0.472 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 6.1 mt -124.22 130.92 53.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.681 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.403 ' CE ' HD13 ' A' ' 15' ' ' ILE . 1.6 tpp -85.45 100.71 12.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 29.8 t80 -126.06 112.47 15.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 27' ' ' TYR . 10.1 ptpt 47.44 29.05 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.31 -19.79 50.26 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.873 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -86.06 114.97 60.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.941 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.34 102.59 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.569 2.179 . . . . 0.0 112.408 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 8.5 mtt -99.28 127.7 45.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.485 HG22 ' HD2' ' A' ' 87' ' ' ARG . 1.5 t -105.55 140.42 38.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.17 151.44 48.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 60.49 102.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -135.46 99.65 4.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.561 . . . . 0.0 111.327 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.25 126.88 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.842 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.69 118.94 26.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.966 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.69 123.86 62.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -116.31 116.07 27.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.413 HG21 ' OG1' ' A' ' 44' ' ' THR . 0.1 OUTLIER -144.89 129.28 8.97 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.729 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -52.45 8.28 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.365 2.043 . . . . 0.0 112.592 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.74 -39.19 18.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 41' ' ' THR . 0.1 OUTLIER -97.3 95.33 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.042 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -118.79 27.2 9.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.059 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.449 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 18.0 m80 -141.03 62.89 17.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 46' ' ' HIS . 3.4 Cg_exo -80.17 -61.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.979 2.453 . . . . 0.0 111.951 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -157.18 29.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.782 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.56 -10.86 60.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.307 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.594 ' C ' ' HA2' ' A' ' 55' ' ' GLY . . . 116.17 -48.11 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.548 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.57 ' HA ' ' N ' ' A' ' 55' ' ' GLY . 13.2 p -57.99 -11.78 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.32 -45.4 8.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.493 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HB3' ' N ' ' A' ' 110' ' ' LYS . 4.4 tptt -112.25 -28.51 7.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.67 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -169.61 -26.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.594 ' HA2' ' C ' ' A' ' 50' ' ' GLY . . . 85.58 -101.04 2.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.29 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 64.5 Cg_exo -40.77 -28.65 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.46 2.107 . . . . 0.0 112.724 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -73.11 -45.38 57.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.202 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . . . -51.49 -49.07 62.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 p -64.06 -37.63 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' GLU . . . -47.91 -34.1 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.16 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.816 ' CZ ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -53.54 -44.35 69.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.314 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.816 HG23 ' CZ ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -94.03 -28.39 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.417 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -69.42 -22.11 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ALA . 6.3 mtpt -84.96 -33.15 22.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.032 0.444 . . . . 0.0 109.941 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.575 ' O ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.39 -14.37 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.431 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 14' ' ' LEU . 30.2 m -107.76 -41.68 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.8 mt-10 -95.47 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.39 -28.9 69.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.685 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -86.91 171.65 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.433 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.84 -60.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.71 169.72 24.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.668 HG21 ' HB ' ' A' ' 92' ' ' ILE . 3.6 mp -141.51 157.11 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.8 mt-10 -134.65 171.2 14.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.968 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 12' ' ' ALA . 21.5 t -107.84 115.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.356 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.7 85.69 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.75 ' O ' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.89 130.35 55.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.908 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -63.64 -53.61 48.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.0 -35.83 16.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.64 78.47 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -117.7 110.72 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -28.15 7.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 7.6 p -89.95 -175.79 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.006 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 82' ' ' THR . 4.0 m-20 81.09 -57.5 0.28 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -69.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.674 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -153.5 11.37 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.566 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.45 24.03 71.73 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.221 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HD2' HG22 ' A' ' 33' ' ' THR . 2.6 ptt180 167.99 -24.15 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.633 0.254 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.39 -39.16 5.5 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.11 109.58 21.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.59 28.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.082 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.424 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -105.28 126.22 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 72' ' ' ILE . 16.1 pt -125.72 143.49 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 111.453 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.61 ' C ' HG23 ' A' ' 72' ' ' ILE . 73.3 m-85 -140.24 107.98 5.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.556 ' HB2' ' HG3' ' A' ' 65' ' ' MET . . . -79.23 107.31 11.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.403 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.78 47.13 8.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.58 77.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -107.34 119.05 38.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -98.53 83.91 3.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.754 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.44 -27.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.25 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.555 ' OD1' HG21 ' A' ' 104' ' ' VAL . 32.3 t30 -56.46 -41.75 77.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 105' ' ' ARG . 8.8 mt-10 -86.38 -18.71 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.331 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -24.86 20.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 103' ' ' LEU . 2.8 tm? -111.22 -66.21 1.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.555 HG21 ' OD1' ' A' ' 100' ' ' ASN . 15.0 t -52.98 -37.31 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.692 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -69.77 -15.9 63.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.379 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.58 5.87 26.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.53 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.14 29.08 8.18 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.529 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 5.6 mt 64.27 107.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.651 0.263 . . . . 0.0 111.112 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 58' ' ' ALA . . . 82.41 -117.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.439 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.473 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.6 p -103.34 100.14 10.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -62.85 160.01 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 p -91.85 115.88 28.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.19 137.83 47.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -91.84 109.62 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -127.01 131.42 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.919 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -120.0 110.18 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -101.13 107.36 18.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -138.44 152.42 71.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.795 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.68 120.85 8.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.517 2.144 . . . . 0.0 112.148 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' CB ' HG13 ' A' ' 74' ' ' VAL . . . -145.35 107.91 4.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -120.49 159.4 25.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.997 HD13 HG23 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -102.71 141.39 35.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.9 mt -77.49 -58.96 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.239 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.72 124.03 36.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.81 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . -113.99 111.29 21.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -94.84 -49.08 12.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.514 ' OD2' HG21 ' A' ' 62' ' ' THR . 3.2 m-20 76.05 -54.89 0.61 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.18 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.39 -25.52 4.42 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.035 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -132.79 -79.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 0.0 111.019 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 m -140.82 158.82 43.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 17' ' ' ALA . 3.3 t -132.58 155.27 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.52 134.28 44.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.12 155.99 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.1 ttp -102.77 101.24 11.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.712 ' HE2' HG21 ' A' ' 74' ' ' VAL . 43.2 t80 -114.5 94.79 4.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.011 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 tttm 56.18 29.86 15.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.56 56.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.714 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.81 126.69 65.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.54 0.209 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 95.92 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.428 2.086 . . . . 0.0 112.429 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.5 mtt -77.42 99.97 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.59 HG23 ' HG2' ' A' ' 87' ' ' ARG . 1.8 t -70.93 132.58 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.728 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 9.5 t80 -116.79 134.85 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 59.58 164.11 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -127.32 155.43 43.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.33 102.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.996 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -60.82 177.06 0.34 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' HD12 ' A' ' 38' ' ' LEU . 21.4 t -76.23 154.76 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.081 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 39' ' ' VAL . 66.4 m-20 -120.96 104.28 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -84.77 121.23 74.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.25 -27.82 23.68 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.44 2.093 . . . . 0.0 112.39 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -47.06 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 47' ' ' PRO . 12.9 p -96.46 -77.34 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.79 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.12 30.39 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.486 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.59 ' ND1' HG11 ' A' ' 51' ' ' VAL . 6.1 t60 -176.56 -61.29 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.234 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 66.4 Cg_endo -72.4 -3.75 13.97 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.497 2.131 . . . . 0.0 113.092 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.7 -43.0 2.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.694 0.283 . . . . 0.0 111.473 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 46' ' ' HIS . 4.2 ptpt -56.85 -38.05 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.348 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.58 23.95 7.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.752 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG11 ' ND1' ' A' ' 46' ' ' HIS . 7.4 p -49.73 -26.17 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 0.0 111.242 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HG2' ' HD3' ' A' ' 53' ' ' LYS . 2.2 pt-20 -57.04 -30.43 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.325 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.714 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -107.69 -41.22 5.07 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.549 ' HA ' ' CB ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -108.11 21.38 17.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 111.704 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 51' ' ' VAL . . . -82.91 -107.78 0.48 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.161 -1.019 . . . . 0.0 110.954 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.9 2.54 7.01 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.55 2.167 . . . . 0.0 111.913 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -97.23 -68.06 0.82 Allowed 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.836 ' CB ' HD22 ' A' ' 108' ' ' LEU . . . -40.8 -56.43 2.19 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.18 0.514 . . . . 0.0 111.953 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -57.37 -18.68 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.908 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -91.1 -40.51 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.443 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.555 ' CD2' HD11 ' A' ' 103' ' ' LEU . 11.0 t80 -62.35 -62.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.514 HG21 ' OD2' ' A' ' 19' ' ' ASP . 39.1 p -53.29 -35.75 60.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.961 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 59' ' ' SER . 3.8 tppp? -48.88 -31.9 8.0 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.616 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -83.31 -36.93 24.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.996 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.08 -0.8 37.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.741 178.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.997 HG23 HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -109.9 -41.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.386 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 66' ' ' VAL . 13.3 tt0 -95.26 -72.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.922 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.43 -45.05 85.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.46 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.996 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -98.46 141.44 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.972 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.65 29.06 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.59 61.6 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 2.0 mp -110.16 146.59 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -130.68 162.28 29.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.712 HG21 ' HE2' ' A' ' 27' ' ' TYR . 7.2 m -95.97 117.26 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.214 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.86 166.13 15.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.715 ' H ' HD23 ' A' ' 7' ' ' LEU . 16.0 m-85 60.68 163.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -66.68 -17.9 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -177.37 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 110.933 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.97 88.7 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.496 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.22 111.01 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.17 -36.0 5.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.028 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.759 ' H ' HD12 ' A' ' 89' ' ' LEU . 1.9 m -105.95 -176.39 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 82' ' ' THR . 2.4 m-20 -109.21 -18.3 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.672 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -58.38 -161.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.483 ' CE1' ' HB2' ' A' ' 87' ' ' ARG . 1.2 p90 -84.34 11.68 8.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.791 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 89' ' ' LEU . . . 108.13 35.93 2.43 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.486 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.59 ' HG2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -101.89 -24.11 14.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.163 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.88 60.38 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.207 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -107.89 113.08 26.04 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.251 0.526 . . . . 0.0 111.381 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB3' ' CD1' ' A' ' 34' ' ' PHE . . . -144.36 109.87 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.023 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.39 126.61 35.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.688 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.599 HG22 ' CE ' ' A' ' 65' ' ' MET . 3.2 mp -116.14 107.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.602 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.453 ' C ' HG23 ' A' ' 72' ' ' ILE . 48.1 m-85 -130.07 84.47 2.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . . . -79.52 110.39 14.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.183 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t70 48.69 30.58 2.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.039 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.45 26.27 63.8 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.323 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -79.75 164.05 23.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.89 83.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.666 HG11 ' HE3' ' A' ' 65' ' ' MET . 9.7 m -91.4 -34.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 2.1 p-10 -66.71 -33.21 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.29 -20.7 21.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.517 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.5 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -58.43 -84.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.55 0.215 . . . . 0.0 111.483 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -112.16 -24.23 9.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 111.238 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.69 ' N ' HD22 ' A' ' 103' ' ' LEU . 53.4 t -57.99 -19.38 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.272 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -56.99 -34.86 68.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.917 0.389 . . . . 0.0 110.423 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -98.61 21.97 10.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.684 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 108' ' ' LEU . . . 97.15 -4.59 62.69 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.178 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.836 HD22 ' CB ' ' A' ' 58' ' ' ALA . 6.0 mt 140.9 -25.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.595 0.758 . . . . 0.0 111.156 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . . . -168.57 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' H ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.692 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.75 126.37 54.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -67.7 125.3 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.959 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m -104.94 107.09 17.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.88 122.92 42.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' C ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -94.94 125.47 39.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.958 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 7' ' ' LEU . 1.2 mm? -119.99 106.55 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.46 152.34 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -105.98 106.95 17.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.528 ' O ' HG22 ' A' ' 74' ' ' VAL . 3.4 mt-10 -114.17 148.26 39.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.92 120.74 8.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.379 2.053 . . . . 0.0 112.463 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.671 ' CB ' HG13 ' A' ' 74' ' ' VAL . . . -145.35 107.84 4.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.649 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -115.94 158.73 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.921 0.391 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.06 HD13 HG12 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.04 142.06 36.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.612 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 16' ' ' LYS . 3.4 tt -95.9 -47.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.822 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' N ' HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -155.22 132.87 11.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 111.344 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.916 ' HB2' HG23 ' A' ' 23' ' ' VAL . . . -114.25 149.75 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.905 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.699 ' CG2' HG22 ' A' ' 22' ' ' THR . 2.8 tt -53.65 -44.24 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.126 0.488 . . . . 0.0 110.143 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.6 OUTLIER 169.1 -108.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.708 ' HA3' HD21 ' A' ' 108' ' ' LEU . . . -93.6 -10.05 59.49 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.123 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -95.52 -82.19 0.39 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.699 HG22 ' CG2' ' A' ' 18' ' ' ILE . 14.6 t -96.45 159.37 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.916 HG23 ' HB2' ' A' ' 17' ' ' ALA . 3.8 p -148.1 133.17 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.721 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -82.79 143.83 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 3.0 mt -133.32 149.06 51.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.36 97.63 7.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 74' ' ' VAL . 31.8 t80 -105.44 106.27 16.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.981 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 58.33 30.29 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.95 -12.86 66.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.789 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.94 125.38 68.77 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.613 0.244 . . . . 0.0 110.723 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.57 93.78 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.404 2.069 . . . . 0.0 112.321 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.574 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 5.6 tpt -80.73 120.64 24.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -91.85 121.51 33.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 17.8 t80 -105.14 61.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 85' ' ' TYR . 1.7 mtt-85 -66.65 93.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -110.04 81.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.809 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.92 127.77 50.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.33 -176.52 6.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.839 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.431 HG12 HG23 ' A' ' 41' ' ' THR . 21.5 t -65.41 122.89 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.093 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.19 110.06 18.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.431 HG23 HG12 ' A' ' 39' ' ' VAL . 32.9 p -144.13 157.03 57.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.764 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.9 59.39 3.52 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.127 . . . . 0.0 112.321 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -164.03 -44.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.746 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 t -99.67 26.03 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.96 -65.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.746 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.436 ' CG ' ' HA2' ' A' ' 50' ' ' GLY . 5.3 m-70 60.48 71.78 0.81 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.63 14.24 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.84 2.36 . . . . 0.0 112.876 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -84.22 0.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.629 0.252 . . . . 0.0 111.041 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -107.07 -38.23 6.08 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 55' ' ' GLY . . . 66.05 32.76 83.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.709 ' HA ' ' N ' ' A' ' 55' ' ' GLY . 12.7 p -86.1 27.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.692 0.282 . . . . 0.0 111.486 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -50.02 -32.55 15.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.898 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -125.93 -27.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.54 178.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.601 ' H ' ' HB1' ' A' ' 109' ' ' ALA . 1.3 t80 -176.72 -25.56 0.01 OUTLIER 'General case' 0 C--N 1.345 0.4 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.666 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.709 ' N ' ' HA ' ' A' ' 51' ' ' VAL . . . 79.99 -104.81 2.26 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.601 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 2.2 Cg_endo -41.13 -28.07 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.912 2.408 . . . . 0.0 112.608 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 15.7 tp10 -78.56 -30.7 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.191 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . . . -39.27 -60.16 0.95 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -84.09 -47.39 10.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.74 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -48.5 -31.35 6.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.381 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.442 ' CD2' ' HG ' ' A' ' 103' ' ' LEU . 54.8 t80 -56.85 -58.49 7.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.225 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.405 HG23 ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -79.25 -23.39 43.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.557 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -25.26 63.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -87.13 -26.92 23.38 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.0 110.296 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.959 ' HA ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -70.16 -6.44 34.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.572 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 1.06 HG12 HD13 ' A' ' 14' ' ' LEU . 20.7 m -112.3 -41.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 66' ' ' VAL . 4.6 mt-10 -87.92 -68.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.593 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -73.53 -32.54 64.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.923 0.392 . . . . 0.0 111.251 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.959 ' HB3' ' HA ' ' A' ' 65' ' ' MET . . . -113.97 149.39 35.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.086 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -165.35 70.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -141.86 84.52 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 94' ' ' ALA . 3.2 mp -135.65 150.73 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.101 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.22 149.96 47.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.645 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.671 HG13 ' CB ' ' A' ' 12' ' ' ALA . 6.2 m -95.91 109.87 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.925 0.393 . . . . 0.0 110.804 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.1 82.91 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.432 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 7' ' ' LEU . 45.5 p90 -178.85 133.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.013 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.18 16.76 19.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -64.92 -34.67 78.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.51 27.53 68.11 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.95 110.8 20.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.979 0.418 . . . . 0.0 110.81 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -4.66 13.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.405 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -89.78 -175.69 4.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.8 0.333 . . . . 0.0 110.994 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 82' ' ' THR . 3.6 t0 84.94 -49.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.474 ' CD ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -85.03 -67.86 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.868 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 35' ' ' ARG . 70.5 t80 -149.32 11.4 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.72 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 70.44 18.08 75.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.532 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 169.19 -24.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.622 0.249 . . . . 0.0 111.186 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.87 -38.77 86.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.919 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD23 ' CD ' ' A' ' 84' ' ' LYS . 1.5 tm? -80.42 109.88 15.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.574 ' HB2' ' HE2' ' A' ' 32' ' ' MET . . . -144.19 117.95 9.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.218 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 93.68 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.684 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.464 HG22 HG12 ' A' ' 74' ' ' VAL . 3.0 pt -112.71 158.18 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.43 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.66 89.56 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.759 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.87 141.25 36.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.571 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 49.18 31.25 3.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.434 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.1 -37.62 3.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.744 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -139.33 139.59 37.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.004 0.43 . . . . 0.0 111.235 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.2 mtm -58.31 94.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.112 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.8 m -84.33 -28.66 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.405 ' ND2' HG23 ' A' ' 62' ' ' THR . 14.4 m120 -66.01 -37.4 85.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -29.73 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.3 -33.95 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -59.29 -58.15 9.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.66 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.82 HG13 HD12 ' A' ' 108' ' ' LEU . 33.9 t -66.09 -14.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.537 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -24.88 60.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.68 0.276 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -94.35 23.29 5.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.17 -3.32 61.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.596 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.82 HD12 HG13 ' A' ' 104' ' ' VAL . 2.6 tt 69.55 86.02 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.945 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . . . -166.63 -41.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.088 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' C ' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.903 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.51 113.77 15.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.7 t -106.56 153.32 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 m -80.63 139.33 36.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.851 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 100.86 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -123.87 139.25 54.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.9 112.91 14.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -82.04 109.64 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.644 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.7 111.09 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -129.25 143.05 47.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.07 120.86 7.97 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.491 2.127 . . . . 0.0 112.52 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 107.94 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.649 HG21 ' HG2' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -124.04 149.87 45.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.924 HD12 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -98.56 139.6 34.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.722 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.58 -34.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -137.87 93.27 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.563 ' HB1' ' CB ' ' A' ' 62' ' ' THR . . . -99.58 111.06 23.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.527 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 22' ' ' THR . 7.3 mt -101.07 -46.9 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.677 ' H ' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER 69.7 -61.62 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.235 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -46.33 -27.7 2.92 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.834 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -127.42 -76.09 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.929 0.395 . . . . 0.0 110.781 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -140.24 146.82 39.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.677 HG22 ' H ' ' A' ' 19' ' ' ASP . 10.7 t -120.77 143.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -128.65 109.47 11.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.774 HD21 ' CD2' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -101.88 154.26 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.689 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.8 tpp -85.62 94.92 9.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.673 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.547 ' CE1' HG11 ' A' ' 74' ' ' VAL . 53.1 t80 -120.71 93.66 4.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 tttm 54.54 41.17 32.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.9 16.03 78.26 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -118.0 142.29 30.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.643 0.259 . . . . 0.0 110.761 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.15 97.98 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.578 2.185 . . . . 0.0 112.41 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.0 107.75 7.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 p -72.05 125.94 28.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -115.23 95.94 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.76 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 62.07 89.91 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 171.95 12.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.6 tp -81.32 103.12 10.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.57 158.96 36.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -126.78 112.1 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.182 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -154.9 87.74 1.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.03 75.78 10.65 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.21 82.67 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.715 2.277 . . . . 0.0 112.418 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.33 -65.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.992 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.5 -28.05 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.323 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 pttm 44.22 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.549 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 86.7 t60 -122.22 50.89 2.78 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.297 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 46' ' ' HIS . 95.5 Cg_endo -77.47 -1.8 11.97 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.548 2.165 . . . . 0.0 112.668 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -73.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.797 0.332 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -90.83 -38.2 13.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.22 42.03 94.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.418 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 51' ' ' VAL . 14.7 t -96.26 23.79 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.797 0.332 . . . . 0.0 111.278 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' LYS . 1.3 mt-10 -111.11 13.17 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.989 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.827 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER 161.34 -2.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.465 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 8.2 m-85 -131.11 -1.53 4.06 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.12 -140.05 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.443 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 2.41 7.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.551 2.167 . . . . 0.0 112.864 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HB2' ' CA ' ' A' ' 109' ' ' ALA . 9.9 mt-10 -95.98 -63.8 1.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.358 -0.137 . . . . 0.0 111.105 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 53' ' ' LYS . . . -40.43 -33.35 0.25 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.789 0.328 . . . . 0.0 111.517 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -81.65 -57.95 3.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.481 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -50.05 -28.39 7.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.503 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.66 ' HD2' HG23 ' A' ' 62' ' ' THR . 61.4 t80 -57.64 -65.12 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.64 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.66 HG23 ' HD2' ' A' ' 61' ' ' PHE . 67.6 p -79.58 -26.49 41.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 22.7 ttmt -60.16 -24.73 64.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG2' ' CB ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -92.07 -25.09 18.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.919 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.584 ' HB2' HD11 ' A' ' 14' ' ' LEU . 0.7 OUTLIER -63.7 -9.23 13.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.527 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.924 HG13 HD12 ' A' ' 14' ' ' LEU . 28.3 m -114.72 -41.31 3.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.6 mt-10 -88.12 -68.87 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.345 . . . . 0.0 111.912 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' CB ' ' HG2' ' A' ' 64' ' ' LYS . 1.0 OUTLIER -68.58 -29.96 68.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -72.29 170.47 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.185 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -108.61 -55.92 2.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.649 ' HG2' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER -166.51 163.74 17.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.705 HG21 ' CG2' ' A' ' 92' ' ' ILE . 1.6 mp -142.4 162.91 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -135.04 137.44 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.43 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.2 p -95.83 109.81 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.157 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 4.5 pt-20 -129.62 139.79 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.97 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -166.99 132.01 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.0 -30.28 71.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.983 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -107.81 -47.35 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.838 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.86 -40.66 2.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.75 116.52 32.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -83.18 -55.04 4.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.549 ' HB ' ' CD ' ' A' ' 84' ' ' LYS . 96.4 m -121.96 158.02 30.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.027 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -98.89 47.06 0.98 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.761 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.549 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -92.21 -38.79 11.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.723 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.483 ' N ' ' HG2' ' A' ' 84' ' ' LYS . 4.9 t80 -158.3 11.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.415 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.94 32.05 78.5 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.365 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.88 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.559 0.219 . . . . 0.0 111.234 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -45.43 -79.66 0.06 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.945 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.431 ' H ' ' HD2' ' A' ' 84' ' ' LYS . 0.3 OUTLIER -80.86 122.13 26.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.865 0.365 . . . . 0.0 110.78 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.13 148.35 34.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.483 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -72.35 142.07 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.784 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.705 ' CG2' HG21 ' A' ' 72' ' ' ILE . 17.6 mm -128.53 120.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.187 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 75' ' ' GLU . 1.1 m-85 -116.64 78.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.691 ' CA ' HG23 ' A' ' 72' ' ' ILE . . . -79.6 111.19 15.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 68.4 45.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.326 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.24 24.64 52.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.062 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -134.19 150.44 51.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.283 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.22 107.19 15.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.7 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 99' ' ' VAL . 11.9 t -72.5 -7.9 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.774 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 4.9 m-80 -58.66 -20.32 47.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.19 -18.72 24.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.394 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -61.71 -84.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.14 -22.23 11.08 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.716 HG22 ' CD2' ' A' ' 108' ' ' LEU . 14.6 t -54.83 -23.29 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.659 0.266 . . . . 0.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -57.72 -24.12 55.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.963 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -103.76 19.12 20.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.69 ' O ' HD12 ' A' ' 108' ' ' LEU . . . 82.29 -3.2 82.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.854 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.716 ' CD2' HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER 78.38 74.0 0.05 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.584 0.231 . . . . 0.0 110.874 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.62 ' CB ' ' O ' ' A' ' 108' ' ' LEU . . . 131.15 -71.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.638 0.775 . . . . 0.0 110.226 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.985 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.838 0.352 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.6 t -115.82 139.96 49.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -103.59 126.91 51.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -67.82 126.07 28.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -81.81 125.85 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.929 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.49 110.75 18.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 mt -127.06 103.96 7.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -94.55 128.8 41.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.732 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -81.21 115.73 20.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -135.87 129.29 18.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.443 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.67 120.52 8.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.368 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB3' HG13 ' A' ' 74' ' ' VAL . . . -145.42 107.39 4.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -116.99 164.08 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.112 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.907 ' HB2' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -96.92 144.04 27.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.896 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -90.21 -40.61 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.858 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HB2' HD13 ' A' ' 15' ' ' ILE . 0.5 OUTLIER 178.57 126.02 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.985 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.789 ' CB ' HG12 ' A' ' 23' ' ' VAL . . . -103.84 148.59 25.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 21' ' ' ASP . 4.2 pt -51.12 -40.36 21.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 4.5 p30 165.11 -113.66 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.37 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.31 -10.12 59.77 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.618 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.534 ' HB3' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -72.64 -82.46 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.489 ' H ' HD11 ' A' ' 18' ' ' ILE . 91.4 m -130.14 159.43 36.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 111.418 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.024 HG11 HG21 ' A' ' 62' ' ' THR . 22.9 m -124.8 154.4 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.229 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -114.99 135.33 54.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.838 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 4.5 mp -110.95 159.89 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.9 94.91 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.33 95.35 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.11 30.16 19.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.01 43.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.685 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -85.81 114.99 59.9 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.518 0.199 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.88 102.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.504 2.136 . . . . 0.0 112.337 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.414 ' HE1' HD22 ' A' ' 25' ' ' LEU . 4.2 ttp -87.6 150.04 23.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.911 HG21 HD23 ' A' ' 36' ' ' LEU . 3.5 m -104.84 140.01 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' HB2' HD13 ' A' ' 25' ' ' LEU . 13.6 t80 -124.56 112.85 17.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.73 87.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.211 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.911 HD23 HG21 ' A' ' 33' ' ' THR . 0.3 OUTLIER -105.75 81.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.84 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD23 HG22 ' A' ' 39' ' ' VAL . 3.2 tp -125.53 145.7 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.01 105.22 12.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.674 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG22 HD23 ' A' ' 37' ' ' LEU . 5.4 m -153.75 142.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.947 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -145.8 87.38 1.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 0.0 110.875 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.51 75.44 10.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 75.6 Cg_endo -88.1 -14.22 3.47 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.806 2.338 . . . . 0.0 112.438 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 1.1 tm-20 165.89 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.528 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -154.09 -64.45 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.498 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.84 -55.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.7 p80 178.32 83.34 0.15 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.53 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.52 -26.35 12.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.535 2.157 . . . . 0.0 111.876 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 pttt 175.83 -53.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.396 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' O ' ' CA ' ' A' ' 55' ' ' GLY . 4.5 mtmp? -107.81 -38.81 5.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' GLY . . . 106.89 35.32 2.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.312 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.568 HG12 ' HB1' ' A' ' 109' ' ' ALA . 18.4 t -66.56 1.41 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 42' ' ' PRO . 5.8 mm-40 -89.54 15.01 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.836 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 8.3 tttt -167.06 -45.8 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 0.1 OUTLIER 169.81 -22.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.14 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . 46.78 -111.75 0.77 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.214 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.42 -19.79 45.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.002 1.801 . . . . 0.0 111.011 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.882 ' HB3' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -88.56 -20.82 24.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.657 ' HB2' ' CD1' ' A' ' 54' ' ' TYR . . . -39.98 -35.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.452 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -79.21 -43.32 24.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 0.0 109.719 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' GLU . . . -50.71 -40.37 53.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.527 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CE1' HG12 ' A' ' 99' ' ' VAL . 10.6 t80 -40.23 -61.58 0.87 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.948 0.404 . . . . 0.0 110.427 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.024 HG21 HG11 ' A' ' 23' ' ' VAL . 2.4 m -88.19 -49.74 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.114 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HA ' ' CG1' ' A' ' 66' ' ' VAL . 34.1 ttmt -40.34 -29.32 0.08 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 2.9 tttm -85.8 -33.25 21.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.0 110.421 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.895 ' HG2' HG22 ' A' ' 99' ' ' VAL . 6.7 tpp -94.15 -0.67 55.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.011 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 62' ' ' THR . 7.4 p -123.48 -41.72 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -95.59 -55.2 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 111.828 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -87.06 5.26 38.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.791 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -99.54 173.53 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.403 . . . . 0.0 111.482 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 -66.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.83 -176.72 3.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.109 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.648 HG23 ' N ' ' A' ' 94' ' ' ALA . 4.1 mp -143.68 145.58 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -113.72 133.14 55.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.403 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.671 HG13 ' HB3' ' A' ' 12' ' ' ALA . 4.2 m -95.67 118.54 42.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 111.207 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 7.6 tt0 -94.61 78.58 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.285 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 74' ' ' VAL . 8.0 p90 -171.21 136.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.75 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -63.92 -60.86 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.471 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.31 -30.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.281 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -41.73 134.75 3.4 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.26 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' CG ' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -67.95 142.49 55.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -34.08 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 89' ' ' LEU . 2.4 p -122.09 147.16 46.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -89.42 -9.9 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -27.77 6.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -178.13 -37.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 80' ' ' GLN . . . 109.06 -10.23 34.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.633 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.22 -5.6 6.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.508 0.194 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.54 -76.28 0.64 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.545 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.581 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.3 OUTLIER -74.01 110.08 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 0.0 110.829 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.92 139.82 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -75.39 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -109.37 156.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.639 ' C ' HG23 ' A' ' 72' ' ' ILE . 88.8 m-85 -141.99 83.56 1.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.981 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.648 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -79.9 106.81 12.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.014 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t0 64.77 42.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.801 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 21.75 74.43 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.669 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -158.0 156.66 31.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.06 166.75 22.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.895 HG22 ' HG2' ' A' ' 65' ' ' MET . 19.6 t -84.49 -35.5 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.458 HD22 HG11 ' A' ' 104' ' ' VAL . 21.3 m120 -58.59 -28.12 65.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.982 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.58 -18.84 61.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.3 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.48 -74.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.794 0.33 . . . . 0.0 111.769 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 57' ' ' GLU . 4.5 tt -95.23 -56.72 2.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.83 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 61' ' ' PHE . 15.0 t -48.03 -26.43 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.94 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -15.68 61.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 0.0 111.311 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -76.08 5.18 7.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.769 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.46 4.54 58.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.394 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.836 ' HB3' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mt 64.46 76.32 0.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.165 0.507 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.568 ' HB1' HG12 ' A' ' 51' ' ' VAL . . . 176.91 103.76 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.822 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.902 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.923 0.392 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.1 p -136.23 127.94 29.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 t -98.13 150.1 21.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.951 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 t -63.11 145.22 55.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 106.49 18.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 131.56 46.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.07 148.55 36.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.31 153.05 39.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.28 127.9 44.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.03 147.13 64.11 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.94 120.54 8.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.422 2.081 . . . . 0.0 112.024 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 74' ' ' VAL . . . -145.64 107.94 4.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.849 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -121.98 168.81 11.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.848 HD11 ' CG2' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -106.23 144.02 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 16' ' ' LYS . 1.4 tt -82.13 -42.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.409 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' N ' HG23 ' A' ' 15' ' ' ILE . 7.6 ttmm -143.55 105.81 4.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.128 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.827 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -114.14 123.68 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 22' ' ' THR . 1.9 mp -94.23 -35.03 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.174 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.08 -64.58 0.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.173 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.06 -26.34 8.74 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.789 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.75 -79.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.663 ' O ' HD12 ' A' ' 18' ' ' ILE . 43.2 m -131.83 158.96 39.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.727 HG23 ' CB ' ' A' ' 17' ' ' ALA . 7.9 p -138.68 145.12 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.31 142.26 51.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 1.6 mt -115.91 152.11 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.82 95.62 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.474 ' HE1' HG11 ' A' ' 74' ' ' VAL . 49.4 t80 -106.6 93.64 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm 58.25 41.84 22.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.973 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.66 24.03 68.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.59 128.04 24.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.604 0.24 . . . . 0.0 110.803 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.82 90.41 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.367 2.045 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ttm -78.41 113.07 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 p -73.54 135.5 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.725 ' HB3' HG13 ' A' ' 23' ' ' VAL . 4.7 t80 -127.79 109.21 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.747 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 64.24 144.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 85' ' ' TYR . 9.3 mp -91.05 172.01 8.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.48 99.43 10.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.7 tp -132.38 106.44 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 40' ' ' ASP . 17.3 t -136.38 159.23 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 39' ' ' VAL . 2.2 t0 -92.87 127.2 38.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 t -124.05 85.78 54.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.82 -55.14 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.502 2.135 . . . . 0.0 112.38 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -24.63 9.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.3 -54.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -48.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.711 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.68 143.8 49.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.717 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -86.6 26.23 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.851 2.368 . . . . 0.0 112.687 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 mttm 59.3 27.89 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.789 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -107.12 -38.16 6.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.2 95.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.252 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 51' ' ' VAL . 14.4 p -117.3 16.86 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.709 0.29 . . . . 0.0 111.454 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 11.1 mt-10 -116.0 13.31 15.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.412 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.865 ' CB ' HD22 ' A' ' 108' ' ' LEU . 18.8 ptpt 139.96 44.6 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.346 1.058 . . . . 0.0 108.474 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.47 ' CG ' ' CB ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER 50.53 25.35 1.94 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 -178.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -109.47 1.85 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.252 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 2.36 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.678 2.252 . . . . 0.0 113.024 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' CB ' ' CG ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -85.59 -62.97 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 53' ' ' LYS . . . -45.77 -48.92 15.39 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.723 0.296 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 13.0 t -48.53 -29.48 4.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . . . -91.46 -38.19 12.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.605 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.2 -65.4 0.56 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.241 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -60.68 -20.4 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -65.62 -33.4 75.81 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.889 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.16 -21.34 20.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.148 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.628 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -75.0 -5.32 43.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.011 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.93 ' HA ' HD11 ' A' ' 72' ' ' ILE . 22.6 m -123.39 -41.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.705 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' N ' HG23 ' A' ' 66' ' ' VAL . 28.1 tt0 -74.73 -66.8 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.903 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -92.83 5.39 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.628 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -98.96 92.07 5.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.487 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm 60.17 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.214 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 13' ' ' THR . 8.0 mttt 166.95 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.93 HD11 ' HA ' ' A' ' 66' ' ' VAL . 2.7 mt 79.23 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 72' ' ' ILE . 17.0 pt-20 -141.28 140.11 33.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.692 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 12' ' ' ALA . 13.8 p -95.92 109.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.111 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HG3' ' CD2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -124.84 -86.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.831 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.486 ' CE1' ' CD2' ' A' ' 91' ' ' TYR . 2.7 t80 59.75 117.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.834 0.35 . . . . 0.0 111.163 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -86.03 57.17 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.454 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -166.73 -44.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.34 144.63 9.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.453 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.682 ' CB ' HD12 ' A' ' 89' ' ' LEU . 5.7 pm0 -106.39 110.15 22.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.0 110.722 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -114.34 -55.72 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.565 ' O ' ' CB ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -141.4 -175.3 4.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.729 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 82' ' ' THR . 24.2 t70 104.02 -72.67 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.532 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.687 ' H ' HD22 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -92.15 90.6 7.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.394 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' HB2' HD11 ' A' ' 36' ' ' LEU . 43.1 t80 64.86 11.35 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.921 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 82' ' ' THR . . . 58.75 30.79 66.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.465 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 165.35 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.464 0.306 . . . . 0.0 110.789 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.72 -12.87 36.57 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.062 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.687 HD22 ' H ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -83.7 109.77 17.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 34' ' ' PHE . . . -144.23 134.74 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.993 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.486 ' CD2' ' CE1' ' A' ' 76' ' ' PHE . 5.5 m-85 -112.11 119.92 40.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.24 136.07 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.604 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' HG3' ' A' ' 75' ' ' GLU . 74.5 m-85 -127.34 77.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.784 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.06 141.81 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.246 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 p30 48.88 31.23 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.651 0.739 . . . . 0.0 109.505 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.51 -47.01 2.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.059 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -161.7 111.69 1.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.764 0.282 . . . . 0.0 111.589 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.774 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 15.3 ttm -147.41 80.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.283 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -98.95 -59.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.111 0.482 . . . . 0.0 111.961 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 105' ' ' ARG . 5.8 p-10 -89.56 -57.21 2.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.215 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.404 ' HG3' ' HG3' ' A' ' 98' ' ' MET . 6.5 pt-20 -40.56 -28.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.774 ' HB2' ' HG2' ' A' ' 98' ' ' MET . . . -67.18 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.657 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.623 HD11 HD23 ' A' ' 108' ' ' LEU . 1.3 tm? -114.42 -57.58 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.456 0.646 . . . . 0.0 111.469 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 100' ' ' ASN . 18.5 t -48.82 -16.5 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.012 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -49.93 -28.66 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.975 0.417 . . . . 0.0 110.486 179.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -98.41 23.04 8.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.068 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.85 38.65 65.28 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.865 HD22 ' CB ' ' A' ' 53' ' ' LYS . 33.0 mt 55.87 87.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 110.62 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.61 -6.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HA ' ' CD2' ' A' ' 54' ' ' TYR . 8.1 ptpt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.2 p -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.932 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 p -71.93 116.95 12.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.999 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.3 m -101.6 147.58 26.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -84.14 134.22 34.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.906 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 105.41 17.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -127.07 104.05 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.56 106.53 18.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.03 106.91 17.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 74' ' ' VAL . 6.5 mt-10 -128.24 126.54 23.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.36 121.46 9.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.385 2.057 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.15 107.43 4.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 72' ' ' ILE . 2.5 p -125.44 150.58 47.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.872 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.58 141.74 41.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.695 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 16' ' ' LYS . 15.4 tt -88.64 -47.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.703 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' N ' HG23 ' A' ' 15' ' ' ILE . 19.1 mttt -155.07 130.3 9.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.823 0.344 . . . . 0.0 111.46 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.03 133.51 55.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.698 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 19' ' ' ASP . 17.3 tt -54.66 -49.45 67.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.778 0.323 . . . . 0.0 111.23 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 166.93 -152.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.84 -10.52 4.79 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.449 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 18' ' ' ILE . 29.2 t70 -67.15 -71.17 0.21 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.026 0.413 . . . . 0.0 111.129 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -147.0 159.05 44.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 23' ' ' VAL . 29.4 m -121.45 117.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.978 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -83.34 124.9 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 2.4 mp -89.67 160.85 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.1 ttt -113.03 94.97 5.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.63 98.32 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.971 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt 57.57 43.42 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.32 22.56 76.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.597 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -114.31 133.64 22.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.576 0.226 . . . . 0.0 110.815 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.06 99.49 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.458 2.105 . . . . 0.0 112.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 mtt -95.9 149.75 21.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -108.88 144.55 36.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.976 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 90' ' ' ALA . 32.5 t80 -138.02 122.81 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 62.86 145.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.26 103.09 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.74 102.82 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.839 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.97 107.76 17.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.61 140.26 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -141.72 89.73 2.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -62.65 145.84 94.92 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.99 -50.65 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.418 2.079 . . . . 0.0 112.371 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -159.3 28.51 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.802 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 t -150.77 -168.28 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.768 ' CD2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -70.2 -62.35 2.29 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.683 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 51' ' ' VAL . 3.3 Cg_endo -46.38 -44.7 20.1 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.817 2.345 . . . . 0.0 112.548 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -28.03 64.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -73.39 -30.08 63.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.1 42.08 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.625 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' A' ' 46' ' ' HIS . 31.4 m -95.8 -30.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.054 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 13.7 mt-10 -92.71 13.56 19.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HB3' ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER 64.81 4.67 2.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD1' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER 172.11 -25.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.736 0.303 . . . . 0.0 110.813 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.15 -102.07 2.88 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.371 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.96 -25.69 63.9 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.689 ' OE1' ' HB3' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -73.61 -36.93 65.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . . . -47.89 -26.23 1.62 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -32.37 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.689 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -54.82 -47.14 74.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.512 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.657 ' HB2' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -47.85 -47.87 31.26 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.885 0.374 . . . . 0.0 110.488 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.7 t -81.94 -26.15 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -26.77 65.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.747 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 69' ' ' ALA . 11.9 mttp -92.02 -24.86 19.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.48 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 24.6 ttp -57.21 -15.25 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.414 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.497 HG12 ' HG ' ' A' ' 14' ' ' LEU . 33.4 m -105.23 -42.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 66' ' ' VAL . 1.3 mt-10 -95.6 -69.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.714 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.24 -20.49 62.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.592 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -93.08 -179.84 5.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.805 0.336 . . . . 0.0 111.356 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -69.45 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.068 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 172.61 149.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.922 0.391 . . . . 0.0 110.924 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.609 ' H ' HG22 ' A' ' 13' ' ' THR . 1.8 mp -102.78 161.61 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.051 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.3 mt-10 -133.78 149.55 51.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.6 p -100.48 109.82 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.967 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -88.48 -178.54 5.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 75' ' ' GLU . 15.5 p90 46.94 117.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.04 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.08 32.02 6.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -59.26 -27.55 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.069 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.45 -84.06 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.21 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.27 110.82 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.601 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -110.11 -40.29 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.511 HG21 ' O ' ' A' ' 89' ' ' LEU . 82.7 p -130.1 133.94 47.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.38 -8.31 58.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.087 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.59 70.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -177.19 -37.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.05 -10.27 34.03 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.536 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.552 ' HB3' HG23 ' A' ' 33' ' ' THR . 1.4 mpp_? -123.21 -24.11 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.54 -84.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.736 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' HG21 ' A' ' 82' ' ' THR . 3.1 tp -89.08 116.22 27.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.335 . . . . 0.0 110.887 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.541 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . . . -144.04 141.88 30.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 1.5 m-85 -80.89 127.3 32.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.13 149.77 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -134.42 89.12 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 72' ' ' ILE . . . -79.25 115.55 18.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.24 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 t70 67.57 26.64 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.13 -31.26 7.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.816 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -134.17 131.43 38.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 111.025 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.18 158.36 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' VAL . 12.2 t -95.12 -8.64 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.859 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 0.9 OUTLIER -63.06 -16.57 60.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -18.83 30.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -61.53 -84.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.517 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.995 HD23 ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -111.64 -24.07 10.3 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.626 ' N ' HD22 ' A' ' 103' ' ' LEU . 63.6 t -58.93 -31.47 45.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -98.17 -16.01 19.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -83.87 -25.2 30.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.533 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.12 47.8 2.16 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.332 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' N ' ' HB3' ' A' ' 53' ' ' LYS . 2.6 tt -147.98 6.16 0.78 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.995 ' HB3' HD23 ' A' ' 103' ' ' LEU . . . 176.32 86.78 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.587 ' C ' ' HB1' ' A' ' 58' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.829 0.347 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -111.33 95.15 5.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 p -90.41 119.05 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.6 p -74.44 128.31 35.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.03 138.44 52.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.826 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -103.14 138.57 39.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 111.119 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.596 HD22 ' H ' ' A' ' 7' ' ' LEU . 1.6 mm? -79.06 112.87 16.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.034 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -70.0 153.21 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -106.95 106.91 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -110.52 129.65 23.73 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.379 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.1 120.02 7.58 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.253 1.969 . . . . 0.0 112.486 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -146.0 107.81 4.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.472 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 t -117.49 163.41 16.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.021 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.656 HD21 ' CB ' ' A' ' 66' ' ' VAL . 1.6 pp -106.23 144.19 33.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.606 HD11 ' SD ' ' A' ' 26' ' ' MET . 38.3 mm -62.2 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HG2' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -168.99 135.42 1.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.808 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.146 ' HB2' HG23 ' A' ' 23' ' ' VAL . . . -114.12 137.73 51.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.132 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 19' ' ' ASP . 6.8 tt -57.71 -46.36 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' HG23 ' A' ' 18' ' ' ILE . 1.1 p30 166.45 -110.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.41 -10.62 59.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.54 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.493 ' HB2' HG21 ' A' ' 18' ' ' ILE . 3.7 m-20 -70.17 -80.75 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.714 0.292 . . . . 0.0 111.435 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -131.48 157.76 42.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.378 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.146 HG23 ' HB2' ' A' ' 17' ' ' ALA . 7.5 p -147.96 107.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -83.5 111.37 19.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.514 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HA ' ' CB ' ' A' ' 14' ' ' LEU . 3.6 mt -89.74 161.71 15.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.634 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.606 ' SD ' HD11 ' A' ' 15' ' ' ILE . 7.2 ttp -106.41 109.04 20.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.989 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -126.1 92.67 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.839 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.02 41.04 5.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 25.86 37.97 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.644 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -124.74 114.86 26.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.519 0.2 . . . . 0.0 110.876 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.75 83.0 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.487 2.124 . . . . 0.0 112.275 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 mtm -80.94 123.46 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.693 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -110.23 148.08 32.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.897 ' CD1' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -88.83 -171.02 3.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HG2' ' CD2' ' A' ' 34' ' ' PHE . 6.9 ptt180 -46.68 148.42 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.438 HD12 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -88.76 172.12 9.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 37' ' ' LEU . 1.4 pt? -94.41 156.15 16.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.93 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.44 -178.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 41' ' ' THR . 21.7 t -80.3 138.44 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.194 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -98.66 96.17 7.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.429 HG23 HG12 ' A' ' 39' ' ' VAL . 24.0 p -123.71 156.18 65.29 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 41' ' ' THR . 33.7 Cg_endo -64.32 -14.71 45.6 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.605 2.203 . . . . 0.0 112.425 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.38 -28.41 65.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.11 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.5 m -161.0 78.94 0.6 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -74.54 154.14 38.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' CG ' ' HA3' ' A' ' 50' ' ' GLY . 13.1 m170 -96.86 101.82 10.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.1 -43.84 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.415 2.077 . . . . 0.0 112.201 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -145.01 -55.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.712 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 67.9 mttt -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.352 0.596 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' HA3' ' CG ' ' A' ' 46' ' ' HIS . . . 70.23 -51.9 0.79 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.574 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' H ' ' A' ' 52' ' ' GLU . 2.1 p -130.43 -67.37 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.214 1.007 . . . . 0.0 112.216 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.701 ' H ' HG13 ' A' ' 51' ' ' VAL . 29.1 tp10 -121.29 -78.11 0.59 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.682 0.754 . . . . 0.0 111.317 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.87 2.12 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.521 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 76.7 t80 -83.47 0.97 43.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.224 0.535 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.55 -60.36 1.81 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.712 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 85.7 Cg_endo -92.06 -48.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.674 2.916 . . . . 0.0 113.153 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.466 ' CG ' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -65.03 -56.92 10.28 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . . . -45.95 -49.33 15.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 111.428 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' LYS . 4.2 m -60.06 -19.97 55.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.73 -58.12 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.128 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -72.85 -62.63 1.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.911 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.78 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.9 m -49.63 -27.58 4.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.219 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 59' ' ' SER . 37.3 ttmt -76.61 -21.77 55.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -23.27 23.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.647 ' C ' ' HB3' ' A' ' 69' ' ' ALA . 5.0 mmt -89.95 -1.03 57.9 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.783 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 62' ' ' THR . 15.9 m -123.3 -41.69 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -85.7 -72.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.58 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.49 -20.69 64.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.063 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' ' C ' ' A' ' 65' ' ' MET . . . -102.46 111.14 23.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.685 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.58 51.35 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 30.2 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.63 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.571 HG21 HG12 ' A' ' 92' ' ' ILE . 1.2 mp -80.87 149.73 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.67 168.43 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.2 109.79 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 5.3 mm-40 -91.45 82.24 5.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.537 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.4 m-85 -168.66 117.8 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 7' ' ' LEU . 2.9 t0 -65.65 -44.82 85.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.898 0.38 . . . . 0.0 110.804 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -169.49 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.378 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -44.18 149.45 0.88 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.873 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.8 160.99 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 mtt-85 -95.12 -55.29 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.006 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.608 HG21 ' HB2' ' A' ' 89' ' ' LEU . 10.9 p -140.19 157.55 45.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.184 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -98.79 -25.44 14.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.676 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.44 ' HE3' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -45.87 -29.33 1.34 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.452 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -176.28 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.38 25.72 6.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -160.73 -24.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.13 -80.27 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.608 ' HB2' HG21 ' A' ' 82' ' ' THR . 4.7 mp -74.09 117.22 15.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.0 159.87 41.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.121 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 36.0 m-85 -103.35 142.17 34.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -120.53 110.92 30.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 91' ' ' TYR . 17.3 m-85 -113.69 71.73 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.183 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB2' HD11 ' A' ' 92' ' ' ILE . . . -79.58 101.28 8.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.059 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 67.37 35.06 4.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.54 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 35.8 83.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.04 157.27 16.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.829 0.347 . . . . 0.0 111.119 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.34 84.08 2.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.539 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 30.1 m -60.97 -47.24 94.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.273 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.483 ' N ' HG23 ' A' ' 99' ' ' VAL . 3.3 t30 -49.19 -24.1 1.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.506 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -91.31 -63.12 1.3 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.15 -15.73 30.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 109' ' ' ALA . 4.9 tt -99.91 -49.04 4.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 109' ' ' ALA . 22.9 t -90.12 -62.26 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -58.65 -24.53 61.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.692 0.282 . . . . 0.0 111.227 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -70.19 -17.67 63.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.342 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.707 ' C ' HD12 ' A' ' 108' ' ' LEU . . . 97.32 47.17 2.24 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.474 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.707 HD12 ' C ' ' A' ' 107' ' ' GLY . 5.8 mp -153.22 34.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.805 ' O ' HG13 ' A' ' 104' ' ' VAL . . . 167.7 42.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.767 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.789 179.971 . . . . . . . . 0 0 . 1 stop_ save_